[{"title":"European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia","googleId":"14eQbpNLPqMJ","googleLink":"https://www.nature.com/articles/s41375-020-0776-2","googleCitationCount":144,"googleAuthor":"","doi":"10.1038/s41375-020-0776-2","elsevierAuthor":"Hochhaus A.","publicationName":"Leukemia","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"April 2020","elsevierCitationCount":"79"},{"title":"COVID-19 in persons with haematological cancers","googleId":"HqIZ4mImQXQJ","googleLink":"https://www.nature.com/articles/s41375-020-0836-7","googleCitationCount":164,"googleAuthor":"","doi":"10.1038/s41375-020-0836-7","elsevierAuthor":"He W.","publicationName":"Leukemia","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"118"},{"title":"Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis","googleId":"FQLTrJQtUikJ","googleLink":"https://www.nature.com/articles/s41375-020-0848-3","googleCitationCount":137,"googleAuthor":"RP Gale","doi":"10.1038/s41375-020-0848-3","elsevierAuthor":"Li H.","publicationName":"Leukemia","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"67"},{"title":"The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19 with severe systemic hyperinflammation","googleId":"-wodUl9I358J","googleLink":"https://www.nature.com/articles/s41375-020-0891-0","googleCitationCount":82,"googleAuthor":"","doi":"10.1038/s41375-020-0891-0","elsevierAuthor":"La Rosée F.","publicationName":"Leukemia","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"49"},{"title":"Management of patients with multiple myeloma in the era of COVID-19 pandemic: a consensus paper from the European Myeloma Network (EMN)","googleId":"9vQLANf7KOEJ","googleLink":"https://www.nature.com/articles/s41375-020-0876-z","googleCitationCount":44,"googleAuthor":"E Terpos","doi":"10.1038/s41375-020-0876-z","elsevierAuthor":"Terpos E.","publicationName":"Leukemia","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"28"},{"title":"Long-term efficacy and safety of first-line ibrutinib treatment for patients with CLL/SLL: 5 years of follow-up from the phase 3 RESONATE-2 study","googleId":"CckrBxQOETwJ","googleLink":"https://www.nature.com/articles/s41375-019-0602-x","googleCitationCount":86,"googleAuthor":"JA Burger","doi":"10.1038/s41375-019-0602-x","elsevierAuthor":"Burger J.A.","publicationName":"Leukemia","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"43"},{"title":"B-cell maturation antigen (BCMA) in multiple myeloma: rationale for targeting and current therapeutic approaches","googleId":"taagBS5icycJ","googleLink":"https://www.nature.com/articles/s41375-020-0734-z","googleCitationCount":44,"googleAuthor":"SZ Usmani","doi":"10.1038/s41375-020-0734-z","elsevierAuthor":"Shah N.","publicationName":"Leukemia","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"April 2020","elsevierCitationCount":"25"},{"title":"Anti-BCMA CAR T-cell therapy in multiple myeloma: can we do better?","googleId":"aXG5pwMiDaAJ","googleLink":"https://www.nature.com/articles/s41375-019-0669-4","googleCitationCount":47,"googleAuthor":"M D'Agostino","doi":"10.1038/s41375-019-0669-4","elsevierAuthor":"D’Agostino M.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"1 January 2020","elsevierCitationCount":"31"},{"title":"Frequently asked questions regarding SARS-CoV-2 in cancer patients—recommendations for clinicians caring for patients with malignant diseases","googleId":"fK6xOMDLqAUJ","googleLink":"https://www.nature.com/articles/s41375-020-0832-y","googleCitationCount":32,"googleAuthor":"O Cornely","doi":"10.1038/s41375-020-0832-y","elsevierAuthor":"von Lilienfeld-Toal M.","publicationName":"Leukemia","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"23"},{"title":"SARS-CoV-2 infection and overactivation of Nlrp3 inflammasome as a trigger of cytokine “storm” and risk factor for damage of hematopoietic stem cells","googleId":"w4lSH6Pe9rgJ","googleLink":"https://www.nature.com/articles/s41375-020-0887-9","googleCitationCount":47,"googleAuthor":"","doi":"10.1038/s41375-020-0887-9","elsevierAuthor":"Ratajczak M.Z.","publicationName":"Leukemia","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"31"},{"title":"Daratumumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: extended follow-up of POLLUX, a randomized, open-label …","googleId":"7fgflXjP3wAJ","googleLink":"https://www.nature.com/articles/s41375-020-0711-6","googleCitationCount":33,"googleAuthor":"NJ Bahlis","doi":"10.1038/s41375-020-0711-6","elsevierAuthor":"Bahlis N.J.","publicationName":"Leukemia","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"23"},{"title":"COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL …","googleId":"WCJUEQjBa6kJ","googleLink":"https://www.nature.com/articles/s41375-020-0959-x","googleCitationCount":36,"googleAuthor":"GM Rigolin","doi":"10.1038/s41375-020-0959-x","elsevierAuthor":"Scarfò L.","publicationName":"Leukemia","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"21"},{"title":"COVID-19 in persons with chronic myeloid leukaemia","googleId":"SbGv6Lrn1oUJ","googleLink":"https://www.nature.com/articles/s41375-020-0853-6?fbclid=IwAR2_rED78SaYkxJcVbA9eF5btw_U5kDWbeypNOCwn2rqnmv9Q-YwUJ9372I","googleCitationCount":35,"googleAuthor":"RP Gale","doi":"10.1038/s41375-020-0853-6","elsevierAuthor":"Li W.","publicationName":"Leukemia","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"23"},{"title":"A novel BCMA PBD-ADC with ATM/ATR/WEE1 inhibitors or bortezomib induce synergistic lethality in multiple myeloma","googleId":"Qt3igbtVawAJ","googleLink":"https://www.nature.com/articles/s41375-020-0745-9.pdf?origin=ppub","googleCitationCount":17,"googleAuthor":"L Xing","doi":"10.1038/s41375-020-0745-9","elsevierAuthor":"Xing L.","publicationName":"Leukemia","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"16"},{"title":"The Nlrp3 inflammasome as a “rising star” in studies of normal and malignant hematopoiesis","googleId":"4GWHILEIU1oJ","googleLink":"https://www.nature.com/articles/s41375-020-0827-8","googleCitationCount":18,"googleAuthor":"K Bujko","doi":"10.1038/s41375-020-0827-8","elsevierAuthor":"Ratajczak M.Z.","publicationName":"Leukemia","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"17"},{"title":"FLT3 inhibitors in acute myeloid leukemia: ten frequently asked questions","googleId":"bq7EGhE-mAMJ","googleLink":"https://www.nature.com/articles/s41375-019-0694-3","googleCitationCount":29,"googleAuthor":"A Bazarbachi","doi":"10.1038/s41375-019-0694-3","elsevierAuthor":"Antar A.I.","publicationName":"Leukemia","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"22"},{"title":"Response to “COVID-19 in persons with haematological cancers”","googleId":"A9jclJ9eDUMJ","googleLink":"https://www.nature.com/articles/s41375-020-0914-x","googleCitationCount":25,"googleAuthor":"","doi":"10.1038/s41375-020-0914-x","elsevierAuthor":"Hatzl S.","publicationName":"Leukemia","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"2"},{"title":"Risk factors for death in 1859 subjects with COVID-19","googleId":"OaA66naHt5EJ","googleLink":"https://www.nature.com/articles/s41375-020-0911-0","googleCitationCount":40,"googleAuthor":"","doi":"10.1038/s41375-020-0911-0","elsevierAuthor":"Chen L.","publicationName":"Leukemia","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"21"},{"title":"A simplified frailty scale predicts outcomes in transplant-ineligible patients with newly diagnosed multiple myeloma treated in the FIRST (MM-020) trial","googleId":"Nfp9VLq7qAYJ","googleLink":"https://www.nature.com/articles/s41375-019-0539-0","googleCitationCount":33,"googleAuthor":"MA Dimopoulos","doi":"10.1038/s41375-019-0539-0","elsevierAuthor":"Facon T.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"1 January 2020","elsevierCitationCount":"26"},{"title":"Validation and refinement of the revised 2017 European LeukemiaNet genetic risk stratification of acute myeloid leukemia","googleId":"wcsnfZYFFGIJ","googleLink":"https://www.nature.com/articles/s41375-020-0806-0.pdf?origin=ppub","googleCitationCount":19,"googleAuthor":"T Herold"},{"title":"Early treatment with FCR versus watch and wait in patients with stage Binet A high-risk chronic lymphocytic leukemia (CLL): a randomized phase 3 trial","googleId":"ctBkcBw2C20J","googleLink":"https://www.nature.com/articles/s41375-020-0747-7","googleCitationCount":22,"googleAuthor":"","doi":"10.1038/s41375-020-0747-7","elsevierAuthor":"Herling C.D.","publicationName":"Leukemia","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"10"},{"title":"Targeting an adenosine-mediated “don't eat me signal” augments anti-lymphoma immunity by anti-CD20 monoclonal antibody","googleId":"sQUqyCFI4y4J","googleLink":"https://www.nature.com/articles/s41375-020-0811-3","googleCitationCount":10,"googleAuthor":"K Nakamura","doi":"10.1038/s41375-020-0811-3","elsevierAuthor":"Nakamura K.","publicationName":"Leukemia","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"8"},{"title":"MYC dysregulation in the progression of multiple myeloma","googleId":"Hqfigwq-6goJ","googleLink":"https://www.nature.com/articles/s41375-019-0543-4","googleCitationCount":37,"googleAuthor":"CK Stein","doi":"10.1038/s41375-019-0543-4","elsevierAuthor":"Misund K.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"1 January 2020","elsevierCitationCount":"14"},{"title":"Daratumumab monotherapy for patients with intermediate-risk or high-risk smoldering multiple myeloma: a randomized, open-label, multicenter, phase 2 …","googleId":"aHSWstfkt_0J","googleLink":"https://www.nature.com/articles/s41375-020-0718-z","googleCitationCount":18,"googleAuthor":"A Spencer","doi":"10.1038/s41375-020-0718-z","elsevierAuthor":"Landgren C.O.","publicationName":"Leukemia","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"15"},{"title":"A phase 1b study of dual PD-1 and CTLA-4 or KIR blockade in patients with relapsed/refractory lymphoid malignancies","googleId":"A_5FXuIp4tMJ","googleLink":"https://www.nature.com/articles/s41375-020-0939-1","googleCitationCount":14,"googleAuthor":"","doi":"10.1038/s41375-020-0939-1","elsevierAuthor":"Armand P.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"13"},{"title":"Integrated safety profile of selinexor in multiple myeloma: experience from 437 patients enrolled in clinical trials","googleId":"3zvr2zDcKgsJ","googleLink":"https://www.nature.com/articles/s41375-020-0756-6.pdf?origin=ppub","googleCitationCount":18,"googleAuthor":"M Gavriatopoulou"},{"title":"Anti-human CD117 CAR T-cells efficiently eliminate healthy and malignant CD117-expressing hematopoietic cells","googleId":"TjGMya1q4PwJ","googleLink":"https://www.nature.com/articles/s41375-020-0818-9","googleCitationCount":11,"googleAuthor":"R Myburgh","doi":"10.1038/s41375-020-0818-9","elsevierAuthor":"Myburgh R.","publicationName":"Leukemia","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"7"},{"title":"Treatment and unmet needs in steroid-refractory acute graft-versus-host disease","googleId":"KRP6SWl8NsQJ","googleLink":"https://www.nature.com/articles/s41375-020-0804-2","googleCitationCount":13,"googleAuthor":"","doi":"10.1038/s41375-020-0804-2","elsevierAuthor":"Malard F.","publicationName":"Leukemia","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"5"},{"title":"Recent drug approvals for newly diagnosed acute myeloid leukemia: gifts or a Trojan horse?","googleId":"ZEL8GMVAdlkJ","googleLink":"https://www.nature.com/articles/s41375-019-0704-5","googleCitationCount":21,"googleAuthor":"A Emadi","doi":"10.1038/s41375-019-0704-5","elsevierAuthor":"Estey E.","publicationName":"Leukemia","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"17"},{"title":"Compassionate use of JAK1/2 inhibitor ruxolitinib for severe COVID-19: a prospective observational study","googleId":"a8jRpOmIwgIJ","googleLink":"https://www.nature.com/articles/s41375-020-01018-y","googleCitationCount":9,"googleAuthor":"","doi":"10.1038/s41375-020-01018-y","elsevierAuthor":"Vannucchi A.M.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"8"},{"title":"CLL and COVID-19 at the Hospital Clinic of Barcelona: an interim report","googleId":"cg63JsuxxSUJ","googleLink":"https://www.nature.com/articles/s41375-020-0870-5","googleCitationCount":20,"googleAuthor":"J Delgado","doi":"10.1038/s41375-020-0870-5","elsevierAuthor":"Baumann T.","publicationName":"Leukemia","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"12"},{"title":"Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab","googleId":"diby46APo60J","googleLink":"https://www.nature.com/articles/s41375-020-0840-y","googleCitationCount":12,"googleAuthor":"S Doose","doi":"10.1038/s41375-020-0840-y","elsevierAuthor":"García-Guerrero E.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"January 2021","elsevierCitationCount":"3"},{"title":"Hematological features of persons with COVID-19","googleId":"6rMTXUHbuUsJ","googleLink":"https://www.nature.com/articles/s41375-020-0910-1","googleCitationCount":29,"googleAuthor":"Q Li","doi":"10.1038/s41375-020-0910-1","elsevierAuthor":"Li Q.","publicationName":"Leukemia","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"14"},{"title":"Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era …","googleId":"zWArVkeskQoJ","googleLink":"https://www.nature.com/articles/s41375-020-0791-3","googleCitationCount":12,"googleAuthor":"Y Yang","doi":"10.1038/s41375-020-0791-3","elsevierAuthor":"Chen S.Y.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"January 2021","elsevierCitationCount":"4"},{"title":"Loss of glucocorticoid receptor expression mediates in vivo dexamethasone resistance in T-cell acute lymphoblastic leukemia","googleId":"5wdy7pKhG2YJ","googleLink":"https://www.nature.com/articles/s41375-020-0748-6","googleCitationCount":9,"googleAuthor":"H Yan","doi":"10.1038/s41375-020-0748-6","elsevierAuthor":"Wandler A.M.","publicationName":"Leukemia","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"3"},{"title":"Preclinical evaluation of CD8+ anti-BCMA mRNA CAR T cells for treatment of multiple myeloma","googleId":"Bww5nEdweQIJ","googleLink":"https://www.nature.com/articles/s41375-020-0951-5?elqTrackId=24f50fff33834a4d80fa943488666baa","googleCitationCount":7,"googleAuthor":"L Lin","doi":"10.1038/s41375-020-0951-5","elsevierAuthor":"Lin L.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"4"},{"title":"Loss of KDM6A confers drug resistance in acute myeloid leukemia","googleId":"UIoyPqc_szwJ","googleLink":"https://www.nature.com/articles/s41375-019-0497-6","googleCitationCount":26,"googleAuthor":"","doi":"10.1038/s41375-019-0497-6","elsevierAuthor":"Stief S.M.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"1 January 2020","elsevierCitationCount":"15"},{"title":"Iberdomide (CC-220) is a potent cereblon E3 ligase modulator with antitumor and immunostimulatory activities in lenalidomide-and pomalidomide-resistant …","googleId":"_gkKsKQy-xQJ","googleLink":"https://www.nature.com/articles/s41375-019-0620-8","googleCitationCount":22,"googleAuthor":"","doi":"10.1038/s41375-019-0620-8","elsevierAuthor":"Bjorklund C.C.","publicationName":"Leukemia","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"April 2020","elsevierCitationCount":"21"},{"title":"CAR T-cells that target acute B-lineage leukemia irrespective of CD19 expression","googleId":"4L8-pj1FVLIJ","googleLink":"https://www.nature.com/articles/s41375-020-0792-2","googleCitationCount":11,"googleAuthor":"SK Joseph","doi":"10.1038/s41375-020-0792-2","elsevierAuthor":"Fousek K.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"January 2021","elsevierCitationCount":"5"},{"title":"Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial","googleId":"3UJwE2ivWlIJ","googleLink":"https://www.nature.com/articles/s41375-020-0838-5","googleCitationCount":10,"googleAuthor":"","doi":"10.1038/s41375-020-0838-5","elsevierAuthor":"Wulf G.G.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"January 2021","elsevierCitationCount":"1"},{"title":"MDM2 inhibition: An important step forward in cancer therapy","googleId":"Obm_ldg-24MJ","googleLink":"https://www.nature.com/articles/s41375-020-0949-z","googleCitationCount":9,"googleAuthor":"G Martinelli","doi":"10.1038/s41375-020-0949-z","elsevierAuthor":"Konopleva M.","publicationName":"Leukemia","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"1 November 2020","elsevierCitationCount":"6"},{"title":"Multiple myeloma and COVID-19","googleId":"-_J-2vbCoaMJ","googleLink":"https://www.nature.com/articles/s41375-020-0879-9.pdf?origin=ppub","googleCitationCount":19,"googleAuthor":"B Dhakal"},{"title":"The relative importance of factors predicting outcome for myeloma patients at different ages: results from 3894 patients in the Myeloma XI trial","googleId":"guDjTu2rA7QJ","googleLink":"https://www.nature.com/articles/s41375-019-0595-5","googleCitationCount":17,"googleAuthor":"M Kaiser","doi":"10.1038/s41375-019-0595-5","elsevierAuthor":"Pawlyn C.","publicationName":"Leukemia","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"1 February 2020","elsevierCitationCount":"15"},{"title":"A dose-finding Phase 2 study of single agent isatuximab (anti-CD38 mAb) in relapsed/refractory multiple myeloma","googleId":"YjA3Wo4xQkUJ","googleLink":"https://www.nature.com/articles/s41375-020-0857-2","googleCitationCount":13,"googleAuthor":"J Mikhael","doi":"10.1038/s41375-020-0857-2","elsevierAuthor":"Mikhael J.","publicationName":"Leukemia","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"6"},{"title":"SHMT inhibition is effective and synergizes with methotrexate in T-cell acute lymphoblastic leukemia","googleId":"CPQctCbM_7wJ","googleLink":"https://www.nature.com/articles/s41375-020-0845-6.pdf?origin=ppub","googleCitationCount":8,"googleAuthor":"JC García-Cañaveras","doi":"10.1038/s41375-020-0845-6","elsevierAuthor":"García-Cañaveras J.C.","publicationName":"Leukemia","elsevierCoverDate":"2021-02-01","elsevierCoverDisplayDate":"February 2021","elsevierCitationCount":"4"},{"title":"Long non-coding RNA NEAT1 targeting impairs the DNA repair machinery and triggers anti-tumor activity in multiple myeloma","googleId":"7jd_eOSQ6rAJ","googleLink":"https://www.nature.com/articles/s41375-019-0542-5","googleCitationCount":22,"googleAuthor":"","doi":"10.1038/s41375-019-0542-5","elsevierAuthor":"Taiana E.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"1 January 2020","elsevierCitationCount":"17"},{"title":"Extracellular microvesicles/exosomes: discovery, disbelief, acceptance, and the future?","googleId":"MG4krqW4tsEJ","googleLink":"https://www.nature.com/articles/s41375-020-01041-z","googleCitationCount":6,"googleAuthor":"","doi":"10.1038/s41375-020-01041-z","elsevierAuthor":"Ratajczak M.Z.","publicationName":"Leukemia","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"3"},{"title":"Response-adapted lenalidomide maintenance in newly diagnosed myeloma: results from the phase III GMMG-MM5 trial","googleId":"9oe5-AsjhrcJ","googleLink":"https://www.nature.com/articles/s41375-020-0724-1","googleCitationCount":13,"googleAuthor":"EK Mai","doi":"10.1038/s41375-020-0724-1","elsevierAuthor":"Goldschmidt H.","publicationName":"Leukemia","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"6"},{"title":"Extramedullary multiple myeloma","googleId":"OsFHB52PT1EJ","googleLink":"https://www.nature.com/articles/s41375-019-0660-0","googleCitationCount":17,"googleAuthor":"DM Foureau","doi":"10.1038/s41375-019-0660-0","elsevierAuthor":"Mesas A.E.","publicationName":"PLoS ONE","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"November 2020","elsevierCitationCount":"7"},{"title":"Richter transformation in chronic lymphocytic leukemia (CLL)—a pooled analysis of German CLL Study Group (GCLLSG) front line treatment trials","googleId":"Oq73dMQAOf8J","googleLink":"https://www.nature.com/articles/s41375-020-0797-x","googleCitationCount":9,"googleAuthor":"O Al-Sawaf","doi":"10.1038/s41375-020-0797-x","elsevierAuthor":"Al-Sawaf O.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"January 2021","elsevierCitationCount":"4"},{"title":"Immunomodulatory drugs activate NK cells via both Zap-70 and cereblon-dependent pathways","googleId":"2dbnKkhFz9IJ","googleLink":"https://www.nature.com/articles/s41375-020-0809-x","googleCitationCount":8,"googleAuthor":"J Liu","doi":"10.1038/s41375-020-0809-x","elsevierAuthor":"Hideshima T.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"January 2021","elsevierCitationCount":"5"},{"title":"H3K79me2/3 controls enhancer–promoter interactions and activation of the pan-cancer stem cell marker PROM1/CD133 in MLL-AF4 leukemia cells","googleId":"GuWEsJG_XGkJ","googleLink":"https://www.nature.com/articles/s41375-020-0808-y","googleCitationCount":8,"googleAuthor":"L Godfrey","doi":"10.1038/s41375-020-0808-y","elsevierAuthor":"Godfrey L.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"January 2021","elsevierCitationCount":"3"},{"title":"Single-agent activity of phosphatidylinositol 3-kinase inhibition with copanlisib in patients with molecularly defined relapsed or refractory diffuse large B-cell …","googleId":"OyJJuph1Ar4J","googleLink":"https://www.nature.com/articles/s41375-020-0743-y","googleCitationCount":9,"googleAuthor":"E Hawkes","doi":"10.1038/s41375-020-0743-y","elsevierAuthor":"Lenz G.","publicationName":"Leukemia","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"9"},{"title":"Chronic myeloid leukemia management at the time of the COVID-19 pandemic in Italy. A campus CML survey","googleId":"2_asUKbWx-gJ","googleLink":"https://www.nature.com/articles/s41375-020-0904-z","googleCitationCount":15,"googleAuthor":"M Breccia","doi":"10.1038/s41375-020-0904-z","elsevierAuthor":"Breccia M.","publicationName":"Leukemia","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"10"},{"title":"Comprehensive diagnostics of acute myeloid leukemia by whole transcriptome RNA sequencing","googleId":"LchTTML_b9IJ","googleLink":"https://www.nature.com/articles/s41375-020-0762-8.pdf?origin=ppub","googleCitationCount":7,"googleAuthor":"RAL de Groen"},{"title":"Haploidentical vs. unrelated allogeneic stem cell transplantation for acute lymphoblastic leukemia in first complete remission: on behalf of the ALWP of the EBMT","googleId":"aExURNiY69YJ","googleLink":"https://www.nature.com/articles/s41375-019-0544-3","googleCitationCount":20,"googleAuthor":"M Labopin","doi":"10.1038/s41375-019-0544-3","elsevierAuthor":"Shem-Tov N.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"1 January 2020","elsevierCitationCount":"13"},{"title":"Treatment of relapsed or refractory classical Hodgkin lymphoma with the anti-PD-1, tislelizumab: results of a phase 2, single-arm, multicenter study","googleId":"YK6jlRsahCsJ","googleLink":"https://www.nature.com/articles/s41375-019-0545-2","googleCitationCount":22,"googleAuthor":"","doi":"10.1038/s41375-019-0545-2","elsevierAuthor":"Song Y.","publicationName":"Leukemia","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"1 February 2020","elsevierCitationCount":"13"},{"title":"Development of CAR-T cell therapies for multiple myeloma","googleId":"5T2wO-_YdiUJ","googleLink":"https://www.nature.com/articles/s41375-020-0930-x?elqTrackId=f880ef7c73784a40b295e514dfa461eb","googleCitationCount":9,"googleAuthor":"K Riecken","doi":"10.1038/s41375-020-0930-x","elsevierAuthor":"Gagelmann N.","publicationName":"Leukemia","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"8"},{"title":"Soluble SLAMF7 promotes the growth of myeloma cells via homophilic interaction with surface SLAMF7","googleId":"TqoQw2COepsJ","googleLink":"https://www.nature.com/articles/s41375-019-0525-6","googleCitationCount":19,"googleAuthor":"","doi":"10.1038/s41375-019-0525-6","elsevierAuthor":"Kikuchi J.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"1 January 2020","elsevierCitationCount":"13"},{"title":"Transcriptional profiling of circulating tumor cells in multiple myeloma: a new model to understand disease dissemination","googleId":"vnGk2lkuEBUJ","googleLink":"https://www.nature.com/articles/s41375-019-0588-4","googleCitationCount":15,"googleAuthor":"JJ Garcés","doi":"10.1038/s41375-019-0588-4","elsevierAuthor":"Garcés J.J.","publicationName":"Leukemia","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"1 February 2020","elsevierCitationCount":"7"},{"title":"Decitabine-and 5-azacytidine resistance emerges from adaptive responses of the pyrimidine metabolism network","googleId":"CgcO-iT-0YEJ","googleLink":"https://www.nature.com/articles/s41375-020-1003-x","googleCitationCount":6,"googleAuthor":"M Hasipek","doi":"10.1038/s41375-020-1003-x","elsevierAuthor":"Gu X.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"5"},{"title":"Fedratinib, a newly approved treatment for patients with myeloproliferative neoplasm-associated myelofibrosis","googleId":"OPLvJ4re2W4J","googleLink":"https://www.nature.com/articles/s41375-020-0954-2","googleCitationCount":10,"googleAuthor":"","doi":"10.1038/s41375-020-0954-2","elsevierAuthor":"Talpaz M.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"January 2021","elsevierCitationCount":"6"},{"title":"Management of hyperleukocytosis and impact of leukapheresis among patients with acute myeloid leukemia (AML) on short-and long-term clinical outcomes: a large …","googleId":"shvOr-l09gkJ","googleLink":"https://www.nature.com/articles/s41375-020-0783-3","googleCitationCount":9,"googleAuthor":"M Stahl","doi":"10.1038/s41375-020-0783-3","elsevierAuthor":"Stahl M.","publicationName":"Leukemia","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"8"},{"title":"Clinical impact of clonal hematopoiesis in patients with lymphoma undergoing ASCT: a national population-based cohort study","googleId":"CgVGyA9nMcYJ","googleLink":"https://www.nature.com/articles/s41375-020-0795-z","googleCitationCount":9,"googleAuthor":"S Husby","doi":"10.1038/s41375-020-0795-z","elsevierAuthor":"Husby S.","publicationName":"Leukemia","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"7"},{"title":"Advances in understanding of angioimmunoblastic T-cell lymphoma","googleId":"X2fad4iHr28J","googleLink":"https://www.nature.com/articles/s41375-020-0990-y","googleCitationCount":7,"googleAuthor":"","doi":"10.1038/s41375-020-0990-y","elsevierAuthor":"Chiba S.","publicationName":"Leukemia","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"3"},{"title":"Pomalidomide, dexamethasone, and daratumumab in relapsed refractory multiple myeloma after lenalidomide treatment","googleId":"WBeFYvlLki0J","googleLink":"https://www.nature.com/articles/s41375-020-0813-1","googleCitationCount":9,"googleAuthor":"DS Siegel","doi":"10.1038/s41375-020-0813-1","elsevierAuthor":"Siegel D.S.","publicationName":"Leukemia","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"6"},{"title":"Efficacy of third-party chimeric antigen receptor modified peripheral blood natural killer cells for adoptive cell therapy of B-cell precursor acute lymphoblastic leukemia","googleId":"HxVONKrfyrgJ","googleLink":"https://www.nature.com/articles/s41375-019-0613-7","googleCitationCount":18,"googleAuthor":"S Sivori","doi":"10.1038/s41375-019-0613-7","elsevierAuthor":"Quintarelli C.","publicationName":"Leukemia","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"April 2020","elsevierCitationCount":"15"},{"title":"Cytokine IL-36γ improves CAR T-cell functionality and induces endogenous antitumor response","googleId":"OAezZE9rMkgJ","googleLink":"https://www.nature.com/articles/s41375-020-0874-1","googleCitationCount":7,"googleAuthor":"","doi":"10.1038/s41375-020-0874-1","elsevierAuthor":"Li X.","publicationName":"Leukemia","elsevierCoverDate":"2021-02-01","elsevierCoverDisplayDate":"February 2021","elsevierCitationCount":"2"},{"title":"Clinical, molecular, and prognostic correlates of number, type, and functional localization of TET2 mutations in chronic myelomonocytic leukemia (CMML)—a study of …","googleId":"QrtCei_vOqMJ","googleLink":"https://www.nature.com/articles/s41375-019-0690-7","googleCitationCount":14,"googleAuthor":"G Coltro","doi":"10.1038/s41375-019-0690-7","elsevierAuthor":"Coltro G.","publicationName":"Leukemia","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"11"},{"title":"Reply to “COVID-19 in persons with haematological cancers”: a focus on myeloid neoplasms and risk factors for mortality","googleId":"Ngpgl0K3kgAJ","googleLink":"https://www.nature.com/articles/s41375-020-0877-y","googleCitationCount":12,"googleAuthor":"B Fattizzo","doi":"10.1038/s41375-020-0877-y","elsevierAuthor":"Fattizzo B.","publicationName":"Leukemia","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"8"},{"title":"Additional gene mutations may refine the 2017 European LeukemiaNet classification in adult patients with de novo acute myeloid leukemia aged< 60 years","googleId":"FBd-oe8EBTEJ","googleLink":"https://www.nature.com/articles/s41375-020-0872-3","googleCitationCount":9,"googleAuthor":"A Mims","doi":"10.1038/s41375-020-0872-3","elsevierAuthor":"Eisfeld A.K.","publicationName":"Leukemia","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"5"},{"title":"Defining the vulnerable patient with myeloma—a frailty position paper of the European Myeloma Network","googleId":"AS1-Br-8TlcJ","googleLink":"https://www.nature.com/articles/s41375-020-0918-6","googleCitationCount":5,"googleAuthor":"G Cook","doi":"10.1038/s41375-020-0918-6","elsevierAuthor":"Cook G.","publicationName":"Leukemia","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"3"},{"title":"Safety and efficacy of talacotuzumab plus decitabine or decitabine alone in patients with acute myeloid leukemia not eligible for chemotherapy: results from a …","googleId":"CtXfZ6CBGo0J","googleLink":"https://www.nature.com/articles/s41375-020-0773-5","googleCitationCount":8,"googleAuthor":"M Subklewe","doi":"10.1038/s41375-020-0773-5","elsevierAuthor":"Montesinos P.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"January 2021","elsevierCitationCount":"4"},{"title":"Specific, targetable interactions with the microenvironment influence imatinib-resistant chronic myeloid leukemia","googleId":"T9pzKc7ddzkJ","googleLink":"https://www.nature.com/articles/s41375-020-0866-1","googleCitationCount":6,"googleAuthor":"","doi":"10.1038/s41375-020-0866-1","elsevierAuthor":"Kumar R.","publicationName":"Leukemia","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"4"},{"title":"Clonal myelopoiesis in the UK Biobank cohort: ASXL1 mutations are strongly associated with smoking","googleId":"fLl-yIimKOcJ","googleLink":"https://www.nature.com/articles/s41375-020-0896-8","googleCitationCount":5,"googleAuthor":"AAZ Dawoud","doi":"10.1038/s41375-020-0896-8","elsevierAuthor":"Dawoud A.A.Z.","publicationName":"Leukemia","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"5"},{"title":"RNA-binding protein IGF2BP1 maintains leukemia stem cell properties by regulating HOXB4, MYB, and ALDH1A1","googleId":"ONEkGYbOplYJ","googleLink":"https://www.nature.com/articles/s41375-019-0656-9","googleCitationCount":14,"googleAuthor":"IA Elcheva","doi":"10.1038/s41375-019-0656-9","elsevierAuthor":"Elcheva I.A.","publicationName":"Leukemia","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"10"},{"title":"A proof of concept phase I/II pilot trial of LSD1 inhibition by tranylcypromine combined with ATRA in refractory/relapsed AML patients not eligible for intensive …","googleId":"G4l7Bk6l0n8J","googleLink":"https://www.nature.com/articles/s41375-020-0892-z","googleCitationCount":8,"googleAuthor":"RF Schlenk","doi":"10.1038/s41375-020-0892-z","elsevierAuthor":"Wass M.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"5"},{"title":"A randomised phase II trial of hydroxychloroquine and imatinib versus imatinib alone for patients with chronic myeloid leukaemia in major cytogenetic …","googleId":"K5sz65qHRB0J","googleLink":"https://www.nature.com/articles/s41375-019-0700-9","googleCitationCount":16,"googleAuthor":"","doi":"10.1038/s41375-019-0700-9","elsevierAuthor":"Horne G.A.","publicationName":"Leukemia","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"11"},{"title":"Targeting nuclear import and export in hematological malignancies","googleId":"H7clyzvTOZQJ","googleLink":"https://www.nature.com/articles/s41375-020-0958-y","googleCitationCount":5,"googleAuthor":"","doi":"10.1038/s41375-020-0958-y","elsevierAuthor":"Nachmias B.","publicationName":"Leukemia","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"1 November 2020","elsevierCitationCount":"4"},{"title":"Impact of Covid-19 on the treatment of acute myeloid leukemia","googleId":"1pvqnhGQlbQJ","googleLink":"https://www.nature.com/articles/s41375-020-0925-7","googleCitationCount":10,"googleAuthor":"","doi":"10.1038/s41375-020-0925-7","elsevierAuthor":"Ferrara F.","publicationName":"Leukemia","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"8"},{"title":"Targeting NAD immunometabolism limits severe graft-versus-host disease and has potent antileukemic activity","googleId":"zzWX10wfxOcJ","googleLink":"https://www.nature.com/articles/s41375-020-0709-0","googleCitationCount":5,"googleAuthor":"RR Gerner","doi":"10.1038/s41375-020-0709-0","elsevierAuthor":"Gerner R.R.","publicationName":"Leukemia","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"4"},{"title":"Leukemia-induced dysfunctional TIM-3+ CD4+ bone marrow T cells increase risk of relapse in pediatric B-precursor ALL patients","googleId":"6d6EoCSASNUJ","googleLink":"https://www.nature.com/articles/s41375-020-0793-1","googleCitationCount":6,"googleAuthor":"F Blaeschke","doi":"10.1038/s41375-020-0793-1","elsevierAuthor":"Blaeschke F.","publicationName":"Leukemia","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"6"},{"title":"T-cells in chronic lymphocytic leukemia: Guardians or drivers of disease?","googleId":"2s2UOMjT-8IJ","googleLink":"https://www.nature.com/articles/s41375-020-0873-2","googleCitationCount":7,"googleAuthor":"","doi":"10.1038/s41375-020-0873-2","elsevierAuthor":"Roessner P.M.","publicationName":"Leukemia","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"5"},{"title":"Expert opinion—management of chronic myeloid leukemia after resistance to second-generation tyrosine kinase inhibitors","googleId":"GFCUF7_xjxQJ","googleLink":"https://www.nature.com/articles/s41375-020-0842-9","googleCitationCount":8,"googleAuthor":"M Breccia","doi":"10.1038/s41375-020-0842-9","elsevierAuthor":"Hochhaus A.","publicationName":"Leukemia","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"5"},{"title":"Haploidentical transplantation might have superior graft-versus-leukemia effect than HLA-matched sibling transplantation for high-risk acute myeloid leukemia in first …","googleId":"Ct5BZPOBLksJ","googleLink":"https://www.nature.com/articles/s41375-019-0686-3","googleCitationCount":15,"googleAuthor":"","doi":"10.1038/s41375-019-0686-3","elsevierAuthor":"Yu S.","publicationName":"Leukemia","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"10"},{"title":"Targeting of inflammatory pathways with R2CHOP in high-risk DLBCL","googleId":"Wme1J_pRuHwJ","googleLink":"https://www.nature.com/articles/s41375-020-0766-4","googleCitationCount":5,"googleAuthor":"K Wenzl","doi":"10.1038/s41375-020-0766-4","elsevierAuthor":"Hartert K.T.","publicationName":"Leukemia","elsevierCoverDate":"2021-02-01","elsevierCoverDisplayDate":"February 2021","elsevierCitationCount":"1"},{"title":"Contribution of CTCF binding to transcriptional activity at the HOXA locus in NPM1-mutant AML cells","googleId":"jdjrNFdw9tkJ","googleLink":"https://www.nature.com/articles/s41375-020-0856-3.pdf?origin=ppub","googleCitationCount":7,"googleAuthor":"R Ghasemi"},{"title":"Prognostic impact of RAS-pathway mutations in patients with myelofibrosis","googleId":"jIZmwk9Q47EJ","googleLink":"https://www.nature.com/articles/s41375-019-0603-9","googleCitationCount":17,"googleAuthor":"FPS Santos","doi":"10.1038/s41375-019-0603-9","elsevierAuthor":"Santos F.P.S.","publicationName":"Leukemia","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"10"},{"title":"A phase 1/2 study of ruxolitinib and decitabine in patients with post-myeloproliferative neoplasm acute myeloid leukemia","googleId":"lfcyewlG1dAJ","googleLink":"https://www.nature.com/articles/s41375-020-0778-0","googleCitationCount":9,"googleAuthor":"","doi":"10.1038/s41375-020-0778-0","elsevierAuthor":"Bose P.","publicationName":"Leukemia","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"5"},{"title":"PD-L1/L2 protein levels rapidly increase on monocytes via trogocytosis from tumor cells in classical Hodgkin lymphoma","googleId":"P2xyGSnEOXQJ","googleLink":"https://www.nature.com/articles/s41375-020-0737-9","googleCitationCount":5,"googleAuthor":"J Carreras","doi":"10.1038/s41375-020-0737-9","elsevierAuthor":"Kawashima M.","publicationName":"Leukemia","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"4"},{"title":"Systemic amyloidosis: moving into the spotlight","googleId":"NwVjqKkTsuwJ","googleLink":"https://www.nature.com/articles/s41375-020-0802-4","googleCitationCount":5,"googleAuthor":"","doi":"10.1038/s41375-020-0802-4","elsevierAuthor":"Cohen O.C.","publicationName":"Leukemia","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"3"},{"title":"Overcoming microenvironment-mediated protection from ATRA using CYP26-resistant retinoids","googleId":"BXmpaKa0yxoJ","googleLink":"https://www.nature.com/articles/s41375-020-0790-4","googleCitationCount":7,"googleAuthor":"","doi":"10.1038/s41375-020-0790-4","elsevierAuthor":"Hernandez D.","publicationName":"Leukemia","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"1 November 2020","elsevierCitationCount":"6"},{"title":"Targeting histone deacetylase 3 (HDAC3) in the bone marrow microenvironment inhibits multiple myeloma proliferation by modulating exosomes and IL-6 …","googleId":"KUyv1uMrRGgJ","googleLink":"https://www.nature.com/articles/s41375-019-0493-x","googleCitationCount":16,"googleAuthor":"M Ho","doi":"10.1038/s41375-019-0493-x","elsevierAuthor":"Ho M.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"1 January 2020","elsevierCitationCount":"11"},{"title":"The clinical mutatome of core binding factor leukemia","googleId":"2GfHwrRUpr8J","googleLink":"https://www.nature.com/articles/s41375-019-0697-0","googleCitationCount":15,"googleAuthor":"SA Bamopoulos","doi":"10.1038/s41375-019-0697-0","elsevierAuthor":"Opatz S.","publicationName":"Leukemia","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"10"},{"title":"Determinants of survival in myelofibrosis patients undergoing allogeneic hematopoietic cell transplantation","googleId":"rLncvHrmEm0J","googleLink":"https://www.nature.com/articles/s41375-020-0815-z","googleCitationCount":5,"googleAuthor":"N Kröger","doi":"10.1038/s41375-020-0815-z","elsevierAuthor":"Hernández-Boluda J.C.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"January 2021","elsevierCitationCount":"4"},{"title":"Low-frequency TP53 hotspot mutation contributes to chemoresistance through clonal expansion in acute myeloid leukemia","googleId":"TeLsYMrngggJ","googleLink":"https://www.nature.com/articles/s41375-020-0710-7","googleCitationCount":5,"googleAuthor":"B Yan","doi":"10.1038/s41375-020-0710-7","elsevierAuthor":"Yan B.","publicationName":"Leukemia","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"4"},{"title":"Isatuximab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma patients with renal impairment: ICARIA-MM subgroup analysis","googleId":"glVUX_Q5aB8J","googleLink":"https://www.nature.com/articles/s41375-020-0868-z","googleCitationCount":5,"googleAuthor":"MA Dimopoulos","doi":"10.1038/s41375-020-0868-z","elsevierAuthor":"Dimopoulos M.A.","publicationName":"Leukemia","elsevierCoverDate":"2021-02-01","elsevierCoverDisplayDate":"February 2021","elsevierCitationCount":"3"},{"title":"Circ-RPL15: a plasma circular RNA as novel oncogenic driver to promote progression of chronic lymphocytic leukemia","googleId":"JytVpmXHy9EJ","googleLink":"https://www.nature.com/articles/s41375-019-0594-6","googleCitationCount":15,"googleAuthor":"","doi":"10.1038/s41375-019-0594-6","elsevierAuthor":"Wu Z.","publicationName":"Leukemia","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"16"},{"title":"Prognostic model for newly diagnosed CLL patients in Binet stage a: results of the multicenter, prospective CLL1 trial of the German CLL study group","googleId":"qlVGTjBm5UsJ","googleLink":"https://www.nature.com/articles/s41375-020-0727-y","googleCitationCount":10,"googleAuthor":"","doi":"10.1038/s41375-020-0727-y","elsevierAuthor":"Hoechstetter M.A.","publicationName":"Leukemia","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"April 2020","elsevierCitationCount":"7"},{"title":"Knock-in of murine Calr del52 induces essential thrombocythemia with slow-rising dominance in mice and reveals key role of Calr exon 9 in cardiac development","googleId":"fbdL2fWyGIcJ","googleLink":"https://www.nature.com/articles/s41375-019-0538-1","googleCitationCount":14,"googleAuthor":"T Balligand","doi":"10.1038/s41375-019-0538-1","elsevierAuthor":"Balligand T.","publicationName":"Leukemia","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"1 February 2020","elsevierCitationCount":"10"},{"title":"Daratumumab for eradication of minimal residual disease in high-risk advanced relapse of T-cell/CD19/CD22-negative acute lymphoblastic leukemia","googleId":"1F-8F9EflEoJ","googleLink":"https://www.nature.com/articles/s41375-019-0548-z","googleCitationCount":15,"googleAuthor":"Y Ofran","doi":"10.1038/s41375-019-0548-z","elsevierAuthor":"Ofran Y.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"1 January 2020","elsevierCitationCount":"9"},{"title":"High-risk additional chromosomal abnormalities at low blast counts herald death by CML","googleId":"fkTrZGBFENQJ","googleLink":"https://www.nature.com/articles/s41375-020-0826-9","googleCitationCount":5,"googleAuthor":"","doi":"10.1038/s41375-020-0826-9","elsevierAuthor":"Hehlmann R.","publicationName":"Leukemia","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"0"},{"title":"Bone marrow mesenchymal stromal cells from acute myelogenous leukemia patients demonstrate adipogenic differentiation propensity with implications for …","googleId":"ZPNuaFDbbAIJ","googleLink":"https://www.nature.com/articles/s41375-019-0568-8","googleCitationCount":15,"googleAuthor":"HR McMurray","doi":"10.1038/s41375-019-0568-8","elsevierAuthor":"Azadniv M.","publicationName":"Leukemia","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"1 February 2020","elsevierCitationCount":"8"},{"title":"Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification—an approach to classification of patients with …","googleId":"rS0iHvqYCSEJ","googleLink":"https://www.nature.com/articles/s41375-020-0917-7","googleCitationCount":6,"googleAuthor":"","doi":"10.1038/s41375-020-0917-7","elsevierAuthor":"Kuendgen A.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"3"},{"title":"CRISPR/Cas9-generated models uncover therapeutic vulnerabilities of del (11q) CLL cells to dual BCR and PARP inhibition","googleId":"Rrx5BRlqCdQJ","googleLink":"https://www.nature.com/articles/s41375-020-0714-3","googleCitationCount":4,"googleAuthor":"M Quijada-Álamo","doi":"10.1038/s41375-020-0714-3","elsevierAuthor":"Quijada-Álamo M.","publicationName":"Leukemia","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"3"},{"title":"Anti-SARS-CoV-2 antibody response in patients with chronic lymphocytic leukemia","googleId":"jBHhRMTdIjoJ","googleLink":"https://www.nature.com/articles/s41375-020-01030-2","googleCitationCount":12,"googleAuthor":"DA Knorr","doi":"10.1038/s41375-020-01030-2","elsevierAuthor":"Roeker L.E.","publicationName":"Leukemia","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"1 November 2020","elsevierCitationCount":"5"},{"title":"SIRT7: an influence factor in healthy aging and the development of age-dependent myeloid stem-cell disorders","googleId":"fzs_spe4GUYJ","googleLink":"https://www.nature.com/articles/s41375-020-0803-3","googleCitationCount":5,"googleAuthor":"O Huber","doi":"10.1038/s41375-020-0803-3","elsevierAuthor":"Kaiser A.","publicationName":"Leukemia","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"3"},{"title":"Disease risk and GVHD biomarkers can stratify patients for risk of relapse and nonrelapse mortality post hematopoietic cell transplant","googleId":"OSB1Ki14RAcJ","googleLink":"https://www.nature.com/articles/s41375-020-0726-z","googleCitationCount":5,"googleAuthor":"U Kapoor","doi":"10.1038/s41375-020-0726-z","elsevierAuthor":"Aziz M.D.","publicationName":"Leukemia","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"4"},{"title":"miR-146a rs2431697 identifies myeloproliferative neoplasm patients with higher secondary myelofibrosis progression risk","googleId":"8SbXelQhCvgJ","googleLink":"https://www.nature.com/articles/s41375-020-0767-3","googleCitationCount":5,"googleAuthor":"AB Arroyo","doi":"10.1038/s41375-020-0767-3","elsevierAuthor":"Ferrer-Marín F.","publicationName":"Leukemia","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"2"},{"title":"Investigating the role of the innate immune response in relapse or blast crisis in chronic myeloid leukemia","googleId":"F9h3jJbw7nQJ","googleLink":"https://www.nature.com/articles/s41375-020-0771-7","googleCitationCount":5,"googleAuthor":"","doi":"10.1038/s41375-020-0771-7","elsevierAuthor":"Huang W.","publicationName":"Leukemia","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"4"},{"title":"Genetic characterization of ABT-199 sensitivity in human AML","googleId":"EluB7UdphncJ","googleLink":"https://www.nature.com/articles/s41375-019-0485-x","googleCitationCount":16,"googleAuthor":"","doi":"10.1038/s41375-019-0485-x","elsevierAuthor":"Bisaillon R.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"1 January 2020","elsevierCitationCount":"6"},{"title":"Bone marrow niche-derived extracellular matrix-degrading enzymes influence the progression of B-cell acute lymphoblastic leukemia","googleId":"0y08FpkbCS4J","googleLink":"https://www.nature.com/articles/s41375-019-0674-7","googleCitationCount":11,"googleAuthor":"D Verma","doi":"10.1038/s41375-019-0674-7","elsevierAuthor":"Verma D.","publicationName":"Leukemia","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"9"},{"title":"Familial myeloid malignancies with germline TET2 mutation","googleId":"lIb8ZZy-TssJ","googleLink":"https://www.nature.com/articles/s41375-019-0675-6","googleCitationCount":12,"googleAuthor":"N Duployez","doi":"10.1038/s41375-019-0675-6","elsevierAuthor":"Duployez N.","publicationName":"Leukemia","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"8"},{"title":"Mutant calreticulin interacts with MPL in the secretion pathway for activation on the cell surface","googleId":"h66BaIwloM0J","googleLink":"https://www.nature.com/articles/s41375-019-0564-z","googleCitationCount":12,"googleAuthor":"","doi":"10.1038/s41375-019-0564-z","elsevierAuthor":"Masubuchi N.","publicationName":"Leukemia","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"1 February 2020","elsevierCitationCount":"5"},{"title":"Phase 1 study of the anti-BCMA antibody-drug conjugate AMG 224 in patients with relapsed/refractory multiple myeloma","googleId":"nFi7rWDvedQJ","googleLink":"https://www.nature.com/articles/s41375-020-0834-9","googleCitationCount":7,"googleAuthor":"","doi":"10.1038/s41375-020-0834-9","elsevierAuthor":"Lee H.C.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"January 2021","elsevierCitationCount":"4"},{"title":"Thrombospondin-1 promotes tumor progression in cutaneous T-cell lymphoma via CD47","googleId":"gGc4u_VCFuoJ","googleLink":"https://www.nature.com/articles/s41375-019-0622-6","googleCitationCount":9,"googleAuthor":"","doi":"10.1038/s41375-019-0622-6","elsevierAuthor":"Kamijo H.","publicationName":"Leukemia","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"8"},{"title":"Synonymous GATA2 mutations result in selective loss of mutated RNA and are common in patients with GATA2 deficiency","googleId":"fm7cm8Pe2UsJ","googleLink":"https://www.nature.com/articles/s41375-020-0899-5","googleCitationCount":3,"googleAuthor":"VB Pastor","doi":"10.1038/s41375-020-0899-5","elsevierAuthor":"Kozyra E.J.","publicationName":"Leukemia","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"4"},{"title":"miR-21 antagonism abrogates Th17 tumor promoting functions in multiple myeloma","googleId":"c41wBFrPMa0J","googleLink":"https://www.nature.com/articles/s41375-020-0947-1?elqTrackId=ceb1fdb647944ccaa1aafe7be0e6ab52","googleCitationCount":3,"googleAuthor":"C Botta","doi":"10.1038/s41375-020-0947-1","elsevierAuthor":"Rossi M.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"3"},{"title":"Predicting ultrahigh risk multiple myeloma by molecular profiling: an analysis of newly diagnosed transplant eligible myeloma XI trial patients","googleId":"72nu9BwWdNwJ","googleLink":"https://www.nature.com/articles/s41375-020-0750-z","googleCitationCount":7,"googleAuthor":"AL Sherborne","doi":"10.1038/s41375-020-0750-z","elsevierAuthor":"Shah V.","publicationName":"Leukemia","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"1 November 2020","elsevierCitationCount":"5"},{"title":"Prognostic factors for adult single cord blood transplantation among European and Japanese populations: the Eurocord/ALWP-EBMT and JSHCT/JDCHCT …","googleId":"QTvIoQAyfJEJ","googleLink":"https://www.nature.com/articles/s41375-019-0534-5","googleCitationCount":14,"googleAuthor":"J Kanda","doi":"10.1038/s41375-019-0534-5","elsevierAuthor":"Kanda J.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"1 January 2020","elsevierCitationCount":"12"},{"title":"Regional BCG vaccination policy in former East-and West Germany may impact on both severity of SARS-CoV-2 and incidence of childhood leukemia","googleId":"T-GK_O73YVwJ","googleLink":"https://www.nature.com/articles/s41375-020-0871-4","googleCitationCount":7,"googleAuthor":"A Borkhardt","doi":"10.1038/s41375-020-0871-4","elsevierAuthor":"Hauer J.","publicationName":"Leukemia","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"5"},{"title":"SF3B1 mutations induce R-loop accumulation and DNA damage in MDS and leukemia cells with therapeutic implications","googleId":"PbC2-eiHoFgJ","googleLink":"https://www.nature.com/articles/s41375-020-0753-9","googleCitationCount":7,"googleAuthor":"S Singh","doi":"10.1038/s41375-020-0753-9","elsevierAuthor":"Singh S.","publicationName":"Leukemia","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"4"},{"title":"ATIR101 administered after T-cell-depleted haploidentical HSCT reduces NRM and improves overall survival in acute leukemia","googleId":"cCIqMH-a_nwJ","googleLink":"https://www.nature.com/articles/s41375-020-0733-0","googleCitationCount":4,"googleAuthor":"DC Roy","doi":"10.1038/s41375-020-0733-0","elsevierAuthor":"Roy D.C.","publicationName":"Leukemia","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"3"},{"title":"Oncolytic measles virus therapy enhances tumor antigen-specific T-cell responses in patients with multiple myeloma","googleId":"AaZwMtNGDXsJ","googleLink":"https://www.nature.com/articles/s41375-020-0828-7","googleCitationCount":4,"googleAuthor":"N Packiriswamy","doi":"10.1038/s41375-020-0828-7","elsevierAuthor":"Packiriswamy N.","publicationName":"Leukemia","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"4"},{"title":"Health-related quality of life of newly diagnosed chronic myeloid leukemia patients treated with first-line dasatinib versus imatinib therapy","googleId":"_LlrmQu97YgJ","googleLink":"https://www.nature.com/articles/s41375-019-0563-0","googleCitationCount":14,"googleAuthor":"M Breccia","doi":"10.1038/s41375-019-0563-0","elsevierAuthor":"Efficace F.","publicationName":"Leukemia","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"1 February 2020","elsevierCitationCount":"7"},{"title":"A proposal for a new staging system for extranodal natural killer T-cell lymphoma: a multicenter study from China and Asia Lymphoma Study Group","googleId":"e95-DGOoRgoJ","googleLink":"https://www.nature.com/articles/s41375-020-0740-1","googleCitationCount":7,"googleAuthor":"","doi":"10.1038/s41375-020-0740-1","elsevierAuthor":"Hong H.","publicationName":"Leukemia","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"3"},{"title":"The novel lncRNA BlackMamba controls the neoplastic phenotype of ALK− anaplastic large cell lymphoma by regulating the DNA helicase HELLS","googleId":"RTDTNNe5hcEJ","googleLink":"https://www.nature.com/articles/s41375-020-0754-8","googleCitationCount":4,"googleAuthor":"V Fragliasso","doi":"10.1038/s41375-020-0754-8","elsevierAuthor":"Fragliasso V.","publicationName":"Leukemia","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"1 November 2020","elsevierCitationCount":"3"},{"title":"HKDC1 C-terminal based peptides inhibit extranodal natural killer/T-cell lymphoma by modulation of mitochondrial function and EBV suppression","googleId":"S8HSUAFxzpIJ","googleLink":"https://www.nature.com/articles/s41375-020-0801-5","googleCitationCount":3,"googleAuthor":"","doi":"10.1038/s41375-020-0801-5","elsevierAuthor":"Chen Q.","publicationName":"Leukemia","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"3"},{"title":"Role of AID in the temporal pattern of acquisition of driver mutations in multiple myeloma","googleId":"X03XwgAppY0J","googleLink":"https://www.nature.com/articles/s41375-019-0689-0","googleCitationCount":14,"googleAuthor":"V Yellapantula","doi":"10.1038/s41375-019-0689-0","elsevierAuthor":"Maura F.","publicationName":"Leukemia","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"7"},{"title":"Cancer increases risk of in-hospital death from COVID-19 in persons< 65 years and those not in complete remission","googleId":"1Duu5x6kWKUJ","googleLink":"https://www.nature.com/articles/s41375-020-0986-7","googleCitationCount":6,"googleAuthor":"Q Li","doi":"10.1038/s41375-020-0986-7","elsevierAuthor":"Li Q.","publicationName":"Leukemia","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"2"},{"title":"Validation of the FIRST simplified frailty scale using the ECOG performance status instead of patient-reported activities","googleId":"Dgl02Fv8eJoJ","googleLink":"https://www.nature.com/articles/s41375-020-0713-4","googleCitationCount":6,"googleAuthor":"AG Dinmohamed","doi":"10.1038/s41375-020-0713-4","elsevierAuthor":"Stege C.A.M.","publicationName":"Leukemia","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"5"},{"title":"Retention of CD19 intron 2 contributes to CART-19 resistance in leukemias with subclonal frameshift mutations in CD19","googleId":"TCDShdmOtxYJ","googleLink":"https://www.nature.com/articles/s41375-019-0580-z","googleCitationCount":11,"googleAuthor":"KE Hayer","doi":"10.1038/s41375-019-0580-z","elsevierAuthor":"Asnani M.","publicationName":"Leukemia","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"April 2020","elsevierCitationCount":"7"},{"title":"Aberrant RAG-mediated recombination contributes to multiple structural rearrangements in lymphoid blast crisis of chronic myeloid leukemia","googleId":"8dtgXke3A5kJ","googleLink":"https://www.nature.com/articles/s41375-020-0751-y","googleCitationCount":3,"googleAuthor":"NH Shahrin","doi":"10.1038/s41375-020-0751-y","elsevierAuthor":"Thomson D.W.","publicationName":"Leukemia","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"3"},{"title":"Mesenchymal PGD 2 activates an ILC2-Treg axis to promote proliferation of normal and malignant HSPCs","googleId":"g5ftgeCkY3IJ","googleLink":"https://www.nature.com/articles/s41375-020-0843-8","googleCitationCount":4,"googleAuthor":"MHH Mazumder","doi":"10.1038/s41375-020-0843-8","elsevierAuthor":"Wu L.","publicationName":"Leukemia","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"1 November 2020","elsevierCitationCount":"4"},{"title":"Physiological levels of the PTEN-PI3K-AKT axis activity are required for maintenance of Burkitt lymphoma","googleId":"GPp675ETzcYJ","googleLink":"https://www.nature.com/articles/s41375-019-0628-0","googleCitationCount":9,"googleAuthor":"","doi":"10.1038/s41375-019-0628-0","elsevierAuthor":"Gehringer F.","publicationName":"Leukemia","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"2"},{"title":"The IPSS-R more accurately captures fatigue severity of newly diagnosed patients with myelodysplastic syndromes compared with the IPSS index","googleId":"eeBlExgRqL8J","googleLink":"https://www.nature.com/articles/s41375-020-0746-8","googleCitationCount":4,"googleAuthor":"F Cottone","doi":"10.1038/s41375-020-0746-8","elsevierAuthor":"Efficace F.","publicationName":"Leukemia","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"2"},{"title":"Bosutinib for pretreated patients with chronic phase chronic myeloid leukemia: primary results of the phase 4 BYOND study","googleId":"HL08kMR72RoJ","googleLink":"https://www.nature.com/articles/s41375-020-0915-9","googleCitationCount":5,"googleAuthor":"","doi":"10.1038/s41375-020-0915-9","elsevierAuthor":"Hochhaus A.","publicationName":"Leukemia","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"3"},{"title":"TET1 promotes growth of T-cell acute lymphoblastic leukemia and can be antagonized via PARP inhibition","googleId":"3WHrISEkl1QJ","googleLink":"https://www.nature.com/articles/s41375-020-0864-3","googleCitationCount":3,"googleAuthor":"","doi":"10.1038/s41375-020-0864-3","elsevierAuthor":"Bamezai S.","publicationName":"Leukemia","elsevierCoverDate":"2021-02-01","elsevierCoverDisplayDate":"February 2021","elsevierCitationCount":"1"},{"title":"In vivo vaccination effect in multiple myeloma patients treated with the monoclonal antibody isatuximab","googleId":"r32SL4jiq24J","googleLink":"https://www.nature.com/articles/s41375-019-0536-3","googleCitationCount":13,"googleAuthor":"SK Tantravahi","doi":"10.1038/s41375-019-0536-3","elsevierAuthor":"Atanackovic D.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"1 January 2020","elsevierCitationCount":"7"},{"title":"Prognostic significance of serial molecular annotation in myelodysplastic syndromes (MDS) and secondary acute myeloid leukemia (sAML)","googleId":"U-BmfL6aW2EJ","googleLink":"https://www.nature.com/articles/s41375-020-0997-4","googleCitationCount":5,"googleAuthor":"S Yun","doi":"10.1038/s41375-020-0997-4","elsevierAuthor":"Yun S.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"3"},{"title":"Pan-RAF inhibition induces apoptosis in acute myeloid leukemia cells and synergizes with BCL2 inhibition","googleId":"ZhCM36hNjIEJ","googleLink":"https://www.nature.com/articles/s41375-020-0972-0","googleCitationCount":3,"googleAuthor":"M Tambe","doi":"10.1038/s41375-020-0972-0","elsevierAuthor":"Tambe M.","publicationName":"Leukemia","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"1"},{"title":"Spectrum of abnormalities and clonal transformation in germline RUNX1 familial platelet disorder and a genomic comparative analysis with somatic RUNX1 mutations …","googleId":"3bODoOsfYi8J","googleLink":"https://www.nature.com/articles/s41375-020-0752-x","googleCitationCount":4,"googleAuthor":"G Coltro","doi":"10.1038/s41375-020-0752-x","elsevierAuthor":"DiFilippo E.C.","publicationName":"Leukemia","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"3"},{"title":"Simultaneous kinase inhibition with ibrutinib and BCL2 inhibition with venetoclax offers a therapeutic strategy for acute myeloid leukemia","googleId":"GyAylDQ6rGsJ","googleLink":"https://www.nature.com/articles/s41375-020-0764-6","googleCitationCount":4,"googleAuthor":"A Agarwal","doi":"10.1038/s41375-020-0764-6","elsevierAuthor":"Eide C.A.","publicationName":"Leukemia","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"4"},{"title":"The WNT receptor ROR2 drives the interaction of multiple myeloma cells with the microenvironment through AKT activation","googleId":"b84nzgsWT00J","googleLink":"https://www.nature.com/articles/s41375-019-0486-9","googleCitationCount":14,"googleAuthor":"","doi":"10.1038/s41375-019-0486-9","elsevierAuthor":"Frenquelli M.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"1 January 2020","elsevierCitationCount":"9"},{"title":"Holding CoVID in check through JAK? The MPN-approved compound ruxolitinib as a potential strategy to treat SARS-CoV-2 induced systemic …","googleId":"iJo2N9vr6NAJ","googleLink":"https://www.nature.com/articles/s41375-020-0898-6","googleCitationCount":5,"googleAuthor":"F Heidel","doi":"10.1038/s41375-020-0898-6","elsevierAuthor":"Heidel F.","publicationName":"Leukemia","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"3"},{"title":"Impact of pretransplant measurable residual disease on the outcome of allogeneic hematopoietic cell transplantation in adult monosomal karyotype AML","googleId":"7UjP3LWcsQ8J","googleLink":"https://www.nature.com/articles/s41375-020-0717-0","googleCitationCount":5,"googleAuthor":"ED Bezerra","doi":"10.1038/s41375-020-0717-0","elsevierAuthor":"Morsink L.M.","publicationName":"Leukemia","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"4"},{"title":"CD28/4-1BB CD123 CAR T cells in blastic plasmacytoid dendritic cell neoplasm","googleId":"YYmHdarjCHoJ","googleLink":"https://www.nature.com/articles/s41375-020-0777-1.pdf?origin=ppub","googleCitationCount":3,"googleAuthor":"","doi":"10.1038/s41375-020-0777-1","elsevierAuthor":"Bôle-Richard E.","publicationName":"Leukemia","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"1"},{"title":"PMN-MDSC are a new target to rescue graft-versus-leukemia activity of NK cells in haplo-HSC transplantation","googleId":"vY9KrsrrV6QJ","googleLink":"https://www.nature.com/articles/s41375-019-0585-7","googleCitationCount":12,"googleAuthor":"N Tumino","doi":"10.1038/s41375-019-0585-7","elsevierAuthor":"Tumino N.","publicationName":"Leukemia","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"11"},{"title":"Immunomodulatory effects of pevonedistat, a NEDD8-activating enzyme inhibitor, in chronic lymphocytic leukemia-derived T cells","googleId":"DdbSSIaXGhUJ","googleLink":"https://www.nature.com/articles/s41375-020-0794-0","googleCitationCount":3,"googleAuthor":"S Best","doi":"10.1038/s41375-020-0794-0","elsevierAuthor":"Best S.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"January 2021","elsevierCitationCount":"3"},{"title":"Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma","googleId":"mwy991tQ-GYJ","googleLink":"https://www.nature.com/articles/s41375-020-1000-0","googleCitationCount":4,"googleAuthor":"JQ Lim","doi":"10.1038/s41375-020-1000-0","elsevierAuthor":"Lim J.Q.","publicationName":"Leukemia","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"2"},{"title":"Reply to “CLL and COVID-19 at the Hospital Clinic of Barcelona: an interim report” Analysis of six hematological centers in Lombardy","googleId":"eMV5iq2SHPcJ","googleLink":"https://www.nature.com/articles/s41375-020-0966-y","googleCitationCount":6,"googleAuthor":"","doi":"10.1038/s41375-020-0966-y","elsevierAuthor":"Reda G.","publicationName":"Leukemia","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"2"},{"title":"Deep immune profiling of patients treated with lenalidomide and dexamethasone with or without daratumumab","googleId":"4eAL7m95zSIJ","googleLink":"https://www.nature.com/articles/s41375-020-0855-4","googleCitationCount":7,"googleAuthor":"NWCJ van de Donk","doi":"10.1038/s41375-020-0855-4","elsevierAuthor":"Casneuf T.","publicationName":"Leukemia","elsevierCoverDate":"2021-02-01","elsevierCoverDisplayDate":"February 2021","elsevierCitationCount":"3"},{"title":"SARS-CoV-2 antibody responses in patients with acute leukaemia","googleId":"WS4K_n7z0bIJ","googleLink":"https://www.nature.com/articles/s41375-020-01103-2","googleCitationCount":3,"googleAuthor":"A Rosa","doi":"10.1038/s41375-020-01103-2","elsevierAuthor":"O’Nions J.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"January 2021","elsevierCitationCount":"0"},{"title":"Survival risk score for real-life relapsed/refractory chronic lymphocytic leukemia patients receiving ibrutinib. A campus CLL study","googleId":"_P_yh1JYs0UJ","googleLink":"https://www.nature.com/articles/s41375-020-0833-x.pdf?origin=ppub","googleCitationCount":6,"googleAuthor":"G Del Poeta","doi":"10.1038/s41375-020-0833-x","elsevierAuthor":"Gentile M.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"January 2021","elsevierCitationCount":"5"},{"title":"Hypoxia-inducible factor 1 (HIF-1) is a new therapeutic target in JAK2 V617F-positive myeloproliferative neoplasms","googleId":"S-3LqgIFEk8J","googleLink":"https://www.nature.com/articles/s41375-019-0629-z","googleCitationCount":10,"googleAuthor":"T Maié","doi":"10.1038/s41375-019-0629-z","elsevierAuthor":"Baumeister J.","publicationName":"Leukemia","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"April 2020","elsevierCitationCount":"7"},{"title":"A gene-expression-based signature predicts survival in adults with T-cell lymphoblastic lymphoma: a multicenter study","googleId":"1fPaxW-lZhMJ","googleLink":"https://www.nature.com/articles/s41375-020-0757-5","googleCitationCount":4,"googleAuthor":"","doi":"10.1038/s41375-020-0757-5","elsevierAuthor":"Tian X.P.","publicationName":"Leukemia","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"3"},{"title":"Daratumumab induces mechanisms of immune activation through CD38+ NK cell targeting","googleId":"_GJo7K82R9wJ","googleLink":"https://www.nature.com/articles/s41375-020-0810-4","googleCitationCount":8,"googleAuthor":"A Dona","doi":"10.1038/s41375-020-0810-4","elsevierAuthor":"Viola D.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"January 2021","elsevierCitationCount":"5"},{"title":"Response to the conjugate pneumococcal vaccine (PCV13) in patients with chronic lymphocytic leukemia (CLL)","googleId":"EZL-VwGv51wJ","googleLink":"https://www.nature.com/articles/s41375-020-0884-z","googleCitationCount":3,"googleAuthor":"D Giannarelli","doi":"10.1038/s41375-020-0884-z","elsevierAuthor":"Mauro F.R.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"1"},{"title":"Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS","googleId":"6zteEi5-iccJ","googleLink":"https://www.nature.com/articles/s41375-020-0725-0.pdf?origin=ppub","googleCitationCount":7,"googleAuthor":"G Stuessi","doi":"10.1038/s41375-020-0725-0","elsevierAuthor":"Ossenkoppele G.J.","publicationName":"Leukemia","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"0"},{"title":"Integrated nuclear proteomics and transcriptomics identifies S100A4 as a therapeutic target in acute myeloid leukemia","googleId":"OKsx1LS5_tAJ","googleLink":"https://www.nature.com/articles/s41375-019-0596-4","googleCitationCount":10,"googleAuthor":"N Rastogi","doi":"10.1038/s41375-019-0596-4","elsevierAuthor":"Alanazi B.","publicationName":"Leukemia","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"1 February 2020","elsevierCitationCount":"5"},{"title":"International harmonization in performing and reporting minimal residual disease assessment in multiple myeloma trials","googleId":"hpKTkY9eZ4oJ","googleLink":"https://www.nature.com/articles/s41375-020-01012-4","googleCitationCount":4,"googleAuthor":"BA Derman","doi":"10.1038/s41375-020-01012-4","elsevierAuthor":"Costa L.J.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"January 2021","elsevierCitationCount":"1"},{"title":"Complex landscape of alternative splicing in myeloid neoplasms","googleId":"Rx2Jx6ULPBgJ","googleLink":"https://www.nature.com/articles/s41375-020-1002-y","googleCitationCount":2,"googleAuthor":"CE Hershberger","doi":"10.1038/s41375-020-1002-y","elsevierAuthor":"Hershberger C.E.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"2"},{"title":"RIG-I-based immunotherapy enhances survival in preclinical AML models and sensitizes AML cells to checkpoint blockade","googleId":"UTWVFDOd6FYJ","googleLink":"https://www.nature.com/articles/s41375-019-0639-x","googleCitationCount":9,"googleAuthor":"","doi":"10.1038/s41375-019-0639-x","elsevierAuthor":"Ruzicka M.","publicationName":"Leukemia","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"April 2020","elsevierCitationCount":"6"},{"title":"Survey of ex vivo drug combination effects in chronic lymphocytic leukemia reveals synergistic drug effects and genetic dependencies","googleId":"UsXr6MjB3X8J","googleLink":"https://www.nature.com/articles/s41375-020-0846-5","googleCitationCount":2,"googleAuthor":"B Velten","doi":"10.1038/s41375-020-0846-5","elsevierAuthor":"Lukas M.","publicationName":"Leukemia","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"1 November 2020","elsevierCitationCount":"2"},{"title":"Should persons with acute myeloid leukemia (AML) in 1st histological complete remission who are measurable residual disease (MRD) test positive receive an …","googleId":"FbjzjYOYvKYJ","googleLink":"https://www.nature.com/articles/s41375-020-0780-6","googleCitationCount":5,"googleAuthor":"A Venditti","doi":"10.1038/s41375-020-0780-6","elsevierAuthor":"Venditti A.","publicationName":"Leukemia","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"April 2020","elsevierCitationCount":"5"},{"title":"Genetic T-cell receptor diversity at 1 year following allogeneic hematopoietic stem cell transplantation","googleId":"KAC4zEAB_ykJ","googleLink":"https://www.nature.com/articles/s41375-019-0654-y","googleCitationCount":8,"googleAuthor":"S Buhler","doi":"10.1038/s41375-019-0654-y","elsevierAuthor":"Buhler S.","publicationName":"Leukemia","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"6"},{"title":"The EUTOS long-term survival (ELTS) score is superior to the Sokal score for predicting survival in chronic myeloid leukemia","googleId":"9Sfj1CYBIP8J","googleLink":"https://www.nature.com/articles/s41375-020-0931-9","googleCitationCount":5,"googleAuthor":"","doi":"10.1038/s41375-020-0931-9","elsevierAuthor":"Pfirrmann M.","publicationName":"Leukemia","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"0"},{"title":"Treatment-free remission in chronic myeloid leukemia: the patient perspective and areas of unmet needs","googleId":"PdPhrchkg6AJ","googleLink":"https://www.nature.com/articles/s41375-020-0867-0","googleCitationCount":6,"googleAuthor":"","doi":"10.1038/s41375-020-0867-0","elsevierAuthor":"Sharf G.","publicationName":"Leukemia","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"2"},{"title":"SRSF1 mediates cytokine-induced impaired imatinib sensitivity in chronic myeloid leukemia","googleId":"VFO7LIzcycYJ","googleLink":"https://www.nature.com/articles/s41375-020-0732-1","googleCitationCount":2,"googleAuthor":"KL Lee","doi":"10.1038/s41375-020-0732-1","elsevierAuthor":"Sinnakannu J.R.","publicationName":"Leukemia","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"2"},{"title":"Prevalence of COVID-19 diagnosis in Dutch CML patients during the 2020 SARS-CoV2 pandemic. A prospective cohort study","googleId":"vY0hBvNp7XAJ","googleLink":"https://www.nature.com/articles/s41375-020-0964-0","googleCitationCount":5,"googleAuthor":"","doi":"10.1038/s41375-020-0964-0","elsevierAuthor":"Ector G.I.C.G.","publicationName":"Leukemia","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"2"},{"title":"A novel CDK9 inhibitor increases the efficacy of venetoclax (ABT-199) in multiple models of hematologic malignancies","googleId":"P4fMHi87FLoJ","googleLink":"https://www.nature.com/articles/s41375-019-0652-0","googleCitationCount":8,"googleAuthor":"GP Gregory","doi":"10.1038/s41375-019-0652-0","elsevierAuthor":"Phillips D.C.","publicationName":"Leukemia","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"7"},{"title":"Targeting IRAK4 disrupts inflammatory pathways and delays tumor development in chronic lymphocytic leukemia","googleId":"N5Y3NQoqDhAJ","googleLink":"https://www.nature.com/articles/s41375-019-0507-8","googleCitationCount":12,"googleAuthor":"","doi":"10.1038/s41375-019-0507-8","elsevierAuthor":"Giménez N.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"1 January 2020","elsevierCitationCount":"8"},{"title":"Distinct effects of ruxolitinib and interferon-alpha on murine JAK2V617F myeloproliferative neoplasm hematopoietic stem cell populations","googleId":"zN3agJG02l4J","googleLink":"https://www.nature.com/articles/s41375-019-0638-y","googleCitationCount":8,"googleAuthor":"J Straube","doi":"10.1038/s41375-019-0638-y","elsevierAuthor":"Austin R.J.","publicationName":"Leukemia","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"April 2020","elsevierCitationCount":"6"},{"title":"Gain of chromosome 21 in hematological malignancies: lessons from studying leukemia in children with Down syndrome","googleId":"QZ-sXjBXjXIJ","googleLink":"https://www.nature.com/articles/s41375-020-0854-5","googleCitationCount":2,"googleAuthor":"S Malinge","doi":"10.1038/s41375-020-0854-5","elsevierAuthor":"Laurent A.P.","publicationName":"Leukemia","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"1"},{"title":"Landscape of RAS pathway mutations in patients with myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes: a study of 461 molecularly …","googleId":"KrxLpFak8KUJ","googleLink":"https://www.nature.com/articles/s41375-020-0889-7","googleCitationCount":3,"googleAuthor":"E Bezerra","doi":"10.1038/s41375-020-0889-7","elsevierAuthor":"Buradkar A.","publicationName":"Leukemia","elsevierCoverDate":"2021-02-01","elsevierCoverDisplayDate":"February 2021","elsevierCitationCount":"2"},{"title":"COVID-19 among fit patients with CLL treated with venetoclax-based combinations","googleId":"ZWDcaxZV2aMJ","googleLink":"https://www.nature.com/articles/s41375-020-0941-7","googleCitationCount":5,"googleAuthor":"AM Fink","doi":"10.1038/s41375-020-0941-7","elsevierAuthor":"Fürstenau M.","publicationName":"Leukemia","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"3"},{"title":"CD93 is expressed on chronic myeloid leukemia stem cells and identifies a quiescent population which persists after tyrosine kinase inhibitor therapy","googleId":"YtgoIp_KcU4J","googleLink":"https://www.nature.com/articles/s41375-019-0684-5","googleCitationCount":12,"googleAuthor":"","doi":"10.1038/s41375-019-0684-5","elsevierAuthor":"Kinstrie R.","publicationName":"Leukemia","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"0"},{"title":"Neoplastic fibrocytes play an essential role in bone marrow fibrosis in Jak2V617F-induced primary myelofibrosis mice","googleId":"M1jC_C-pQEkJ","googleLink":"https://www.nature.com/articles/s41375-020-0880-3.pdf?origin=ppub","googleCitationCount":3,"googleAuthor":"K Shide"},{"title":"Long-term results of all-trans retinoic acid and arsenic trioxide in non-high-risk acute promyelocytic leukemia: update of the APL0406 Italian-German randomized trial","googleId":"n1I63b-nhXQJ","googleLink":"https://www.nature.com/articles/s41375-019-0589-3","googleCitationCount":12,"googleAuthor":"F Paoloni","doi":"10.1038/s41375-019-0589-3","elsevierAuthor":"Cicconi L.","publicationName":"Leukemia","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"9"},{"title":"Targeting RNA-binding proteins in acute and chronic leukemia","googleId":"G1Af7hMZYBsJ","googleLink":"https://www.nature.com/articles/s41375-020-01066-4","googleCitationCount":1,"googleAuthor":"IA Elcheva","doi":"10.1038/s41375-020-01066-4","elsevierAuthor":"Elcheva I.A.","publicationName":"Leukemia","elsevierCoverDate":"2021-02-01","elsevierCoverDisplayDate":"February 2021","elsevierCitationCount":"1"},{"title":"Functional characterization of BRCC3 mutations in acute myeloid leukemia with t (8; 21)(q22; q22. 1)","googleId":"rZfoyhdIjqQJ","googleLink":"https://www.nature.com/articles/s41375-019-0578-6","googleCitationCount":6,"googleAuthor":"","doi":"10.1038/s41375-019-0578-6","elsevierAuthor":"Meyer T.","publicationName":"Leukemia","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"1 February 2020","elsevierCitationCount":"6"},{"title":"Risk of HBV reactivation post CD19-CAR-T cell therapy in DLBCL patients with concomitant chronic HBV infection","googleId":"aTtpLc028gIJ","googleLink":"https://www.nature.com/articles/s41375-020-0913-y","googleCitationCount":4,"googleAuthor":"","doi":"10.1038/s41375-020-0913-y","elsevierAuthor":"Yang C.","publicationName":"Leukemia","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"1 November 2020","elsevierCitationCount":"1"},{"title":"Risk of infections in patients with myeloproliferative neoplasms—a population-based cohort study of 8363 patients","googleId":"39nsJoJomlQJ","googleLink":"https://www.nature.com/articles/s41375-020-0909-7","googleCitationCount":4,"googleAuthor":"TML Andersson","doi":"10.1038/s41375-020-0909-7","elsevierAuthor":"Landtblom A.R.","publicationName":"Leukemia","elsevierCoverDate":"2021-02-01","elsevierCoverDisplayDate":"February 2021","elsevierCitationCount":"1"},{"title":"Imatinib is not a potent anti-SARS-CoV-2 drug","googleId":"yuHQe1J3I8cJ","googleLink":"https://www.nature.com/articles/s41375-020-01045-9","googleCitationCount":4,"googleAuthor":"MW Deininger","doi":"10.1038/s41375-020-01045-9","elsevierAuthor":"Zhao H.","publicationName":"Leukemia","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"1 November 2020","elsevierCitationCount":"1"},{"title":"How the coronavirus pandemic has affected the clinical management of Philadelphia-negative chronic myeloproliferative neoplasms in Italy—a GIMEMA MPN …","googleId":"6CM5B31Ua34J","googleLink":"https://www.nature.com/articles/s41375-020-0953-3","googleCitationCount":4,"googleAuthor":"A Piciocchi","doi":"10.1038/s41375-020-0953-3","elsevierAuthor":"Palandri F.","publicationName":"Leukemia","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"3"},{"title":"IgM AL amyloidosis: delineating disease biology and outcomes with clinical, genomic and bone marrow morphological features","googleId":"0a95BiELk5wJ","googleLink":"https://www.nature.com/articles/s41375-019-0667-6","googleCitationCount":10,"googleAuthor":"S Sidana","doi":"10.1038/s41375-019-0667-6","elsevierAuthor":"Sidana S.","publicationName":"Leukemia","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"8"},{"title":"NPM1c impedes CTCF functions through cytoplasmic mislocalization in acute myeloid leukemia","googleId":"Nn5o1Ov3LiYJ","googleLink":"https://www.nature.com/articles/s41375-019-0681-8","googleCitationCount":6,"googleAuthor":"","doi":"10.1038/s41375-019-0681-8","elsevierAuthor":"Wang A.J.","publicationName":"Leukemia","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"4"},{"title":"COVID-19 in Philadelphia-negative myeloproliferative disorders: a GIMEMA survey","googleId":"Bzj9V3fa5gwJ","googleLink":"https://www.nature.com/articles/s41375-020-01032-0","googleCitationCount":4,"googleAuthor":"M Breccia","doi":"10.1038/s41375-020-01032-0","elsevierAuthor":"Breccia M.","publicationName":"Leukemia","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"3"},{"title":"Interferon-free compared to interferon-based antiviral regimens as first-line therapy for B-cell lymphoproliferative disorders associated with hepatitis C virus infection","googleId":"Lb8-MggT4xEJ","googleLink":"https://www.nature.com/articles/s41375-019-0687-2","googleCitationCount":7,"googleAuthor":"C Besson","doi":"10.1038/s41375-019-0687-2","elsevierAuthor":"Frigeni M.","publicationName":"Leukemia","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"6"},{"title":"Fusion driven JMML: a novel CCDC88C–FLT3 fusion responsive to sorafenib identified by RNA sequencing","googleId":"2JDxQcTFdBcJ","googleLink":"https://www.nature.com/articles/s41375-019-0549-y","googleCitationCount":7,"googleAuthor":"JA Meyer","doi":"10.1038/s41375-019-0549-y","elsevierAuthor":"Chao A.K.","publicationName":"Leukemia","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"1 February 2020","elsevierCitationCount":"3"},{"title":"Flow cytometric detection of leukemic blasts in cerebrospinal fluid predicts risk of relapse in childhood acute lymphoblastic leukemia: a Nordic Society of Pediatric …","googleId":"HDAs8qLqyTQJ","googleLink":"https://www.nature.com/articles/s41375-019-0570-1","googleCitationCount":13,"googleAuthor":"","doi":"10.1038/s41375-019-0570-1","elsevierAuthor":"Thastrup M.","publicationName":"Leukemia","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"0"},{"title":"Bone marrow plasma cells 20% or greater discriminate presentation, response, and survival in AL amyloidosis","googleId":"OHNpoItQW9wJ","googleLink":"https://www.nature.com/articles/s41375-019-0655-x","googleCitationCount":10,"googleAuthor":"E Muchtar","doi":"10.1038/s41375-019-0655-x","elsevierAuthor":"Muchtar E.","publicationName":"Leukemia","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"0"},{"title":"Inhibition of ubiquitin-specific protease 7 sensitizes acute myeloid leukemia to chemotherapy","googleId":"OZiL7dRRJacJ","googleLink":"https://www.nature.com/articles/s41375-020-0878-x","googleCitationCount":2,"googleAuthor":"","doi":"10.1038/s41375-020-0878-x","elsevierAuthor":"Cartel M.","publicationName":"Leukemia","elsevierCoverDate":"2021-02-01","elsevierCoverDisplayDate":"February 2021","elsevierCitationCount":"0"},{"title":"Existence of reprogrammed lymphoma stem cells in a murine ALCL-like model","googleId":"T7VybyIDvJcJ","googleLink":"https://www.nature.com/articles/s41375-020-0789-x","googleCitationCount":2,"googleAuthor":"","doi":"10.1038/s41375-020-0789-x","elsevierAuthor":"Kreutmair S.","publicationName":"Leukemia","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"1"},{"title":"Risk of serious infection among individuals with and without low count monoclonal B-cell lymphocytosis (MBL)","googleId":"KkjyoyIWgSIJ","googleLink":"https://www.nature.com/articles/s41375-020-0799-8","googleCitationCount":3,"googleAuthor":"TD Shanafelt","doi":"10.1038/s41375-020-0799-8","elsevierAuthor":"Shanafelt T.D.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"January 2021","elsevierCitationCount":"2"},{"title":"Adult T-cell acute lymphoblastic leukemias with IL7R pathway mutations are slow-responders who do not benefit from allogeneic stem-cell transplantation","googleId":"yaOvOBQA5eIJ","googleLink":"https://www.nature.com/articles/s41375-019-0685-4","googleCitationCount":3,"googleAuthor":"","doi":"10.1038/s41375-019-0685-4","elsevierAuthor":"Kim R.","publicationName":"Leukemia","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"2"},{"title":"Ruxolitinib for the treatment of SARS-CoV-2 induced acute respiratory distress syndrome (ARDS)","googleId":"7brPBUsy010J","googleLink":"https://www.nature.com/articles/s41375-020-0907-9","googleCitationCount":4,"googleAuthor":"T Wiesmann","doi":"10.1038/s41375-020-0907-9","elsevierAuthor":"Neubauer A.","publicationName":"Leukemia","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"3"},{"title":"Single agent talacotuzumab demonstrates limited efficacy but considerable toxicity in elderly high-risk MDS or AML patients failing hypomethylating agents","googleId":"HntyRMXuRbsJ","googleLink":"https://www.nature.com/articles/s41375-019-0645-z","googleCitationCount":7,"googleAuthor":"AS Kubasch","doi":"10.1038/s41375-019-0645-z","elsevierAuthor":"Kubasch A.S.","publicationName":"Leukemia","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"April 2020","elsevierCitationCount":"7"},{"title":"In search of genetic factors predisposing to familial hairy cell leukemia (HCL): exome-sequencing of four multiplex HCL pedigrees","googleId":"enteApMd6XIJ","googleLink":"https://www.nature.com/articles/s41375-019-0702-7","googleCitationCount":4,"googleAuthor":"A Pathak","doi":"10.1038/s41375-019-0702-7","elsevierAuthor":"Pemov A.","publicationName":"Leukemia","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"1"},{"title":"Outcome of older (≥ 70 years) APL patients frontline treated with or without arsenic trioxide—an International Collaborative Study","googleId":"heuE9SruR58J","googleLink":"https://www.nature.com/articles/s41375-020-0758-4","googleCitationCount":4,"googleAuthor":"","doi":"10.1038/s41375-020-0758-4","elsevierAuthor":"Kayser S.","publicationName":"Leukemia","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"3"},{"title":"Monitoring the cytogenetic architecture of minimal residual plasma cells indicates therapy-induced clonal selection in multiple myeloma","googleId":"N14n6ja7aA8J","googleLink":"https://www.nature.com/articles/s41375-019-0590-x","googleCitationCount":5,"googleAuthor":"G An","doi":"10.1038/s41375-019-0590-x","elsevierAuthor":"An G.","publicationName":"Leukemia","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"1 February 2020","elsevierCitationCount":"3"},{"title":"Identifying IGH disease clones for MRD monitoring in childhood B-cell acute lymphoblastic leukemia using RNA-Seq","googleId":"X_6U12eWup4J","googleLink":"https://www.nature.com/articles/s41375-020-0774-4","googleCitationCount":3,"googleAuthor":"","doi":"10.1038/s41375-020-0774-4","elsevierAuthor":"Li Z.","publicationName":"Leukemia","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"2"},{"title":"Ectonucleotidase CD39 is highly expressed on ATLL cells and is responsible for their immunosuppressive function","googleId":"9KUK-YYxBNcJ","googleLink":"https://www.nature.com/articles/s41375-020-0788-y","googleCitationCount":2,"googleAuthor":"D Motooka","doi":"10.1038/s41375-020-0788-y","elsevierAuthor":"Nagate Y.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"January 2021","elsevierCitationCount":"2"},{"title":"Bone marrow versus mobilized peripheral blood stem cell graft in T-cell-replete haploidentical transplantation in acute lymphoblastic leukemia","googleId":"TrtF-btPInIJ","googleLink":"https://www.nature.com/articles/s41375-020-0850-9","googleCitationCount":2,"googleAuthor":"A Nagler","doi":"10.1038/s41375-020-0850-9","elsevierAuthor":"Nagler A.","publicationName":"Leukemia","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"2"},{"title":"A phase 1b/2 study of duvelisib in combination with FCR (DFCR) for frontline therapy for younger CLL patients","googleId":"3pzkc3Tki4MJ","googleLink":"https://www.nature.com/articles/s41375-020-01010-6","googleCitationCount":5,"googleAuthor":"S Tyekucheva","doi":"10.1038/s41375-020-01010-6","elsevierAuthor":"Davids M.S.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"3"},{"title":"A trispecific killer engager molecule against CLEC12A effectively induces NK-cell mediated killing of AML cells","googleId":"KbSlQz1FXYQJ","googleLink":"https://www.nature.com/articles/s41375-020-01065-5?elqTrackId=7bb4ad7979ef40989e7ea978f38e7d5b","googleCitationCount":1,"googleAuthor":"","doi":"10.1038/s41375-020-01065-5","elsevierAuthor":"Arvindam U.S.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"1"},{"title":"Frequent occurrence of CD19-negative relapse after CD19 CAR T and consolidation therapy in 14 TP53-mutated r/r B-ALL children","googleId":"EyjzcfCymGIJ","googleLink":"https://www.nature.com/articles/s41375-020-0831-z","googleCitationCount":4,"googleAuthor":"","doi":"10.1038/s41375-020-0831-z","elsevierAuthor":"Pan J.","publicationName":"Leukemia","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"3"},{"title":"Deepening responses associated with improved progression-free survival with ixazomib versus placebo as posttransplant maintenance in multiple myeloma","googleId":"4Cd2TLGgMuYJ","googleLink":"https://www.nature.com/articles/s41375-020-0819-8","googleCitationCount":2,"googleAuthor":"MA Dimopoulos","doi":"10.1038/s41375-020-0819-8","elsevierAuthor":"Goldschmidt H.","publicationName":"Leukemia","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"1 November 2020","elsevierCitationCount":"2"},{"title":"Differences in expression and function of LEF1 isoforms in normal versus leukemic hematopoiesis","googleId":"9QvNH5PYv5gJ","googleLink":"https://www.nature.com/articles/s41375-019-0635-1","googleCitationCount":7,"googleAuthor":"VPS Rawat","doi":"10.1038/s41375-019-0635-1","elsevierAuthor":"Feder K.","publicationName":"Leukemia","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"April 2020","elsevierCitationCount":"5"},{"title":"Activating JAK-mutations confer resistance to FLT3 kinase inhibitors in FLT3-ITD positive AML in vitro and in vivo","googleId":"nC3mAqdxikkJ","googleLink":"https://www.nature.com/articles/s41375-020-01077-1","googleCitationCount":1,"googleAuthor":"SP Gorantla","doi":"10.1038/s41375-020-01077-1","elsevierAuthor":"Rummelt C.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Genome instability in multiple myeloma","googleId":"JST3EWRlNDgJ","googleLink":"https://www.nature.com/articles/s41375-020-0921-y","googleCitationCount":4,"googleAuthor":"OC Lomas","doi":"10.1038/s41375-020-0921-y","elsevierAuthor":"Neuse C.J.","publicationName":"Leukemia","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"1 November 2020","elsevierCitationCount":"2"},{"title":"A six-gene leukemic stem cell score identifies high risk pediatric acute myeloid leukemia","googleId":"bhEGWilGhFgJ","googleLink":"https://www.nature.com/articles/s41375-019-0604-8","googleCitationCount":7,"googleAuthor":"AH Elsayed","doi":"10.1038/s41375-019-0604-8","elsevierAuthor":"Elsayed A.H.","publicationName":"Leukemia","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"0"},{"title":"OT-82, a novel anticancer drug candidate that targets the strong dependence of hematological malignancies on NAD biosynthesis","googleId":"3_BvetEr9tIJ","googleLink":"https://www.nature.com/articles/s41375-019-0692-5","googleCitationCount":5,"googleAuthor":"","doi":"10.1038/s41375-019-0692-5","elsevierAuthor":"Korotchkina L.","publicationName":"Leukemia","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"5"},{"title":"Chronic lymphocytic leukemia in 2020: a surfeit of riches?","googleId":"_UqjFucKZEoJ","googleLink":"https://www.nature.com/articles/s41375-020-0852-7","googleCitationCount":2,"googleAuthor":"RP Gale","doi":"10.1038/s41375-020-0852-7","elsevierAuthor":"Parikh S.A.","publicationName":"Leukemia","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"1"},{"title":"A Novel TLX1-driven T-ALL zebrafish model: comparative genomic analysis with other leukemia models","googleId":"eQZjZt609lUJ","googleLink":"https://www.nature.com/articles/s41375-020-0938-2","googleCitationCount":2,"googleAuthor":"","doi":"10.1038/s41375-020-0938-2","elsevierAuthor":"Loontiens S.","publicationName":"Leukemia","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"2"},{"title":"Distinct and overlapping mechanisms of resistance to azacytidine and guadecitabine in acute myeloid leukemia","googleId":"VbUvPnK2-hoJ","googleLink":"https://www.nature.com/articles/s41375-020-0973-z","googleCitationCount":2,"googleAuthor":"J Shortt","doi":"10.1038/s41375-020-0973-z","elsevierAuthor":"Gruber E.","publicationName":"Leukemia","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"1"},{"title":"Dasatinib vs. imatinib in patients with chronic myeloid leukemia in chronic phase (CML-CP) who have not achieved an optimal response to 3 months of …","googleId":"6jt572XJzi8J","googleLink":"https://www.nature.com/articles/s41375-020-0805-1","googleCitationCount":3,"googleAuthor":"","doi":"10.1038/s41375-020-0805-1","elsevierAuthor":"Cortes J.E.","publicationName":"Leukemia","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"2"},{"title":"RUNX1 mutations in blast-phase chronic myeloid leukemia associate with distinct phenotypes, transcriptional profiles, and drug responses","googleId":"Qi6_oDSIXzcJ","googleLink":"https://www.nature.com/articles/s41375-020-01011-5","googleCitationCount":1,"googleAuthor":"O Dufva","doi":"10.1038/s41375-020-01011-5","elsevierAuthor":"Adnan Awad S.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"1"},{"title":"Multiple Myeloma DREAM Challenge reveals epigenetic regulator PHF19 as marker of aggressive disease","googleId":"LCwWmabw8MQJ","googleLink":"https://www.nature.com/articles/s41375-020-0742-z","googleCitationCount":6,"googleAuthor":"F Towfic","doi":"10.1038/s41375-020-0742-z","elsevierAuthor":"Mason M.J.","publicationName":"Leukemia","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"4"},{"title":"KAT7 is a genetic vulnerability of acute myeloid leukemias driven by MLL rearrangements","googleId":"luKgMn8-TbcJ","googleLink":"https://www.nature.com/articles/s41375-020-1001-z","googleCitationCount":2,"googleAuthor":"","doi":"10.1038/s41375-020-1001-z","elsevierAuthor":"Au Y.Z.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"1"},{"title":"Interferon alpha therapy in essential thrombocythemia and polycythemia vera—a systematic review and meta-analysis","googleId":"oapHhDUiNbUJ","googleLink":"https://www.nature.com/articles/s41375-020-01020-4","googleCitationCount":1,"googleAuthor":"JP Bewersdorf","doi":"10.1038/s41375-020-01020-4","elsevierAuthor":"Bewersdorf J.P.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"1"},{"title":"DPP4+ exosomes in AML patients' plasma suppress proliferation of hematopoietic progenitor cells","googleId":"zJLf20IpWJcJ","googleLink":"https://www.nature.com/articles/s41375-020-01047-7","googleCitationCount":2,"googleAuthor":"","doi":"10.1038/s41375-020-01047-7","elsevierAuthor":"Namburi S.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"1"},{"title":"Frequency of infections in 948 MPN patients: a prospective multicenter patient-reported pilot study","googleId":"ktgWFPhzQUYJ","googleLink":"https://www.nature.com/articles/s41375-020-0890-1","googleCitationCount":4,"googleAuthor":"S Koschmieder","doi":"10.1038/s41375-020-0890-1","elsevierAuthor":"Crodel C.C.","publicationName":"Leukemia","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"1 November 2020","elsevierCitationCount":"0"},{"title":"Oxidative stress as candidate therapeutic target to overcome microenvironmental protection of CLL","googleId":"fox17UfGjWEJ","googleLink":"https://www.nature.com/articles/s41375-019-0513-x","googleCitationCount":8,"googleAuthor":"DY Yosifov","doi":"10.1038/s41375-019-0513-x","elsevierAuthor":"Yosifov D.Y.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"1 January 2020","elsevierCitationCount":"6"},{"title":"Leptin receptor, a surface marker for a subset of highly engrafting long-term functional hematopoietic stem cells","googleId":"9k034uPweMwJ","googleLink":"https://www.nature.com/articles/s41375-020-01079-z?elqTrackId=374f9472bbac48a09b99b9edb7090829","googleCitationCount":2,"googleAuthor":"EF Srour","doi":"10.1038/s41375-020-01079-z","elsevierAuthor":"Trinh T.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Long-term follow-up of patients with mantle cell lymphoma (MCL) treated with the selective Bruton's tyrosine kinase inhibitor tirabrutinib (GS/ONO-4059)","googleId":"5LEB87a9HlMJ","googleLink":"https://www.nature.com/articles/s41375-019-0658-7","googleCitationCount":7,"googleAuthor":"","doi":"10.1038/s41375-019-0658-7","elsevierAuthor":"Rule S.A.","publicationName":"Leukemia","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"6"},{"title":"Wnt5a enhances proliferation of chronic lymphocytic leukemia and ERK1/2 phosphorylation via a ROR1/DOCK2-dependent mechanism","googleId":"b6BHz9KHd7MJ","googleLink":"https://www.nature.com/articles/s41375-020-01055-7","googleCitationCount":2,"googleAuthor":"MK Hasan","doi":"10.1038/s41375-020-01055-7","elsevierAuthor":"Hasan M.K.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network","googleId":"VhqXXjUF4cMJ","googleLink":"https://www.nature.com/articles/s41375-020-01016-0","googleCitationCount":2,"googleAuthor":"M Boccadoro","doi":"10.1038/s41375-020-01016-0","elsevierAuthor":"Ludwig H.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"January 2021","elsevierCitationCount":"1"},{"title":"CTCF-mediated genome organization and leukemogenesis","googleId":"WequCFRkqB0J","googleLink":"https://www.nature.com/articles/s41375-020-0906-x","googleCitationCount":1,"googleAuthor":"Y Qiu","doi":"10.1038/s41375-020-0906-x","elsevierAuthor":"Qiu Y.","publicationName":"Leukemia","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"0"},{"title":"Evaluating the efficacy of multiple myeloma cell lines as models for patient tumors via transcriptomic correlation analysis","googleId":"Q5jutiQcFioJ","googleLink":"https://www.nature.com/articles/s41375-020-0785-1","googleCitationCount":7,"googleAuthor":"","doi":"10.1038/s41375-020-0785-1","elsevierAuthor":"Sarin V.","publicationName":"Leukemia","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"2"},{"title":"Genomic characterization of patients with polycythemia vera developing resistance to hydroxyurea","googleId":"R-ycSAIepK8J","googleLink":"https://www.nature.com/articles/s41375-020-0849-2","googleCitationCount":2,"googleAuthor":"","doi":"10.1038/s41375-020-0849-2","elsevierAuthor":"Alvarez-Larrán A.","publicationName":"Leukemia","elsevierCoverDate":"2021-02-01","elsevierCoverDisplayDate":"February 2021","elsevierCitationCount":"0"},{"title":"Chromatin remodeler Znhit1 preserves hematopoietic stem cell quiescence by determining the accessibility of distal enhancers","googleId":"83jhyvaYTrkJ","googleLink":"https://www.nature.com/articles/s41375-020-0988-5","googleCitationCount":1,"googleAuthor":"","doi":"10.1038/s41375-020-0988-5","elsevierAuthor":"Sun S.","publicationName":"Leukemia","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"1"},{"title":"Simplified frailty assessment tools: are we really capturing frailty or something else?","googleId":"nXek7eqttZYJ","googleLink":"https://www.nature.com/articles/s41375-020-0712-5","googleCitationCount":4,"googleAuthor":"S Giri","doi":"10.1038/s41375-020-0712-5","elsevierAuthor":"Giri S.","publicationName":"Leukemia","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"3"},{"title":"Significance of minimal residual disease in pediatric mixed phenotype acute leukemia: a multicenter cohort study","googleId":"Z5vRhoJF8lsJ","googleLink":"https://www.nature.com/articles/s41375-020-0741-0","googleCitationCount":3,"googleAuthor":"MJ Oberley","doi":"10.1038/s41375-020-0741-0","elsevierAuthor":"Oberley M.J.","publicationName":"Leukemia","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"3"},{"title":"B-cell leukemia transdifferentiation to macrophage involves reconfiguration of DNA methylation for long-range regulation","googleId":"ltOgxG2QgL0J","googleLink":"https://www.nature.com/articles/s41375-019-0643-1","googleCitationCount":5,"googleAuthor":"BM Javierre","doi":"10.1038/s41375-019-0643-1","elsevierAuthor":"Bueno-Costa A.","publicationName":"Leukemia","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"April 2020","elsevierCitationCount":"4"},{"title":"Genetic predisposition for multiple myeloma","googleId":"tAM2bOOme6QJ","googleLink":"https://www.nature.com/articles/s41375-019-0703-6","googleCitationCount":5,"googleAuthor":"M Went","doi":"10.1038/s41375-019-0703-6","elsevierAuthor":"Pertesi M.","publicationName":"Leukemia","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"3"},{"title":"The transcription factor IRF4 represses proapoptotic BMF and BIM to licence multiple myeloma survival","googleId":"fMLqiStRFOwJ","googleLink":"https://www.nature.com/articles/s41375-020-01078-0","googleCitationCount":1,"googleAuthor":"Y Liao","doi":"10.1038/s41375-020-01078-0","elsevierAuthor":"Fedele P.L.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Bortezomib resistance mutations in PSMB5 determine response to second-generation proteasome inhibitors in multiple myeloma","googleId":"b37bvAuUV1oJ","googleLink":"https://www.nature.com/articles/s41375-020-0989-4","googleCitationCount":2,"googleAuthor":"RU Müller","doi":"10.1038/s41375-020-0989-4","elsevierAuthor":"Allmeroth K.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"1"},{"title":"Pomalidomide, bortezomib, and dexamethasone for multiple myeloma previously treated with lenalidomide (OPTIMISMM): outcomes by prior treatment at first …","googleId":"jkmrkbJvtvEJ","googleLink":"https://www.nature.com/articles/s41375%C2%A0020%2001021-3","googleCitationCount":2,"googleAuthor":"M Dimopoulos"},{"title":"Mutations associated with age-related clonal hematopoiesis in PMF patients with rapid progression to myelofibrosis","googleId":"v9sqbY9ue5IJ","googleLink":"https://www.nature.com/articles/s41375-019-0668-5","googleCitationCount":7,"googleAuthor":"M Faisal","doi":"10.1038/s41375-019-0668-5","elsevierAuthor":"Bartels S.","publicationName":"Leukemia","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"5"},{"title":"Breaking the spatial constraint between neighboring zinc fingers: a new germline mutation in GATA2 deficiency syndrome","googleId":"Iw5xnsSIt2wJ","googleLink":"https://www.nature.com/articles/s41375-020-0820-2","googleCitationCount":2,"googleAuthor":"KR Katsumura","doi":"10.1038/s41375-020-0820-2","elsevierAuthor":"Cavalcante de Andrade Silva M.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"January 2021","elsevierCitationCount":"3"},{"title":"Frequent mutations in the amino-terminal domain of BCL7A impair its tumor suppressor role in DLBCL","googleId":"fA-sBHRhJeoJ","googleLink":"https://www.nature.com/articles/s41375-020-0919-5","googleCitationCount":1,"googleAuthor":"A Andrades","doi":"10.1038/s41375-020-0919-5","elsevierAuthor":"Baliñas-Gavira C.","publicationName":"Leukemia","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"1"},{"title":"Pharmacological activation of nitric oxide signaling promotes human hematopoietic stem cell homing and engraftment","googleId":"QLn-EWb-Ez0J","googleLink":"https://www.nature.com/articles/s41375-020-0787-z","googleCitationCount":3,"googleAuthor":"B Guo","doi":"10.1038/s41375-020-0787-z","elsevierAuthor":"Xu D.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"January 2021","elsevierCitationCount":"1"},{"title":"Donor-derived CD19 CAR-T cell therapy of relapse of CD19-positive B-ALL post allotransplant","googleId":"ScFb-Nv312cJ","googleLink":"https://www.nature.com/articles/s41375-020-01056-6","googleCitationCount":1,"googleAuthor":"","doi":"10.1038/s41375-020-01056-6","elsevierAuthor":"Zhang C.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"1"},{"title":"Interaction kinetics with transcriptomic and secretory responses of CD19-CAR natural killer-cell therapy in CD20 resistant non-hodgkin lymphoma","googleId":"R6YAahhoQCMJ","googleLink":"https://www.nature.com/articles/s41375-019-0663-x","googleCitationCount":6,"googleAuthor":"S Sarkar","doi":"10.1038/s41375-019-0663-x","elsevierAuthor":"Ravi D.","publicationName":"Leukemia","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"6"},{"title":"Clinicopathologic characteristics, prognostication and treatment outcomes for myelodysplastic/myeloproliferative neoplasm, unclassifiable (MDS/MPN-U): Mayo Clinic …","googleId":"0dkcNtuGQhYJ","googleLink":"https://www.nature.com/articles/s41375-019-0574-x","googleCitationCount":9,"googleAuthor":"AA Mangaonkar","doi":"10.1038/s41375-019-0574-x","elsevierAuthor":"Mangaonkar A.A.","publicationName":"Leukemia","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"1 February 2020","elsevierCitationCount":"6"},{"title":"Prognostic models for chronic lymphocytic leukemia (CLL): a systematic review and meta-analysis","googleId":"ZWsOSzFG1NsJ","googleLink":"https://www.nature.com/articles/s41375-020-0924-8","googleCitationCount":2,"googleAuthor":"D Giannarelli","doi":"10.1038/s41375-020-0924-8","elsevierAuthor":"Molica S.","publicationName":"Leukemia","elsevierCoverDate":"2021-02-01","elsevierCoverDisplayDate":"February 2021","elsevierCitationCount":"2"},{"title":"Synthetic lethal targeting of TET2-mutant hematopoietic stem and progenitor cells (HSPCs) with TOP1-targeted drugs and PARP1 inhibitors","googleId":"anLHCwepiIIJ","googleLink":"https://www.nature.com/articles/s41375-020-0927-5?elqTrackId=a57dfb1af4e24a33994cb82cb05a063a","googleCitationCount":1,"googleAuthor":"CB Jing","doi":"10.1038/s41375-020-0927-5","elsevierAuthor":"Jing C.B.","publicationName":"Leukemia","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"1 November 2020","elsevierCitationCount":"1"},{"title":"Large granular lymphocytic leukemia coexists with myeloid clones and myelodysplastic syndrome","googleId":"T-a_5IqrElMJ","googleLink":"https://www.nature.com/articles/s41375-019-0601-y","googleCitationCount":6,"googleAuthor":"H Awada","doi":"10.1038/s41375-019-0601-y","elsevierAuthor":"Durrani J.","publicationName":"Leukemia","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"3"},{"title":"DNA methyltransferase inhibitors upregulate CD38 protein expression and enhance daratumumab efficacy in multiple myeloma","googleId":"ABjzP5Gc5l4J","googleLink":"https://www.nature.com/articles/s41375-019-0587-5","googleCitationCount":7,"googleAuthor":"P Choudhry","doi":"10.1038/s41375-019-0587-5","elsevierAuthor":"Choudhry P.","publicationName":"Leukemia","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"4"},{"title":"COVID-19 infection in hematopoietic cell transplantation: age, time from transplant and steroids matter","googleId":"b6i9o93-qRAJ","googleLink":"https://www.nature.com/articles/s41375-020-01019-x","googleCitationCount":4,"googleAuthor":"A Varma","doi":"10.1038/s41375-020-01019-x","elsevierAuthor":"Varma A.","publicationName":"Leukemia","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"3"},{"title":"Targeting tryptophan catabolic kynurenine pathway enhances antitumor immunity and cytotoxicity in multiple myeloma","googleId":"RIjLP2AcZ-MJ","googleLink":"https://www.nature.com/articles/s41375-019-0558-x","googleCitationCount":6,"googleAuthor":"Y Song","doi":"10.1038/s41375-019-0558-x","elsevierAuthor":"Ray A.","publicationName":"Leukemia","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"1 February 2020","elsevierCitationCount":"5"},{"title":"Biomarkers for RBM39 degradation in acute myeloid leukemia","googleId":"WQNQuPoZDtsJ","googleLink":"https://www.nature.com/articles/s41375-020-0729-9.pdf?origin=ppub","googleCitationCount":3,"googleAuthor":"J Kim","doi":"10.1038/s41375-020-0729-9","elsevierAuthor":"Hsiehchen D.","publicationName":"Leukemia","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"2"},{"title":"Integrative phosphoproteome and interactome analysis of the role of Ubash3b in BCR-ABL signaling","googleId":"m7S4G9CTGdAJ","googleLink":"https://www.nature.com/articles/s41375-019-0535-4","googleCitationCount":6,"googleAuthor":"JA Cutler","doi":"10.1038/s41375-019-0535-4","elsevierAuthor":"Cutler J.A.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"1 January 2020","elsevierCitationCount":"5"},{"title":"Revisiting complete response in light chain amyloidosis","googleId":"nVDBa0J5-ZoJ","googleLink":"https://www.nature.com/articles/s41375-019-0664-9","googleCitationCount":9,"googleAuthor":"S Sidana","doi":"10.1038/s41375-019-0664-9","elsevierAuthor":"Sidana S.","publicationName":"Leukemia","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"5"},{"title":"Mesenchymal stem cells suppress leukemia via macrophage-mediated functional restoration of bone marrow microenvironment","googleId":"-CgW0SHOZiIJ","googleLink":"https://www.nature.com/articles/s41375-020-0775-3","googleCitationCount":8,"googleAuthor":"H Cheng","doi":"10.1038/s41375-020-0775-3","elsevierAuthor":"Xia C.","publicationName":"Leukemia","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"5"},{"title":"Reinstated p53 response and high anti-T-cell leukemia activity by the novel alkylating deacetylase inhibitor tinostamustine","googleId":"bPZK5uaz6lQJ","googleLink":"https://www.nature.com/articles/s41375-020-0772-6","googleCitationCount":5,"googleAuthor":"AK Giri","doi":"10.1038/s41375-020-0772-6","elsevierAuthor":"Pützer S.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"January 2021","elsevierCitationCount":"0"},{"title":"Detection of chronic lymphocytic leukemia subpopulations in peripheral blood by phage ligands of tumor immunoglobulin B cell receptors","googleId":"_maj5gcb7rIJ","googleLink":"https://www.nature.com/articles/s41375-020-0885-y","googleCitationCount":3,"googleAuthor":"S Mimmi","doi":"10.1038/s41375-020-0885-y","elsevierAuthor":"Mimmi S.","publicationName":"Leukemia","elsevierCoverDate":"2021-02-01","elsevierCoverDisplayDate":"February 2021","elsevierCitationCount":"2"},{"title":"Pre-clinical activity of combined LSD1 and mTORC1 inhibition in MLL-translocated acute myeloid leukaemia","googleId":"UOuTkRfBB-0J","googleLink":"https://www.nature.com/articles/s41375-019-0659-6","googleCitationCount":7,"googleAuthor":"B Wingelhofer","doi":"10.1038/s41375-019-0659-6","elsevierAuthor":"Deb G.","publicationName":"Leukemia","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"3"},{"title":"PI3K-p110δ contributes to antibody responses by macrophages in chronic lymphocytic leukemia","googleId":"8sKxKFg4K94J","googleLink":"https://www.nature.com/articles/s41375-019-0556-z","googleCitationCount":7,"googleAuthor":"","doi":"10.1038/s41375-019-0556-z","elsevierAuthor":"Enya Chen Y.C.","publicationName":"Leukemia","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"1 February 2020","elsevierCitationCount":"6"},{"title":"Impact of somatic mutations in myelodysplastic patients with isolated partial or total loss of chromosome 7","googleId":"vBu27Dcvz44J","googleLink":"https://www.nature.com/articles/s41375-020-0728-x","googleCitationCount":2,"googleAuthor":"AG Kulasekararaj","doi":"10.1038/s41375-020-0728-x","elsevierAuthor":"Crisà E.","publicationName":"Leukemia","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"1"},{"title":"Clonal dominance is an adverse prognostic factor in acute myeloid leukemia treated with intensive chemotherapy","googleId":"fX6zz-yeTPgJ","googleLink":"https://www.nature.com/articles/s41375-020-0932-8","googleCitationCount":1,"googleAuthor":"M Cerrano","doi":"10.1038/s41375-020-0932-8","elsevierAuthor":"Cerrano M.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Blinatumomab versus historical standard therapy in pediatric patients with relapsed/refractory Ph-negative B-cell precursor acute lymphoblastic leukemia","googleId":"VsjyDrrj0sQJ","googleLink":"https://www.nature.com/articles/s41375-020-0770-8","googleCitationCount":2,"googleAuthor":"","doi":"10.1038/s41375-020-0770-8","elsevierAuthor":"Locatelli F.","publicationName":"Leukemia","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"1"},{"title":"Dynamic CD138 surface expression regulates switch between myeloma growth and dissemination","googleId":"6M264eBjsH0J","googleLink":"https://www.nature.com/articles/s41375-019-0519-4","googleCitationCount":5,"googleAuthor":"MJ McCarron","doi":"10.1038/s41375-019-0519-4","elsevierAuthor":"Akhmetzyanova I.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"1 January 2020","elsevierCitationCount":"3"},{"title":"Targeting cell membrane HDM2: A novel therapeutic approach for acute myeloid leukemia","googleId":"-kXHshHssEMJ","googleLink":"https://www.nature.com/articles/s41375-019-0522-9","googleCitationCount":5,"googleAuthor":"L Li","doi":"10.1038/s41375-019-0522-9","elsevierAuthor":"Wang H.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"1 January 2020","elsevierCitationCount":"3"},{"title":"Prognostic value of high-sensitivity measurable residual disease assessment after front-line chemoimmunotherapy in chronic lymphocytic leukemia","googleId":"gaQ9nq3shPUJ","googleLink":"https://www.nature.com/articles/s41375-020-01009-z","googleCitationCount":1,"googleAuthor":"","doi":"10.1038/s41375-020-01009-z","elsevierAuthor":"Letestu R.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"1"},{"title":"Evolving treatment patterns and outcomes in older patients (≥ 60 years) with AML: changing everything to change nothing?","googleId":"_YR3WCmIuisJ","googleLink":"https://www.nature.com/articles/s41375-020-01058-4","googleCitationCount":2,"googleAuthor":"D Martínez-Cuadrón","doi":"10.1038/s41375-020-01058-4","elsevierAuthor":"Martínez-Cuadrón D.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"2"},{"title":"Progress against childhood and adolescent acute lymphoblastic leukaemia in the Netherlands, 1990–2015","googleId":"DIj1foZc8FEJ","googleLink":"https://www.nature.com/articles/s41375-020-01024-0","googleCitationCount":1,"googleAuthor":"","doi":"10.1038/s41375-020-01024-0","elsevierAuthor":"Reedijk A.M.J.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"1"},{"title":"Dasatinib overcomes stroma-based resistance to the FLT3 inhibitor quizartinib using multiple mechanisms","googleId":"odWX0Hj1ZeEJ","googleLink":"https://www.nature.com/articles/s41375-020-0858-1","googleCitationCount":1,"googleAuthor":"D Yan","doi":"10.1038/s41375-020-0858-1","elsevierAuthor":"Patel A.B.","publicationName":"Leukemia","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"1 November 2020","elsevierCitationCount":"1"},{"title":"Inhibition of LSD1 in MDS progenitors restores differentiation of CD141 Hi conventional dendritic cells","googleId":"z9pow7exOE0J","googleLink":"https://www.nature.com/articles/s41375-020-0765-5","googleCitationCount":2,"googleAuthor":"P Srivastava","doi":"10.1038/s41375-020-0765-5","elsevierAuthor":"Srivastava P.","publicationName":"Leukemia","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"0"},{"title":"Analysis of chronic myeloid leukaemia during deep molecular response by genomic PCR: A traffic light stratification model with impact on treatment-free remission","googleId":"i8yZ-VtGs-gJ","googleLink":"https://www.nature.com/articles/s41375-020-0882-1","googleCitationCount":2,"googleAuthor":"","doi":"10.1038/s41375-020-0882-1","elsevierAuthor":"Machova Polakova K.","publicationName":"Leukemia","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"1"},{"title":"S100A6 is a critical regulator of hematopoietic stem cells","googleId":"xvdxfmXp0fEJ","googleLink":"https://www.nature.com/articles/s41375-020-0901-2","googleCitationCount":1,"googleAuthor":"THM Grahn","doi":"10.1038/s41375-020-0901-2","elsevierAuthor":"Grahn T.H.M.","publicationName":"Leukemia","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"0"},{"title":"Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of age","googleId":"YyL09Kb3T4wJ","googleLink":"https://www.nature.com/articles/s41375-020-0976-9","googleCitationCount":1,"googleAuthor":"EK Mai","doi":"10.1038/s41375-020-0976-9","elsevierAuthor":"Mai E.K.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"1"},{"title":"High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib","googleId":"bbKBVpyT4-YJ","googleLink":"https://www.nature.com/articles/s41375-020-01107-y","googleCitationCount":1,"googleAuthor":"T Barbui","doi":"10.1038/s41375-020-01107-y","elsevierAuthor":"Barbui T.","publicationName":"Leukemia","elsevierCoverDate":"2021-02-01","elsevierCoverDisplayDate":"February 2021","elsevierCitationCount":"1"},{"title":"BCR-ABL1 compound mutants: prevalence, spectrum and correlation with tyrosine kinase inhibitor resistance in a consecutive series of Philadelphia chromosome …","googleId":"bi2ink9P-oYJ","googleLink":"https://www.nature.com/articles/s41375-020-01098-w","googleCitationCount":1,"googleAuthor":"L Bavaro","doi":"10.1038/s41375-020-01098-w","elsevierAuthor":"Soverini S.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"1"},{"title":"Safety and efficacy of BAY1436032 in IDH1-mutant AML: phase I study results","googleId":"OS2sbJeUcDEJ","googleLink":"https://www.nature.com/articles/s41375-020-0996-5","googleCitationCount":3,"googleAuthor":"A Mims","doi":"10.1038/s41375-020-0996-5","elsevierAuthor":"Heuser M.","publicationName":"Leukemia","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"1 November 2020","elsevierCitationCount":"2"},{"title":"Genotyping circulating tumor DNA of pediatric Hodgkin lymphoma","googleId":"uXYfuF1HlQMJ","googleLink":"https://www.nature.com/articles/s41375-019-0541-6","googleCitationCount":8,"googleAuthor":"","doi":"10.1038/s41375-019-0541-6","elsevierAuthor":"Desch A.K.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"1 January 2020","elsevierCitationCount":"7"},{"title":"Remission of acute myeloid leukemia with t (8; 21) following CD19 CAR T-cells","googleId":"xLNtFyVX-foJ","googleLink":"https://www.nature.com/articles/s41375-020-0719-y","googleCitationCount":3,"googleAuthor":"E Jacoby","doi":"10.1038/s41375-020-0719-y","elsevierAuthor":"Danylesko I.","publicationName":"Leukemia","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"1"},{"title":"Effective drug treatment identified by in vivo screening in a transplantable patient-derived xenograft model of chronic myelomonocytic leukemia","googleId":"dE3fZLf1h84J","googleLink":"https://www.nature.com/articles/s41375-020-0929-3","googleCitationCount":1,"googleAuthor":"R Gabdoulline","doi":"10.1038/s41375-020-0929-3","elsevierAuthor":"Kloos A.","publicationName":"Leukemia","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"1 November 2020","elsevierCitationCount":"1"},{"title":"Bidirectional linkage between the B-cell receptor and NOTCH1 in chronic lymphocytic leukemia and in Richter's syndrome: therapeutic implications","googleId":"FspLgNOxdLkJ","googleLink":"https://www.nature.com/articles/s41375-019-0571-0","googleCitationCount":6,"googleAuthor":"T Vaisitti","doi":"10.1038/s41375-019-0571-0","elsevierAuthor":"Arruga F.","publicationName":"Leukemia","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"0"},{"title":"Platelet count predicts driver mutations' co-occurrence in low JAK2 mutated essential thrombocythemia and myelofibrosis","googleId":"zEaEWmJvQtQJ","googleLink":"https://www.nature.com/articles/s41375-020-01053-9","googleCitationCount":1,"googleAuthor":"M Maffioli","doi":"10.1038/s41375-020-01053-9","elsevierAuthor":"Mora B.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"1"},{"title":"The CD33 splice isoform lacking exon 2 as therapeutic target in human acute myeloid leukemia","googleId":"3VSLGIQ-muUJ","googleLink":"https://www.nature.com/articles/s41375-020-0755-7","googleCitationCount":3,"googleAuthor":"","doi":"10.1038/s41375-020-0755-7","elsevierAuthor":"Godwin C.D.","publicationName":"Leukemia","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"2"},{"title":"Post-transplantation cyclophosphamide GvHD prophylaxis after hematopoietic stem cell transplantation from 9/10 or 10/10 HLA-matched unrelated donors for acute …","googleId":"r7Y3BJaeAvYJ","googleLink":"https://www.nature.com/articles/s41375-020-0863-4","googleCitationCount":1,"googleAuthor":"F Lorentino","doi":"10.1038/s41375-020-0863-4","elsevierAuthor":"Lorentino F.","publicationName":"Leukemia","elsevierCoverDate":"2021-02-01","elsevierCoverDisplayDate":"February 2021","elsevierCitationCount":"0"},{"title":"Allogeneic haemopoietic transplantation for acute myeloid leukaemia in second complete remission: a registry report by the Acute Leukaemia Working Party of the …","googleId":"ebNgMc4MICkJ","googleLink":"https://www.nature.com/articles/s41375-019-0527-4","googleCitationCount":7,"googleAuthor":"M Labopin","doi":"10.1038/s41375-019-0527-4","elsevierAuthor":"Gilleece M.H.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"1 January 2020","elsevierCitationCount":"4"},{"title":"Clinical characteristics and outcome of SARS-CoV-2-infected patients with haematological diseases: a retrospective case study in four hospitals in Italy, Spain …","googleId":"hzJd97Uo3YQJ","googleLink":"https://www.nature.com/articles/s41375-020-0960-4","googleCitationCount":7,"googleAuthor":"","doi":"10.1038/s41375-020-0960-4","elsevierAuthor":"van Doesum J.","publicationName":"Leukemia","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"3"},{"title":"Immunomodulation with pomalidomide at early lymphocyte recovery after induction chemotherapy in newly diagnosed AML and high-risk MDS","googleId":"ddcYIiq121IJ","googleLink":"https://www.nature.com/articles/s41375-019-0693-4","googleCitationCount":4,"googleAuthor":"JF Zeidner","doi":"10.1038/s41375-019-0693-4","elsevierAuthor":"Zeidner J.F.","publicationName":"Leukemia","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"3"},{"title":"Is cancer latency an outdated concept? Lessons from chronic myeloid leukemia","googleId":"MUvKo9SG7sIJ","googleLink":"https://www.nature.com/articles/s41375-020-0957-z.pdf?origin=ppub","googleCitationCount":3,"googleAuthor":"NCP Cross","doi":"10.1038/s41375-020-0957-z","elsevierAuthor":"Abecasis M.","publicationName":"Leukemia","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"3"},{"title":"From leeches to interferon: should cytoreduction be prescribed for all patients with polycythemia vera?","googleId":"FYEAo3sfC0wJ","googleLink":"https://www.nature.com/articles/s41375-020-0984-9","googleCitationCount":2,"googleAuthor":"T Barbui","doi":"10.1038/s41375-020-0984-9","elsevierAuthor":"Kiladjian J.J.","publicationName":"Leukemia","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"1 November 2020","elsevierCitationCount":"2"},{"title":"Efficient treatment of murine acute GvHD by in vitro expanded donor regulatory T cells","googleId":"B9I0UoexyUAJ","googleLink":"https://www.nature.com/articles/s41375-019-0625-3","googleCitationCount":5,"googleAuthor":"","doi":"10.1038/s41375-019-0625-3","elsevierAuthor":"Riegel C.","publicationName":"Leukemia","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"3"},{"title":"Racial and age-related disparities in early mortality affect the outcomes of multiple myeloma patients","googleId":"guMX5fI5lvgJ","googleLink":"https://www.nature.com/articles/s41375-020-0812-2","googleCitationCount":2,"googleAuthor":"F Covut","doi":"10.1038/s41375-020-0812-2","elsevierAuthor":"Covut F.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"January 2021","elsevierCitationCount":"0"},{"title":"Therapeutic targeting of the E3 ubiquitin ligase SKP2 in T-ALL","googleId":"aMQ5ct51mKYJ","googleLink":"https://www.nature.com/articles/s41375-019-0653-z","googleCitationCount":4,"googleAuthor":"S Rodriguez","doi":"10.1038/s41375-019-0653-z","elsevierAuthor":"Rodriguez S.","publicationName":"Leukemia","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"4"},{"title":"Targeted deep sequencing reveals clonal and subclonal mutational signatures in Adult T-cell leukemia/lymphoma and defines an unfavorable indolent subtype","googleId":"yUyV5Pg1Q2gJ","googleLink":"https://www.nature.com/articles/s41375-020-0900-3","googleCitationCount":1,"googleAuthor":"L Lhermitte","doi":"10.1038/s41375-020-0900-3","elsevierAuthor":"Marçais A.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"1"},{"title":"Salvage autologous transplant and lenalidomide maintenance vs. lenalidomide/dexamethasone for relapsed multiple myeloma: the randomized GMMG phase III trial …","googleId":"cSnQ7Z72KpQJ","googleLink":"https://www.nature.com/articles/s41375-020-0948-0","googleCitationCount":5,"googleAuthor":"","doi":"10.1038/s41375-020-0948-0","elsevierAuthor":"Goldschmidt H.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"4"},{"title":"Erdheim–Chester disease: a rapidly evolving disease model","googleId":"rZ4DfBqPJa4J","googleLink":"https://www.nature.com/articles/s41375-020-0944-4","googleCitationCount":1,"googleAuthor":"","doi":"10.1038/s41375-020-0944-4","elsevierAuthor":"Pegoraro F.","publicationName":"Leukemia","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"1 November 2020","elsevierCitationCount":"1"},{"title":"The impact of complex karyotype on the overall survival of patients with relapsed chronic lymphocytic leukemia treated with idelalisib plus rituximab","googleId":"4tMANbiHxCwJ","googleLink":"https://www.nature.com/articles/s41375-019-0533-6","googleCitationCount":6,"googleAuthor":"S Stilgenbauer","doi":"10.1038/s41375-019-0533-6","elsevierAuthor":"Kreuzer K.A.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"1 January 2020","elsevierCitationCount":"6"},{"title":"CD9 blockade suppresses disease progression of high-risk pediatric B-cell precursor acute lymphoblastic leukemia and enhances chemosensitivity","googleId":"4w9YwzZnPksJ","googleLink":"https://www.nature.com/articles/s41375-019-0593-7","googleCitationCount":5,"googleAuthor":"KT Leung","doi":"10.1038/s41375-019-0593-7","elsevierAuthor":"Leung K.T.","publicationName":"Leukemia","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"2"},{"title":"Prevalence and dynamics of clonal hematopoiesis caused by leukemia-associated mutations in elderly individuals without hematologic disorders","googleId":"G2rFxZ11jUIJ","googleLink":"https://www.nature.com/articles/s41375-020-0869-y","googleCitationCount":3,"googleAuthor":"","doi":"10.1038/s41375-020-0869-y","elsevierAuthor":"Midic D.","publicationName":"Leukemia","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"0"},{"title":"CRL3–SPOP ubiquitin ligase complex suppresses the growth of diffuse large B-cell lymphoma by negatively regulating the MyD88/NF-κB signaling","googleId":"dQD__EJaroAJ","googleLink":"https://www.nature.com/articles/s41375-019-0661-z","googleCitationCount":4,"googleAuthor":"Q Shi","doi":"10.1038/s41375-019-0661-z","elsevierAuthor":"Jin X.","publicationName":"Leukemia","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"4"},{"title":"Clinical significance of TP53, BIRC3, ATM and MAPK-ERK genes in chronic lymphocytic leukaemia: data from the randomised UK LRF CLL4 trial","googleId":"HnOQmlUkXqkJ","googleLink":"https://www.nature.com/articles/s41375-020-0723-2","googleCitationCount":6,"googleAuthor":"P Antoniou","doi":"10.1038/s41375-020-0723-2","elsevierAuthor":"Blakemore S.J.","publicationName":"Leukemia","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"3"},{"title":"DUSP16 is a regulator of human hematopoietic stem and progenitor cells and promotes their expansion ex vivo","googleId":"wksTJ89Y35EJ","googleLink":"https://www.nature.com/articles/s41375-020-01064-6","googleCitationCount":1,"googleAuthor":"","doi":"10.1038/s41375-020-01064-6","elsevierAuthor":"Wang X.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Adipocytes in hematopoiesis and acute leukemia: friends, enemies, or innocent bystanders?","googleId":"oGOT1Hxv1bcJ","googleLink":"https://www.nature.com/articles/s41375-020-0886-x","googleCitationCount":1,"googleAuthor":"","doi":"10.1038/s41375-020-0886-x","elsevierAuthor":"Zinngrebe J.","publicationName":"Leukemia","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"1"},{"title":"A novel chimeric antigen receptor redirecting T-cell specificity towards CD26+ cancer cells","googleId":"C_oN9YTuTGEJ","googleLink":"https://www.nature.com/articles/s41375-020-0824-y","googleCitationCount":1,"googleAuthor":"W Li","doi":"10.1038/s41375-020-0824-y","elsevierAuthor":"Zhou S.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"January 2021","elsevierCitationCount":"1"},{"title":"Stat3 mutations impact on overall survival in large granular lymphocyte leukemia: a single-center experience of 205 patients","googleId":"hynt_aFQg98J","googleLink":"https://www.nature.com/articles/s41375-019-0644-0","googleCitationCount":5,"googleAuthor":"A Teramo","doi":"10.1038/s41375-019-0644-0","elsevierAuthor":"Barilà G.","publicationName":"Leukemia","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"April 2020","elsevierCitationCount":"4"},{"title":"Comparison of efficacy and health-related quality of life of first-line haploidentical hematopoietic stem cell transplantation with unrelated cord blood infusion and first …","googleId":"99vGM9PIojcJ","googleLink":"https://www.nature.com/articles/s41375-020-0933-7","googleCitationCount":1,"googleAuthor":"","doi":"10.1038/s41375-020-0933-7","elsevierAuthor":"Liu L.","publicationName":"Leukemia","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"1"},{"title":"Lomustine is beneficial to older AML with ELN2017 adverse risk profile and intermediate karyotype: a FILO study","googleId":"xnjSfmCSqboJ","googleLink":"https://www.nature.com/articles/s41375-020-01031-1","googleCitationCount":1,"googleAuthor":"","doi":"10.1038/s41375-020-01031-1","elsevierAuthor":"Largeaud L.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Effective targeting of NAMPT in patient-derived xenograft models of high-risk pediatric acute lymphoblastic leukemia","googleId":"XTu3mY_T-KgJ","googleLink":"https://www.nature.com/articles/s41375-019-0683-6","googleCitationCount":3,"googleAuthor":"","doi":"10.1038/s41375-019-0683-6","elsevierAuthor":"Somers K.","publicationName":"Leukemia","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"3"},{"title":"Mutational mechanisms of EZH2 inactivation in myeloid neoplasms","googleId":"ayttWPyg1-oJ","googleLink":"https://www.nature.com/articles/s41375-020-0816-y","googleCitationCount":1,"googleAuthor":"A Chase","doi":"10.1038/s41375-020-0816-y","elsevierAuthor":"Chase A.","publicationName":"Leukemia","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"0"},{"title":"Association of progression-free or event-free survival with overall survival in diffuse large B-cell lymphoma after immunochemotherapy: a systematic review","googleId":"DidH352NCeQJ","googleLink":"https://www.nature.com/articles/s41375-020-0963-1","googleCitationCount":1,"googleAuthor":"Y Yang","doi":"10.1038/s41375-020-0963-1","elsevierAuthor":"Zhu J.","publicationName":"Leukemia","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"1"},{"title":"A novel lymphoma-associated macrophage interaction signature (LAMIS) provides robust risk prognostication in diffuse large B-cell lymphoma clinical trial cohorts of …","googleId":"z3L7i1NtCI0J","googleLink":"https://www.nature.com/articles/s41375-019-0573-y","googleCitationCount":4,"googleAuthor":"M Altenbuchinger","doi":"10.1038/s41375-019-0573-y","elsevierAuthor":"Staiger A.M.","publicationName":"Leukemia","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"1 February 2020","elsevierCitationCount":"4"},{"title":"Engraftment kinetics after transplantation of double unit cord blood grafts combined with haplo-identical CD34+ cells without antithymocyte globulin","googleId":"M-wY0yWDSywJ","googleLink":"https://www.nature.com/articles/s41375-020-0922-x?elqTrackId=6e13666615614b9abccb82f668089edc","googleCitationCount":1,"googleAuthor":"I Politikos","doi":"10.1038/s41375-020-0922-x","elsevierAuthor":"Politikos I.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"1"},{"title":"Immunoglobulin gene analysis in chronic lymphocytic leukemia in the era of next generation sequencing","googleId":"nARMQ2H9IdMJ","googleLink":"https://www.nature.com/articles/s41375-020-0923-9","googleCitationCount":3,"googleAuthor":"","doi":"10.1038/s41375-020-0923-9","elsevierAuthor":"Davi F.","publicationName":"Leukemia","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"2"},{"title":"The effects of microRNA deregulation on pre-RNA processing network in multiple myeloma","googleId":"5_OTwAPw6n8J","googleLink":"https://www.nature.com/articles/s41375-019-0498-5","googleCitationCount":4,"googleAuthor":"S Adamia","doi":"10.1038/s41375-019-0498-5","elsevierAuthor":"Adamia S.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"1 January 2020","elsevierCitationCount":"3"},{"title":"Short term results of vaccination with adjuvanted recombinant varicella zoster glycoprotein E during initial BTK inhibitor therapy for CLL or lymphoplasmacytic …","googleId":"Mfw6HmTcW9IJ","googleLink":"https://www.nature.com/articles/s41375-020-01074-4","googleCitationCount":2,"googleAuthor":"CS Zent","doi":"10.1038/s41375-020-01074-4","elsevierAuthor":"Zent C.S.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"1"},{"title":"Serial evaluation of CD19 surface expression in pediatric B-cell malignancies following CD19-targeted therapy","googleId":"apoPj9ZX3QYJ","googleLink":"https://www.nature.com/articles/s41375-020-0760-x","googleCitationCount":2,"googleAuthor":"D Libert","doi":"10.1038/s41375-020-0760-x","elsevierAuthor":"Libert D.","publicationName":"Leukemia","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"1 November 2020","elsevierCitationCount":"2"},{"title":"Gata2 deficiency delays leukemogenesis while contributing to aggressive leukemia phenotype in Cbfb-MYH11 knockin mice","googleId":"YLndJjvm5hoJ","googleLink":"https://www.nature.com/articles/s41375-019-0605-7","googleCitationCount":4,"googleAuthor":"K Yu","doi":"10.1038/s41375-019-0605-7","elsevierAuthor":"Saida S.","publicationName":"Leukemia","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"1"},{"title":"LSD1-mediated repression of GFI1 super-enhancer plays an essential role in erythroleukemia","googleId":"lZ5qNBwEyWgJ","googleLink":"https://www.nature.com/articles/s41375-019-0614-6","googleCitationCount":4,"googleAuthor":"G Tatsumi","doi":"10.1038/s41375-019-0614-6","elsevierAuthor":"Tatsumi G.","publicationName":"Leukemia","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"4"},{"title":"Ibrutinib plus CIT for R/R mature B-NHL in children (SPARKLE trial): initial safety, pharmacokinetics, and efficacy","googleId":"T8lGHOs-9CcJ","googleLink":"https://www.nature.com/articles/s41375-020-0749-5","googleCitationCount":2,"googleAuthor":"","doi":"10.1038/s41375-020-0749-5","elsevierAuthor":"Burke G.A.A.","publicationName":"Leukemia","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"1"},{"title":"Eight novel loci implicate shared genetic etiology in multiple myeloma, AL amyloidosis, and monoclonal gammopathy of unknown significance","googleId":"NV0xkWm4JD4J","googleLink":"https://www.nature.com/articles/s41375-019-0619-1","googleCitationCount":6,"googleAuthor":"S Chattopadhyay","doi":"10.1038/s41375-019-0619-1","elsevierAuthor":"Chattopadhyay S.","publicationName":"Leukemia","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"April 2020","elsevierCitationCount":"4"},{"title":"A three-dimensional in vitro model of erythropoiesis recapitulates erythroid failure in myelodysplastic syndromes","googleId":"UNlnjC8cgCEJ","googleLink":"https://www.nature.com/articles/s41375-019-0532-7","googleCitationCount":6,"googleAuthor":"","doi":"10.1038/s41375-019-0532-7","elsevierAuthor":"Elvarsdóttir E.M.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"1 January 2020","elsevierCitationCount":"2"},{"title":"Spliceosome mutations are common in persons with myeloproliferative neoplasm-associated myelofibrosis with RBC-transfusion-dependence and correlate with …","googleId":"kvbGreQNgKwJ","googleLink":"https://www.nature.com/articles/s41375-020-0979-6","googleCitationCount":1,"googleAuthor":"N Barkas","doi":"10.1038/s41375-020-0979-6","elsevierAuthor":"Chowdhury O.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"1"},{"title":"Molecular characterization of a second myeloid neoplasm developing after treatment for acute myeloid leukemia","googleId":"sFvfm5oj3WQJ","googleLink":"https://www.nature.com/articles/s41375-019-0633-3","googleCitationCount":4,"googleAuthor":"","doi":"10.1038/s41375-019-0633-3","elsevierAuthor":"Hartmann L.","publicationName":"Leukemia","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"2"},{"title":"Cryptic genomic lesions in adverse-risk acute myeloid leukemia identified by integrated whole genome and transcriptome sequencing","googleId":"6Qg0dYjsGEwJ","googleLink":"https://www.nature.com/articles/s41375-019-0546-1","googleCitationCount":5,"googleAuthor":"PC Zuzarte","doi":"10.1038/s41375-019-0546-1","elsevierAuthor":"Kim J.C.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"1 January 2020","elsevierCitationCount":"4"},{"title":"Targeting translation initiation by synthetic rocaglates for treating MYC-driven lymphomas","googleId":"9pcJPZ_FuoUJ","googleLink":"https://www.nature.com/articles/s41375-019-0503-z","googleCitationCount":4,"googleAuthor":"C Bi","doi":"10.1038/s41375-019-0503-z","elsevierAuthor":"Zhang X.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"1 January 2020","elsevierCitationCount":"2"},{"title":"Male predominance in AML is associated with specific preleukemic mutations","googleId":"p-7oy71pqj8J","googleLink":"https://www.nature.com/articles/s41375-020-0935-5","googleCitationCount":1,"googleAuthor":"L Shlush","doi":"10.1038/s41375-020-0935-5","elsevierAuthor":"Locher M.","publicationName":"American Journal of Hematology","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"1"},{"title":"Reconstructing clonal evolution in relapsed and non-relapsed Burkitt lymphoma","googleId":"jiS_WF0kEjIJ","googleLink":"https://www.nature.com/articles/s41375-020-0862-5","googleCitationCount":1,"googleAuthor":"","doi":"10.1038/s41375-020-0862-5","elsevierAuthor":"Reutter K.","publicationName":"Leukemia","elsevierCoverDate":"2021-02-01","elsevierCoverDisplayDate":"February 2021","elsevierCitationCount":"1"},{"title":"Immunogenetic characterization of clonal plasma cells in systemic light-chain amyloidosis","googleId":"EZ783TMzukUJ","googleLink":"https://www.nature.com/articles/s41375-020-0800-6","googleCitationCount":1,"googleAuthor":"","doi":"10.1038/s41375-020-0800-6","elsevierAuthor":"Cuenca I.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"January 2021","elsevierCitationCount":"1"},{"title":"Long-term follow-up of JAK2 exon 12 polycythemia vera: a French Intergroup of Myeloproliferative Neoplasms (FIM) study","googleId":"6tiOZ455evoJ","googleLink":"https://www.nature.com/articles/s41375-020-0991-x","googleCitationCount":1,"googleAuthor":"J Riou","doi":"10.1038/s41375-020-0991-x","elsevierAuthor":"Tondeur S.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"1"},{"title":"The efficacy and safety of CAR-T cell therapy in patients with refractory ALL and concomitant HBV infection","googleId":"KLPpD97QfQ8J","googleLink":"https://www.nature.com/articles/s41375-020-0952-4","googleCitationCount":1,"googleAuthor":"","doi":"10.1038/s41375-020-0952-4","elsevierAuthor":"Lai P.","publicationName":"Leukemia","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"1"},{"title":"Do persons with chronic myeloid leukaemia have normal or near normal survival?","googleId":"ZJohTGCYYbkJ","googleLink":"https://www.nature.com/articles/s41375-019-0699-y","googleCitationCount":5,"googleAuthor":"T Radivoyevitch","doi":"10.1038/s41375-019-0699-y","elsevierAuthor":"Radivoyevitch T.","publicationName":"Leukemia","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"1 February 2020","elsevierCitationCount":"4"},{"title":"The therapeutic effectiveness of 177 Lu-lilotomab in B-cell non-Hodgkin lymphoma involves modulation of G2/M cell cycle arrest","googleId":"33nm3QzHSVYJ","googleLink":"https://www.nature.com/articles/s41375-019-0677-4","googleCitationCount":3,"googleAuthor":"J Constanzo","doi":"10.1038/s41375-019-0677-4","elsevierAuthor":"Pichard A.","publicationName":"Leukemia","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"2"},{"title":"Hematopoietic cell transplantation utilization and outcomes for primary plasma cell leukemia in the current era","googleId":"cgvMAhPXbo4J","googleLink":"https://www.nature.com/articles/s41375-020-0830-0","googleCitationCount":5,"googleAuthor":"B Dhakal","doi":"10.1038/s41375-020-0830-0","elsevierAuthor":"Dhakal B.","publicationName":"Leukemia","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"3"},{"title":"UGT1A1 genotype influences clinical outcome in patients with intermediate-risk acute myeloid leukemia treated with cytarabine-based chemotherapy","googleId":"xUXJQ3nyQOwJ","googleLink":"https://www.nature.com/articles/s41375-020-0784-2","googleCitationCount":2,"googleAuthor":"","doi":"10.1038/s41375-020-0784-2","elsevierAuthor":"Díaz-Santa J.","publicationName":"Leukemia","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"1 November 2020","elsevierCitationCount":"2"},{"title":"Low-dose ruxolitinib plus steroid in severe SARS-CoV-2 pneumonia","googleId":"89SI9yqQiBcJ","googleLink":"https://www.nature.com/articles/s41375-020-01087-z","googleCitationCount":1,"googleAuthor":"A D'Alessio","doi":"10.1038/s41375-020-01087-z","elsevierAuthor":"D’Alessio A.","publicationName":"Leukemia","elsevierCoverDate":"2021-02-01","elsevierCoverDisplayDate":"February 2021","elsevierCitationCount":"0"},{"title":"ATM activity in T cells is critical for immune surveillance of lymphoma in vivo","googleId":"lj7c-52a_VsJ","googleLink":"https://www.nature.com/articles/s41375-019-0618-2","googleCitationCount":3,"googleAuthor":"RD Jachimowicz","doi":"10.1038/s41375-019-0618-2","elsevierAuthor":"Riabinska A.","publicationName":"Leukemia","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"2"},{"title":"Characterization of myelodysplastic syndromes (MDS) with T-cell large granular lymphocyte proliferations (LGL)","googleId":"UKT6-4mjyloJ","googleLink":"https://www.nature.com/articles/s41375-020-0928-4","googleCitationCount":1,"googleAuthor":"E Padron","doi":"10.1038/s41375-020-0928-4","elsevierAuthor":"Komrokji R.S.","publicationName":"Leukemia","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"1 November 2020","elsevierCitationCount":"1"},{"title":"An MDS-specific frailty index based on cumulative deficits adds independent prognostic information to clinical prognostic scoring","googleId":"enpXoyrkOUYJ","googleLink":"https://www.nature.com/articles/s41375-019-0666-7","googleCitationCount":4,"googleAuthor":"RA Wells","doi":"10.1038/s41375-019-0666-7","elsevierAuthor":"Starkman R.","publicationName":"Leukemia","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"4"},{"title":"Activating somatic and germline TERT promoter variants in myeloid malignancies","googleId":"uY0iX3pUlRMJ","googleLink":"https://www.nature.com/articles/s41375-020-0837-6","googleCitationCount":1,"googleAuthor":"","doi":"10.1038/s41375-020-0837-6","elsevierAuthor":"Nofrini V.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"January 2021","elsevierCitationCount":"0"},{"title":"A highly heterogeneous mutational pattern in POEMS syndrome","googleId":"XQum1G2MbGsJ","googleLink":"https://www.nature.com/articles/s41375-020-01101-4","googleCitationCount":1,"googleAuthor":"","doi":"10.1038/s41375-020-01101-4","elsevierAuthor":"Chen J.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Clinical presentation and differential splicing of SRSF2, U2AF1 and SF3B1 mutations in patients with acute myeloid leukemia","googleId":"QsNlMMXmYpEJ","googleLink":"https://www.nature.com/articles/s41375-020-0839-4","googleCitationCount":4,"googleAuthor":"SA Bamopoulos","doi":"10.1038/s41375-020-0839-4","elsevierAuthor":"Bamopoulos S.A.","publicationName":"Leukemia","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"2"},{"title":"Outcomes in first relapsed-refractory younger patients with mantle cell lymphoma: results from the MANTLE-FIRST study","googleId":"HKJyLNlesR4J","googleLink":"https://www.nature.com/articles/s41375-020-01013-3","googleCitationCount":7,"googleAuthor":"C Visco","doi":"10.1038/s41375-020-01013-3","elsevierAuthor":"Visco C.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"2021","elsevierCitationCount":"0"},{"title":"Coordinated inhibition of nuclear export and Bcr-Abl1 selectively targets chronic myeloid leukemia stem cells","googleId":"jznDoE0wiisJ","googleLink":"https://www.nature.com/articles/s41375-020-0708-1","googleCitationCount":1,"googleAuthor":"D Yan","doi":"10.1038/s41375-020-0708-1","elsevierAuthor":"Than H.","publicationName":"Leukemia","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"0"},{"title":"Enhanced expression of the sphingosine-1-phosphate-receptor-3 causes acute myelogenous leukemia in mice","googleId":"4ZTUbC4WLisJ","googleLink":"https://www.nature.com/articles/s41375-019-0577-7","googleCitationCount":2,"googleAuthor":"","doi":"10.1038/s41375-019-0577-7","elsevierAuthor":"Vorbach S.","publicationName":"Leukemia","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"0"},{"title":"Regulation of PD-L1 expression is a novel facet of cyclic-AMP-mediated immunosuppression","googleId":"1IhsCZW5LZYJ","googleLink":"https://www.nature.com/articles/s41375-020-01105-0","googleCitationCount":0,"googleAuthor":"B Sasi","doi":"10.1038/s41375-020-01105-0","elsevierAuthor":"Sasi B.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"BCMA peptide-engineered nanoparticles enhance induction and function of antigen-specific CD8+ cytotoxic T lymphocytes against multiple myeloma: clinical …","googleId":"s_k_LtjjG8IJ","googleLink":"https://www.nature.com/articles/s41375-019-0540-7","googleCitationCount":4,"googleAuthor":"N Parayath","doi":"10.1038/s41375-019-0540-7","elsevierAuthor":"Iannazzo D.","publicationName":"Cancers","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"November 2020","elsevierCitationCount":"0"},{"title":"Can a disease be conquered by extensive publications, reading guidelines and interminable meetings?","googleId":"GpeqtKPcW8EJ","googleLink":"https://www.nature.com/articles/s41375-020-0897-7","googleCitationCount":3,"googleAuthor":"RP Gale","doi":"10.1038/s41375-020-0897-7","elsevierAuthor":"Gale R.P.","publicationName":"Leukemia","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"2"},{"title":"CARM1 inhibition reduces histone acetyltransferase activity causing synthetic lethality in CREBBP/EP300-mutated lymphomas","googleId":"1gRyMtjsk-8J","googleLink":"https://www.nature.com/articles/s41375-020-0908-8","googleCitationCount":1,"googleAuthor":"KJ Veazey","doi":"10.1038/s41375-020-0908-8","elsevierAuthor":"Veazey K.J.","publicationName":"Leukemia","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"1"},{"title":"EOMES and IL-10 regulate antitumor activity of T regulatory type 1 CD4+ T cells in chronic lymphocytic leukemia","googleId":"nJ-ZNnTkf4AJ","googleLink":"https://www.nature.com/articles/s41375-021-01136-1","googleCitationCount":0,"googleAuthor":"T Roider","doi":"10.1038/s41375-021-01136-1","elsevierAuthor":"Roessner P.M.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"2021","elsevierCitationCount":"0"},{"title":"ADARs, RNA editing and more in hematological malignancies","googleId":"3RgyvLQq47sJ","googleLink":"https://www.nature.com/articles/s41375-020-01076-2","googleCitationCount":0,"googleAuthor":"WJ Chng","doi":"10.1038/s41375-020-01076-2","elsevierAuthor":"Teoh P.J.","publicationName":"Leukemia","elsevierCoverDate":"2021-02-01","elsevierCoverDisplayDate":"February 2021","elsevierCitationCount":"0"},{"title":"Extracellular vesicles from myelodysplastic mesenchymal stromal cells induce DNA damage and mutagenesis of hematopoietic stem cells through miRNA transfer","googleId":"7BWNhgPpjHYJ","googleLink":"https://www.nature.com/articles/s41375-020-0738-8","googleCitationCount":1,"googleAuthor":"","doi":"10.1038/s41375-020-0738-8","elsevierAuthor":"Meunier M.","publicationName":"Leukemia","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"1"},{"title":"Clinical relevance of extracellular vesicles in hematological neoplasms: from liquid biopsy to cell biopsy","googleId":"Jo_Mj5u0268J","googleLink":"https://www.nature.com/articles/s41375-020-01104-1","googleCitationCount":0,"googleAuthor":"D Lamorte","doi":"10.1038/s41375-020-01104-1","elsevierAuthor":"Trino S.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Safety and efficacy of chimeric antigen receptor (CAR)-T-cell therapy in persons with advanced B-cell cancers and hepatitis B virus-infection","googleId":"amMImk-p_FQJ","googleLink":"https://www.nature.com/articles/s41375-020-0936-4","googleCitationCount":1,"googleAuthor":"","doi":"10.1038/s41375-020-0936-4","elsevierAuthor":"Wang Y.","publicationName":"Leukemia","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"1"},{"title":"Nanoparticle T-cell engagers as a modular platform for cancer immunotherapy","googleId":"rw9rkIQTCo0J","googleLink":"https://www.nature.com/articles/s41375-021-01127-2","googleCitationCount":0,"googleAuthor":"K Alhallak","doi":"10.1038/s41375-021-01127-2","elsevierAuthor":"Alhallak K.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"2021","elsevierCitationCount":"0"},{"title":"Cytoplasmic DROSHA and non-canonical mechanisms of MiR-155 biogenesis in FLT3-ITD acute myeloid leukemia","googleId":"N_Y8aVHr6C0J","googleLink":"https://www.nature.com/articles/s41375-021-01166-9","googleCitationCount":0,"googleAuthor":"DH Hoang","doi":"10.1038/s41375-021-01166-9","elsevierCitationCount":0},{"title":"Dual targeting of MTOR as a novel therapeutic approach for high-risk B-cell acute lymphoblastic leukemia","googleId":"RBbtvjv8ToUJ","googleLink":"https://www.nature.com/articles/s41375-021-01132-5","googleCitationCount":0,"googleAuthor":"C Song","doi":"10.1038/s41375-021-01132-5","elsevierAuthor":"Ge Z.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"2021","elsevierCitationCount":"0"},{"title":"Hematopoietic stem and progenitor cell signaling in the niche","googleId":"ggESaZt4iiYJ","googleLink":"https://www.nature.com/articles/s41375-020-01062-8?elqTrackId=136efa045af545ddba122c97fd12c8e9","googleCitationCount":2,"googleAuthor":"SN Hurwitz","doi":"10.1038/s41375-020-01062-8","elsevierAuthor":"Hurwitz S.N.","publicationName":"Leukemia","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"0"},{"title":"Selective elimination of immunosuppressive T cells in patients with multiple myeloma","googleId":"UyEa7zr-mYQJ","googleLink":"https://www.nature.com/articles/s41375-021-01172-x","googleCitationCount":0,"googleAuthor":"MHS Awwad","doi":"10.1038/s41375-021-01172-x","elsevierCitationCount":0},{"title":"Recent BCR stimulation induces a negative autoregulatory loop via FBXO10 mediated degradation of HGAL","googleId":"6yjvzRDjef0J","googleLink":"https://www.nature.com/articles/s41375-019-0579-5","googleCitationCount":3,"googleAuthor":"","doi":"10.1038/s41375-019-0579-5","elsevierAuthor":"Guo F.","publicationName":"Leukemia","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"1 February 2020","elsevierCitationCount":"1"},{"title":"Asxl1 C-terminal mutation perturbs neutrophil differentiation in zebrafish","googleId":"Vt-vLQfW4YIJ","googleLink":"https://www.nature.com/articles/s41375-021-01121-8","googleCitationCount":0,"googleAuthor":"K Yen","doi":"10.1038/s41375-021-01121-8","elsevierAuthor":"Fang X.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"2021","elsevierCitationCount":"0"},{"title":"PD-1 blockade in extranodal NK/T-cell lymphoma: who is in charge?","googleId":"x6_EB7gfaKYJ","googleLink":"https://www.nature.com/articles/s41375-020-01046-8","googleCitationCount":2,"googleAuthor":"","doi":"10.1038/s41375-020-01046-8","elsevierAuthor":"Wang L.","publicationName":"Leukemia","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"0"},{"title":"The mevalonate pathway is an actionable vulnerability of t (4; 14)-positive multiple myeloma","googleId":"onO3E0TjR_UJ","googleLink":"https://www.nature.com/articles/s41375-020-0962-2","googleCitationCount":4,"googleAuthor":"J Longo","doi":"10.1038/s41375-020-0962-2","elsevierAuthor":"Longo J.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"1"},{"title":"T-cell acute lymphoblastic leukemia in patients 1–45 years treated with the pediatric NOPHO ALL2008 protocol","googleId":"3clM4i2KBF0J","googleLink":"https://www.nature.com/articles/s41375-019-0598-2","googleCitationCount":10,"googleAuthor":"","doi":"10.1038/s41375-019-0598-2","elsevierAuthor":"Quist-Paulsen P.","publicationName":"Leukemia","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"1 February 2020","elsevierCitationCount":"6"},{"title":"The long non-coding RNA CRNDE regulates growth of multiple myeloma cells via an effect on IL6 signalling","googleId":"816foQ1_JQQJ","googleLink":"https://www.nature.com/articles/s41375-020-01034-y","googleCitationCount":0,"googleAuthor":"A Talbot","doi":"10.1038/s41375-020-01034-y","elsevierAuthor":"David A.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"A modular and controllable T cell therapy platform for acute myeloid leukemia","googleId":"3yoqDwT8OT4J","googleLink":"https://www.nature.com/articles/s41375-020-01109-w?elqTrackId=e7db2af093014e82a745b9906d9b92aa","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-020-01109-w","elsevierAuthor":"Benmebarek M.R.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"2021","elsevierCitationCount":"0"},{"title":"Co-mutation pattern, clonal hierarchy, and clone size concur to determine disease phenotype of SRSF2 P95-mutated neoplasms","googleId":"CoPb-hFUCN4J","googleLink":"https://www.nature.com/articles/s41375-020-01106-z","googleCitationCount":0,"googleAuthor":"P Guglielmelli","doi":"10.1038/s41375-020-01106-z","elsevierAuthor":"Todisco G.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Restoration of microRNA function impairs MYC-dependent maintenance of MLL leukemia","googleId":"bLBkUuBhqL0J","googleLink":"https://www.nature.com/articles/s41375-020-0768-2","googleCitationCount":1,"googleAuthor":"","doi":"10.1038/s41375-020-0768-2","elsevierAuthor":"Zhu S.","publicationName":"Leukemia","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"1"},{"title":"miR-10a as a therapeutic target and predictive biomarker for MDM2 inhibition in acute myeloid leukemia","googleId":"q5vo1KpbyecJ","googleLink":"https://www.nature.com/articles/s41375-020-01095-z","googleCitationCount":0,"googleAuthor":"F Stölzel","doi":"10.1038/s41375-020-01095-z","elsevierAuthor":"Vu T.T.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Exposure to ibritumomab tiuxetan and incidence of treatment-related myeloid neoplasms among older patients with B-cell lymphoma: a population-based study","googleId":"H9LSt2O9VpAJ","googleLink":"https://www.nature.com/articles/s41375-020-0798-9","googleCitationCount":3,"googleAuthor":"M Di","doi":"10.1038/s41375-020-0798-9","elsevierAuthor":"Di M.","publicationName":"Leukemia","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"3"},{"title":"Transcriptomic analysis implicates necroptosis in disease progression and prognosis in myelodysplastic syndromes","googleId":"1spODwsscrsJ","googleLink":"https://www.nature.com/articles/s41375-019-0623-5","googleCitationCount":4,"googleAuthor":"CA Class","doi":"10.1038/s41375-019-0623-5","elsevierAuthor":"Montalban-Bravo G.","publicationName":"Leukemia","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"1"},{"title":"Elevated Hedgehog activity contributes to attenuated DNA damage responses in aged hematopoietic cells","googleId":"-noiSpwpEHYJ","googleLink":"https://www.nature.com/articles/s41375-019-0641-3","googleCitationCount":2,"googleAuthor":"","doi":"10.1038/s41375-019-0641-3","elsevierAuthor":"Scheffold A.","publicationName":"Leukemia","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"April 2020","elsevierCitationCount":"0"},{"title":"Late outcomes in survivors of childhood acute myeloid leukemia: a report from the St. Jude Lifetime Cohort Study","googleId":"P1qVb1oNJqMJ","googleLink":"https://www.nature.com/articles/s41375-021-01134-3","googleCitationCount":0,"googleAuthor":"NS Bhatt","doi":"10.1038/s41375-021-01134-3","elsevierAuthor":"Bhatt N.S.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"2021","elsevierCitationCount":"0"},{"title":"Targeted inhibition of cooperative mutation-and therapy-induced AKT activation in AML effectively enhances response to chemotherapy","googleId":"U68hfCCV7NEJ","googleLink":"https://www.nature.com/articles/s41375-020-01094-0","googleCitationCount":0,"googleAuthor":"K Reckzeh","doi":"10.1038/s41375-020-01094-0","elsevierAuthor":"Estruch M.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"BTK gatekeeper residue variation combined with cysteine 481 substitution causes super-resistance to irreversible inhibitors acalabrutinib, ibrutinib and …","googleId":"O5A8A3BLtEoJ","googleLink":"https://www.nature.com/articles/s41375-021-01123-6","googleCitationCount":0,"googleAuthor":"GCP Schaafsma","doi":"10.1038/s41375-021-01123-6","elsevierAuthor":"Estupiñán H.Y.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"2021","elsevierCitationCount":"0"},{"title":"TCL1 transgenic mice as a model for CD49d-high chronic lymphocytic leukemia","googleId":"eBsBXp0g5LAJ","googleLink":"https://www.nature.com/articles/s41375-020-0759-3","googleCitationCount":1,"googleAuthor":"","doi":"10.1038/s41375-020-0759-3","elsevierAuthor":"Szenes E.","publicationName":"Leukemia","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"0"},{"title":"DNA methylation-based classification reveals difference between pediatric T-cell acute lymphoblastic leukemia and normal thymocytes","googleId":"VeESWjg0ZtQJ","googleLink":"https://www.nature.com/articles/s41375-019-0626-2","googleCitationCount":5,"googleAuthor":"K Yoshida","doi":"10.1038/s41375-019-0626-2","elsevierAuthor":"Kimura S.","publicationName":"Leukemia","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"April 2020","elsevierCitationCount":"3"},{"title":"Posttransplant cyclophosphamide after allogeneic hematopoietic cell transplantation mitigates the immune activation induced by previous nivolumab therapy","googleId":"z-AAGIhvUPIJ","googleLink":"https://www.nature.com/articles/s41375-020-0851-8","googleCitationCount":2,"googleAuthor":"JC Nieto","doi":"10.1038/s41375-020-0851-8","elsevierAuthor":"Nieto J.C.","publicationName":"Leukemia","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"0"},{"title":"The BET inhibitor GS-5829 targets chronic lymphocytic leukemia cells and their supportive microenvironment","googleId":"yfPE2jLu09IJ","googleLink":"https://www.nature.com/articles/s41375-019-0682-7","googleCitationCount":2,"googleAuthor":"M Sivina","doi":"10.1038/s41375-019-0682-7","elsevierAuthor":"Kim E.","publicationName":"Leukemia","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"3"},{"title":"Musashi 2 influences chronic lymphocytic leukemia cell survival and growth making it a potential therapeutic target","googleId":"h8Hupr-c3mMJ","googleLink":"https://www.nature.com/articles/s41375-020-01115-y","googleCitationCount":0,"googleAuthor":"G Ferrer","doi":"10.1038/s41375-020-01115-y","elsevierAuthor":"Palacios F.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"2021","elsevierCitationCount":"0"},{"title":"Characterization of complete lncRNAs transcriptome reveals the functional and clinical impact of lncRNAs in multiple myeloma","googleId":"Jzwal0t3iG4J","googleLink":"https://www.nature.com/articles/s41375-021-01147-y","googleCitationCount":0,"googleAuthor":"C Meydan","doi":"10.1038/s41375-021-01147-y","elsevierCitationCount":0},{"title":"A novel model of alternative NF-κB pathway activation in anaplastic large cell lymphoma","googleId":"NT4-mBoTZwQJ","googleLink":"https://www.nature.com/articles/s41375-020-01088-y","googleCitationCount":1,"googleAuthor":"W Wei","doi":"10.1038/s41375-020-01088-y","elsevierAuthor":"Wang H.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Lineage of measurable residual disease in patients with chronic myeloid leukemia in treatment-free remission","googleId":"ueByB6snHMYJ","googleLink":"https://www.nature.com/articles/s41375-019-0647-x","googleCitationCount":10,"googleAuthor":"IS Pagani","doi":"10.1038/s41375-019-0647-x","elsevierAuthor":"Pagani I.S.","publicationName":"Leukemia","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"April 2020","elsevierCitationCount":"10"},{"title":"MRD response in relapsed/refractory FL after obinutuzumab plus bendamustine or bendamustine alone in the GADOLIN trial","googleId":"Fji8YxwhWEUJ","googleLink":"https://www.nature.com/articles/s41375-019-0559-9","googleCitationCount":4,"googleAuthor":"C Pott","doi":"10.1038/s41375-019-0559-9","elsevierAuthor":"Pott C.","publicationName":"Leukemia","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"1 February 2020","elsevierCitationCount":"3"},{"title":"Impact of measurable residual disease by decentralized flow cytometry: a PETHEMA real-world study in 1076 patients with acute myeloid leukemia","googleId":"bRhxZ4sC2sMJ","googleLink":"https://www.nature.com/articles/s41375-021-01126-3","googleCitationCount":0,"googleAuthor":"E Colado","doi":"10.1038/s41375-021-01126-3","elsevierAuthor":"Paiva B.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"2021","elsevierCitationCount":"0"},{"title":"U2af1 is required for survival and function of hematopoietic stem/progenitor cells","googleId":"lL36PjBfXXcJ","googleLink":"https://www.nature.com/articles/s41375-020-01116-x?elqTrackId=16629c63e6024a45834e964a80bb6169","googleCitationCount":0,"googleAuthor":"A Dutta","doi":"10.1038/s41375-020-01116-x","elsevierAuthor":"Dutta A.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"2021","elsevierCitationCount":"0"},{"title":"Carfilzomib-induced endothelial dysfunction, recovery of proteasome activity, and prediction of cardiovascular complications: a prospective study","googleId":"meFq6BhKOsgJ","googleLink":"https://www.nature.com/articles/s41375-021-01141-4","googleCitationCount":0,"googleAuthor":"E Kastritis","doi":"10.1038/s41375-021-01141-4","elsevierCitationCount":0},{"title":"Changing paradigms in diagnosis and treatment of monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM)","googleId":"WAEucEkBlB4J","googleLink":"https://www.nature.com/articles/s41375-020-01051-x","googleCitationCount":0,"googleAuthor":"M Ho","doi":"10.1038/s41375-020-01051-x","elsevierAuthor":"Ho M.","publicationName":"Leukemia","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"0"},{"title":"IL-6 trans-signaling promotes the expansion and anti-tumor activity of CAR T cells","googleId":"vDDqw-0PV-QJ","googleLink":"https://www.nature.com/articles/s41375-020-01085-1?elqTrackId=5bfd29118d0c4745a77dbd39651056a1","googleCitationCount":1,"googleAuthor":"","doi":"10.1038/s41375-020-01085-1","elsevierAuthor":"Jiang Z.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"1"},{"title":"Maternal exposure to fine particulate matter during pregnancy induces progressive senescence of hematopoietic stem cells under preferential impairment of the bone …","googleId":"vcWbuTEtjiQJ","googleLink":"https://www.nature.com/articles/s41375-019-0665-8","googleCitationCount":3,"googleAuthor":"JB Lee","doi":"10.1038/s41375-019-0665-8","elsevierAuthor":"Bhattarai G.","publicationName":"Leukemia","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"3"},{"title":"Determinants and role of chromatin organization in acute leukemia","googleId":"j6frxMQQ6BIJ","googleLink":"https://www.nature.com/articles/s41375-020-0981-z?elqTrackId=7ada9f41c3ce4ec5b1e633f0955af21b","googleCitationCount":0,"googleAuthor":"C Fang","doi":"10.1038/s41375-020-0981-z","elsevierAuthor":"Fang C.","publicationName":"Leukemia","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"0"},{"title":"Stage-specific trends in primary therapy and survival in follicular lymphoma: a nationwide population-based analysis in the Netherlands, 1989–2016","googleId":"UERvA2tu8BcJ","googleLink":"https://www.nature.com/articles/s41375-020-01048-6","googleCitationCount":1,"googleAuthor":"","doi":"10.1038/s41375-020-01048-6","elsevierAuthor":"Dinnessen M.A.W.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"IDH1/2 mutations in acute myeloid leukemia patients and risk of coronary artery disease and cardiac dysfunction—a retrospective propensity score analysis","googleId":"Bc1-BKTvTlUJ","googleLink":"https://www.nature.com/articles/s41375-020-01043-x","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-020-01043-x","elsevierAuthor":"Kattih B.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Mapping comorbidity in chronic lymphocytic leukemia: impact of individual comorbidities on treatment, mortality, and causes of death","googleId":"q7pr4TmikyYJ","googleLink":"https://www.nature.com/articles/s41375-021-01156-x","googleCitationCount":0,"googleAuthor":"EC Rotbain","doi":"10.1038/s41375-021-01156-x","elsevierCitationCount":0},{"title":"High-dose romiplostim accelerates hematologic recovery in patients with aplastic anemia refractory to eltrombopag","googleId":"8D9Vw399G_EJ","googleLink":"https://www.nature.com/articles/s41375-020-0950-6","googleCitationCount":1,"googleAuthor":"K Hosokawa","doi":"10.1038/s41375-020-0950-6","elsevierAuthor":"Hosokawa K.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"1"},{"title":"Copy number evolution and its relationship with patient outcome—an analysis of 178 matched presentation-relapse tumor pairs from the Myeloma XI trial","googleId":"nEQ9F1GE8KAJ","googleLink":"https://www.nature.com/articles/s41375-020-01096-y","googleCitationCount":0,"googleAuthor":"AL Sherborne","doi":"10.1038/s41375-020-01096-y","elsevierAuthor":"Croft J.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group …","googleId":"w84AqO1hD6gJ","googleLink":"https://www.nature.com/articles/s41375-020-01042-y","googleCitationCount":2,"googleAuthor":"Y Yang","doi":"10.1038/s41375-020-01042-y","elsevierAuthor":"Yang Y.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Targeting the membrane-proximal C2-set domain of CD33 for improved CD33-directed immunotherapy","googleId":"uctev0YRUl0J","googleLink":"https://www.nature.com/articles/s41375-021-01160-1","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-021-01160-1","elsevierCitationCount":0},{"title":"CXCR4 in Waldenström's Macroglobulinema: chances and challenges","googleId":"EjHJLgvzA7wJ","googleLink":"https://www.nature.com/articles/s41375-020-01102-3","googleCitationCount":0,"googleAuthor":"LM Kaiser","doi":"10.1038/s41375-020-01102-3","elsevierAuthor":"Kaiser L.M.","publicationName":"Leukemia","elsevierCoverDate":"2021-02-01","elsevierCoverDisplayDate":"February 2021","elsevierCitationCount":"0"},{"title":"Bcor deficiency perturbs erythro-megakaryopoiesis and cooperates with Dnmt3a loss in acute erythroid leukemia onset in mice","googleId":"N01CW7X4yyAJ","googleLink":"https://www.nature.com/articles/s41375-020-01075-3","googleCitationCount":1,"googleAuthor":"P Sportoletti","doi":"10.1038/s41375-020-01075-3","elsevierAuthor":"Sportoletti P.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"New strategies to treat AML: novel insights into AML survival pathways and combination therapies","googleId":"nrZl0MIFbVkJ","googleLink":"https://www.nature.com/articles/s41375-020-01069-1","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-020-01069-1","elsevierAuthor":"Nair R.","publicationName":"Leukemia","elsevierCoverDate":"2021-02-01","elsevierCoverDisplayDate":"February 2021","elsevierCitationCount":"0"},{"title":"PRL3 enhances T-cell acute lymphoblastic leukemia growth through suppressing T-cell signaling pathways and apoptosis","googleId":"SX-MZhB3HCYJ","googleLink":"https://www.nature.com/articles/s41375-020-0937-3","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-020-0937-3","elsevierAuthor":"Garcia E.G.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Characterization of p190-Bcr-Abl chronic myeloid leukemia reveals specific signaling pathways and therapeutic targets","googleId":"DD5F3-6S0D4J","googleLink":"https://www.nature.com/articles/s41375-020-01082-4","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-020-01082-4","elsevierAuthor":"Adnan-Awad S.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"RNA editing contributes to epitranscriptome diversity in chronic lymphocytic leukemia","googleId":"2B8AmkxkjCsJ","googleLink":"https://www.nature.com/articles/s41375-020-0995-6","googleCitationCount":1,"googleAuthor":"EY Levanon","doi":"10.1038/s41375-020-0995-6","elsevierAuthor":"Gassner F.J.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"1"},{"title":"T-ALL can evolve to oncogene independence","googleId":"ln_43Lz8zVMJ","googleLink":"https://www.nature.com/articles/s41375-021-01120-9","googleCitationCount":0,"googleAuthor":"BJ Shields","doi":"10.1038/s41375-021-01120-9","elsevierAuthor":"Abdulla H.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"2021","elsevierCitationCount":"0"},{"title":"Early hospital discharge after intensive induction chemotherapy for adults with acute myeloid leukemia or other high-grade myeloid neoplasm","googleId":"pjgeiCHlNMwJ","googleLink":"https://www.nature.com/articles/s41375-019-0586-6","googleCitationCount":4,"googleAuthor":"","doi":"10.1038/s41375-019-0586-6","elsevierAuthor":"Halpern A.B.","publicationName":"Leukemia","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"1 February 2020","elsevierCitationCount":"3"},{"title":"Rituximab in newly diagnosed stage IA nodular lymphocyte-predominant Hodgkin lymphoma: long-term follow-up of a phase 2 study from the German Hodgkin Study …","googleId":"6XpMPSA4CtcJ","googleLink":"https://www.nature.com/articles/s41375-019-0609-3","googleCitationCount":4,"googleAuthor":"","doi":"10.1038/s41375-019-0609-3","elsevierAuthor":"Eichenauer D.A.","publicationName":"Leukemia","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"4"},{"title":"Menin is necessary for long term maintenance of meningioma-1 driven leukemia","googleId":"-p8u3dXbROgJ","googleLink":"https://www.nature.com/articles/s41375-021-01146-z","googleCitationCount":0,"googleAuthor":"MC Kingsley","doi":"10.1038/s41375-021-01146-z","elsevierAuthor":"Libbrecht C.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"2021","elsevierCitationCount":"0"},{"title":"Value of flow cytometry for MRD-based relapse prediction in B-cell precursor ALL in a multicenter setting","googleId":"KyNYDbtMo2MJ","googleLink":"https://www.nature.com/articles/s41375-020-01100-5","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-020-01100-5","elsevierCitationCount":0},{"title":"Venetoclax and pegcrisantaspase for complex karyotype acute myeloid leukemia","googleId":"0S9Ue5j9isEJ","googleLink":"https://www.nature.com/articles/s41375-020-01080-6","googleCitationCount":0,"googleAuthor":"A Emadi","doi":"10.1038/s41375-020-01080-6","elsevierAuthor":"Emadi A.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Distinct genetic changes reveal evolutionary history and heterogeneous molecular grade of DLBCL with MYC/BCL2 double-hit","googleId":"IDcaKJk37I0J","googleLink":"https://www.nature.com/articles/s41375-019-0691-6","googleCitationCount":2,"googleAuthor":"F Cucco","doi":"10.1038/s41375-019-0691-6","elsevierAuthor":"Cucco F.","publicationName":"Leukemia","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"2"},{"title":"Inhibitors targeting Bruton's tyrosine kinase in cancers: drug development advances","googleId":"_Tt0tGlDbBMJ","googleLink":"https://www.nature.com/articles/s41375-020-01072-6","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-020-01072-6","elsevierAuthor":"Wen T.","publicationName":"Leukemia","elsevierCoverDate":"2021-02-01","elsevierCoverDisplayDate":"February 2021","elsevierCitationCount":"0"},{"title":"Ethnic and geographic diversity of chronic lymphocytic leukaemia","googleId":"qjB8PSg8droJ","googleLink":"https://www.nature.com/articles/s41375-020-01057-5","googleCitationCount":1,"googleAuthor":"","doi":"10.1038/s41375-020-01057-5","elsevierAuthor":"Yang S.","publicationName":"Leukemia","elsevierCoverDate":"2021-02-01","elsevierCoverDisplayDate":"February 2021","elsevierCitationCount":"0"},{"title":"Allogeneic hematopoietic stem cell transplantation for adult patients with t (4; 11)(q21; q23) KMT2A/AFF1 B-cell precursor acute lymphoblastic leukemia in first …","googleId":"BR4oxJruYzMJ","googleLink":"https://www.nature.com/articles/s41375-021-01135-2","googleCitationCount":0,"googleAuthor":"J Esteve","doi":"10.1038/s41375-021-01135-2","elsevierAuthor":"Esteve J.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"2021","elsevierCitationCount":"0"},{"title":"Two decades of targeted therapies in acute myeloid leukemia","googleId":"zOYAF3dEdzcJ","googleLink":"https://www.nature.com/articles/s41375-021-01164-x","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-021-01164-x","elsevierCitationCount":0},{"title":"Efficacy and safety profile of deep responders to carfilzomib-based therapy: a subgroup analysis from ASPIRE and ENDEAVOR","googleId":"pXqhJMbc4hUJ","googleLink":"https://www.nature.com/articles/s41375-020-01049-5","googleCitationCount":0,"googleAuthor":"MV Mateos","doi":"10.1038/s41375-020-01049-5","elsevierAuthor":"Weisel K.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"The association between deaths from infection and mutations of the BRAF, FBXW7, NRAS and XPO1 genes: a report from the LRF CLL4 trial","googleId":"6POTVxQU85IJ","googleLink":"https://www.nature.com/articles/s41375-021-01165-w","googleCitationCount":0,"googleAuthor":"M Else","doi":"10.1038/s41375-021-01165-w","elsevierCitationCount":0},{"title":"Requirement for LIM kinases in acute myeloid leukemia","googleId":"z5VxK7fvI0kJ","googleLink":"https://www.nature.com/articles/s41375-020-0943-5","googleCitationCount":0,"googleAuthor":"RF Schlenk","doi":"10.1038/s41375-020-0943-5","elsevierAuthor":"Jensen P.","publicationName":"Leukemia","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"0"},{"title":"Which lower risk myelodysplastic syndromes should be treated with allogeneic hematopoietic stem cell transplantation?","googleId":"Ce20Z7_mBOoJ","googleLink":"https://www.nature.com/articles/s41375-020-0967-x","googleCitationCount":1,"googleAuthor":"","doi":"10.1038/s41375-020-0967-x","elsevierAuthor":"Robin M.","publicationName":"Leukemia","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"1"},{"title":"Thiopurine-mediated impairment of hematopoietic stem and leukemia cells in Nudt15 R138C knock-in mice","googleId":"nvQaNjWQUU0J","googleLink":"https://www.nature.com/articles/s41375-019-0583-9","googleCitationCount":2,"googleAuthor":"G Tatsumi","doi":"10.1038/s41375-019-0583-9","elsevierAuthor":"Tatsumi G.","publicationName":"Leukemia","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"2"},{"title":"Cross-talk between GLI transcription factors and FOXC1 promotes T-cell acute lymphoblastic leukemia dissemination","googleId":"PFJ0KqnSK8IJ","googleLink":"https://www.nature.com/articles/s41375-020-0999-2","googleCitationCount":0,"googleAuthor":"Q Pan","doi":"10.1038/s41375-020-0999-2","elsevierAuthor":"Tosello V.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Therapeutic inhibition of FcγRIIb signaling targets leukemic stem cells in chronic myeloid leukemia","googleId":"eft9BCE4V_QJ","googleLink":"https://www.nature.com/articles/s41375-020-0977-8?elqTrackId=8a7e3a03da1b4b4e9dd1b59f6d5334b5","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-020-0977-8","elsevierAuthor":"Parting O.","publicationName":"Leukemia","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"0"},{"title":"An in vitro assay for biomarker discovery and dose prediction applied to ibrutinib plus venetoclax treatment of CLL","googleId":"usjW0VEMbbYJ","googleLink":"https://www.nature.com/articles/s41375-019-0569-7","googleCitationCount":2,"googleAuthor":"","doi":"10.1038/s41375-019-0569-7","elsevierAuthor":"Skånland S.S.","publicationName":"Leukemia","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"1 February 2020","elsevierCitationCount":"2"},{"title":"Long-term outcome of imatinib 400 mg compared to imatinib 600 mg or imatinib 400 mg daily in combination with cytarabine or pegylated interferon alpha 2a for …","googleId":"N0z65_74oMsJ","googleLink":"https://www.nature.com/articles/s41375-020-01117-w","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-020-01117-w","elsevierAuthor":"Guilhot F.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"2021","elsevierCitationCount":"0"},{"title":"Rare germline variant contributions to myeloid malignancy susceptibility","googleId":"zNrVWqbw7wIJ","googleLink":"https://www.nature.com/articles/s41375-019-0701-8","googleCitationCount":2,"googleAuthor":"","doi":"10.1038/s41375-019-0701-8","elsevierAuthor":"Li S.T.","publicationName":"Leukemia","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"2"},{"title":"Randomized post-induction and delayed intensification therapy in high-risk pediatric acute lymphoblastic leukemia: Long-term results of the international AIEOP-BFM …","googleId":"3WkevzqFIvoJ","googleLink":"https://www.nature.com/articles/s41375-019-0670-y","googleCitationCount":2,"googleAuthor":"","doi":"10.1038/s41375-019-0670-y","elsevierAuthor":"Attarbaschi A.","publicationName":"Leukemia","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"1"},{"title":"SLAMF receptors negatively regulate B cell receptor signaling in chronic lymphocytic leukemia via recruitment of prohibitin-2","googleId":"lKeon9Ts698J","googleLink":"https://www.nature.com/articles/s41375-020-01025-z","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-020-01025-z","elsevierAuthor":"von Wenserski L.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Role of MBD3-SOX2 axis in residual myeloma following pomalidomide","googleId":"syMvtt_rw9UJ","googleLink":"https://www.nature.com/articles/s41375-021-01145-0","googleCitationCount":0,"googleAuthor":"AR Branagan","doi":"10.1038/s41375-021-01145-0","elsevierCitationCount":0},{"title":"HLA-matched and HLA-haploidentical allogeneic CD19-directed chimeric antigen receptor T-cell infusions are feasible in relapsed or refractory B-cell acute …","googleId":"EqOeFSOC-F4J","googleLink":"https://www.nature.com/articles/s41375-019-0610-x","googleCitationCount":2,"googleAuthor":"","doi":"10.1038/s41375-019-0610-x","elsevierAuthor":"Jin X.","publicationName":"Leukemia","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"2"},{"title":"Second cancer incidence in CLL patients receiving BTK inhibitors","googleId":"QEf5yavcBKYJ","googleLink":"https://www.nature.com/articles/s41375-020-0987-6","googleCitationCount":6,"googleAuthor":"DA Bond","doi":"10.1038/s41375-020-0987-6","elsevierAuthor":"Bond D.A.","publicationName":"Leukemia","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"1"},{"title":"Myelodysplastic syndromes and the risk of cardiovascular disease in older adults: a SEER-medicare analysis","googleId":"NT19VUg-7EUJ","googleLink":"https://www.nature.com/articles/s41375-019-0673-8","googleCitationCount":2,"googleAuthor":"DA Herrera","doi":"10.1038/s41375-019-0673-8","elsevierAuthor":"Adrianzen Herrera D.","publicationName":"Leukemia","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"1"},{"title":"Is it beneficial to use hydroxychloroquine and imatinib combination in order to achieve deeper molecular responses in patients with chronic myeloid leukemia?","googleId":"BKGPgRrK78EJ","googleLink":"https://www.nature.com/articles/s41375-020-0796-y","googleCitationCount":1,"googleAuthor":"AE Eşkazan","doi":"10.1038/s41375-020-0796-y","elsevierAuthor":"Eşkazan A.E.","publicationName":"Leukemia","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"1"},{"title":"Declaration of Bcr-Abl1 independence","googleId":"EPhIcpKbbWcJ","googleLink":"https://www.nature.com/articles/s41375-020-01037-9","googleCitationCount":0,"googleAuthor":"MW Deininger","doi":"10.1038/s41375-020-01037-9","elsevierAuthor":"Zhao H.","publicationName":"Leukemia","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"1 November 2020","elsevierCitationCount":"0"},{"title":"CXCL13 plasma levels function as a biomarker for disease activity in patients with chronic lymphocytic leukemia","googleId":"7RajVy0b5x8J","googleLink":"https://www.nature.com/articles/s41375-020-01063-7","googleCitationCount":0,"googleAuthor":"M Sivina","doi":"10.1038/s41375-020-01063-7","elsevierAuthor":"Sivina M.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Specific gut microbiota changes heralding bloodstream infection and neutropenic fever during intensive chemotherapy","googleId":"lwM477mjmiUJ","googleLink":"https://www.nature.com/articles/s41375-019-0547-0","googleCitationCount":4,"googleAuthor":"SG Holtan","doi":"10.1038/s41375-019-0547-0","elsevierAuthor":"Rashidi A.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"1 January 2020","elsevierCitationCount":"4"},{"title":"Repolarization of HSC attenuates HSCs failure in Shwachman–Diamond syndrome","googleId":"ikqm71toAIQJ","googleLink":"https://www.nature.com/articles/s41375-020-01054-8?elqTrackId=b08a22ec9d0144eb8d9c3e2a97b61363","googleCitationCount":0,"googleAuthor":"S Kumar","doi":"10.1038/s41375-020-01054-8","elsevierAuthor":"Kumar S.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"The Clinical impact of PTPN11 mutations in adults with acute myeloid leukemia","googleId":"R4hkdJMTLMIJ","googleLink":"https://www.nature.com/articles/s41375-020-0920-z","googleCitationCount":0,"googleAuthor":"M Alfayez","doi":"10.1038/s41375-020-0920-z","elsevierAuthor":"Alfayez M.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"A multicenter prospective, randomized, placebo-controlled phase II/III trial for preemptive acute graft-versus-host disease therapy","googleId":"9g0QnCsjNjsJ","googleLink":"https://www.nature.com/articles/s41375-020-01059-3","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-020-01059-3","elsevierAuthor":"Weissinger E.M.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Safety and efficacy of the maximum tolerated dose of givinostat in polycythemia vera: a two-part Phase Ib/II study","googleId":"tUw2YjDr2mEJ","googleLink":"https://www.nature.com/articles/s41375-020-0735-y","googleCitationCount":9,"googleAuthor":"A Rambaldi","doi":"10.1038/s41375-020-0735-y","elsevierAuthor":"Rambaldi A.","publicationName":"Leukemia","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"8"},{"title":"Clinical impact of panel-based error-corrected next generation sequencing versus flow cytometry to detect measurable residual disease (MRD) in acute …","googleId":"AE45TDqjh0EJ","googleLink":"https://www.nature.com/articles/s41375-021-01131-6","googleCitationCount":0,"googleAuthor":"N Patkar","doi":"10.1038/s41375-021-01131-6","elsevierAuthor":"Patkar N.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"2021","elsevierCitationCount":"0"},{"title":"Association between high-density lipoprotein cholesterol level and risk of hematologic malignancy","googleId":"zqEn6Bf8qY0J","googleLink":"https://www.nature.com/articles/s41375-020-01081-5","googleCitationCount":2,"googleAuthor":"SM Jeong","doi":"10.1038/s41375-020-01081-5","elsevierAuthor":"Jeong S.M.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"1"},{"title":"Genomic and evolutionary portraits of disease relapse in acute myeloid leukemia","googleId":"v3bvVbB6igcJ","googleLink":"https://www.nature.com/articles/s41375-021-01153-0","googleCitationCount":0,"googleAuthor":"F Rapaport","doi":"10.1038/s41375-021-01153-0","elsevierCitationCount":0},{"title":"Positive selection as the unifying force for clonal evolution in multiple myeloma","googleId":"7JlZyOIBgUIJ","googleLink":"https://www.nature.com/articles/s41375-021-01130-7","googleCitationCount":0,"googleAuthor":"V Yellapantula","doi":"10.1038/s41375-021-01130-7","elsevierAuthor":"Diamond B.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"2021","elsevierCitationCount":"0"},{"title":"PRC2 insufficiency causes p53-dependent dyserythropoiesis in myelodysplastic syndrome","googleId":"HA8LPND0MHoJ","googleLink":"https://www.nature.com/articles/s41375-020-01023-1?elqTrackId=5b1053378194414283b8fd3452a039e3","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-020-01023-1","elsevierAuthor":"Aoyama K.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Targeting ubiquitin-specific protease-7 in plasmacytoid dendritic cells triggers anti-myeloma immunity","googleId":"WG6Q61DxBggJ","googleLink":"https://www.nature.com/articles/s41375-021-01129-0","googleCitationCount":0,"googleAuthor":"Y Song","doi":"10.1038/s41375-021-01129-0","elsevierAuthor":"Ray A.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"2021","elsevierCitationCount":"0"},{"title":"Clinical and molecular characterization of patients with acute myeloid leukemia and sole trisomies of chromosomes 4, 8, 11, 13 or 21","googleId":"BcDRbtBOfwMJ","googleLink":"https://www.nature.com/articles/s41375-019-0560-3","googleCitationCount":2,"googleAuthor":"B Bhatnagar","doi":"10.1038/s41375-019-0560-3","elsevierAuthor":"Bhatnagar B.","publicationName":"Leukemia","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"1 February 2020","elsevierCitationCount":"2"},{"title":"Opposing effects of NPM1wt and NPM1c mutants on AKT signaling in AML","googleId":"6A57Rq_jJX0J","googleLink":"https://www.nature.com/articles/s41375-019-0621-7","googleCitationCount":2,"googleAuthor":"","doi":"10.1038/s41375-019-0621-7","elsevierAuthor":"Ren Z.","publicationName":"Leukemia","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"April 2020","elsevierCitationCount":"2"},{"title":"STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma","googleId":"k9jvf1vc8R4J","googleLink":"https://www.nature.com/articles/s41375-020-01093-1","googleCitationCount":0,"googleAuthor":"V Bystry","doi":"10.1038/s41375-020-01093-1","elsevierAuthor":"Lobello C.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Comparative analysis of total body irradiation (TBI)-based and non-TBI-based myeloablative conditioning for acute myeloid leukemia in remission with or without …","googleId":"SdC0tJZcWTwJ","googleLink":"https://www.nature.com/articles/s41375-019-0671-x","googleCitationCount":4,"googleAuthor":"ED Bezerra","doi":"10.1038/s41375-019-0671-x","elsevierAuthor":"Morsink L.M.","publicationName":"Leukemia","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"1"},{"title":"Xenograft and cell culture models of Sézary syndrome reveal cell of origin diversity and subclonal heterogeneity","googleId":"cHPgniZsfqQJ","googleLink":"https://www.nature.com/articles/s41375-020-01068-2","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-020-01068-2","elsevierAuthor":"Poglio S.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Long-term outcomes with frontline nilotinib versus imatinib in newly diagnosed chronic myeloid leukemia in chronic phase: ENESTnd 10-year analysis","googleId":"eLtBg1ZIy3wJ","googleLink":"https://www.nature.com/articles/s41375-020-01111-2","googleCitationCount":0,"googleAuthor":"TP Hughes","doi":"10.1038/s41375-020-01111-2","elsevierAuthor":"Kantarjian H.M.","publicationName":"Leukemia","elsevierCoverDate":"2021-02-01","elsevierCoverDisplayDate":"February 2021","elsevierCitationCount":"0"},{"title":"Selective recruitment of γδ T cells by a bispecific antibody for the treatment of acute myeloid leukemia","googleId":"NXhcc3sfYT0J","googleLink":"https://www.nature.com/articles/s41375-021-01122-7","googleCitationCount":0,"googleAuthor":"R Ganesan","doi":"10.1038/s41375-021-01122-7","elsevierAuthor":"Ganesan R.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"2021","elsevierCitationCount":"0"},{"title":"The impact of anti-thymocyte globulin on the outcomes of patients with AML with or without measurable residual disease at the time of allogeneic hematopoietic cell …","googleId":"l6-FVcLgkwQJ","googleLink":"https://www.nature.com/articles/s41375-019-0631-5","googleCitationCount":2,"googleAuthor":"A Nagler","doi":"10.1038/s41375-019-0631-5","elsevierAuthor":"Nagler A.","publicationName":"Leukemia","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"April 2020","elsevierCitationCount":"2"},{"title":"Clinical features and survival outcomes in IgD myeloma: a study by Asia Myeloma Network (AMN)","googleId":"gZC1V6d06CAJ","googleLink":"https://www.nature.com/articles/s41375-020-01060-w","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-020-01060-w","elsevierAuthor":"Liu J.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Second malignant neoplasms after treatment of non-Hodgkin's lymphoma—a retrospective multinational study of 189 children and adolescents","googleId":"mXeydW_sGNAJ","googleLink":"https://www.nature.com/articles/s41375-020-0841-x","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-020-0841-x","elsevierAuthor":"Attarbaschi A.","publicationName":"Leukemia","elsevierCoverDate":"2021-02-01","elsevierCoverDisplayDate":"February 2021","elsevierCitationCount":"0"},{"title":"Cytogenetic subclone formation and evolution in progressive smoldering multiple myeloma","googleId":"t3hRiNr8KLsJ","googleLink":"https://www.nature.com/articles/s41375-019-0634-2","googleCitationCount":3,"googleAuthor":"M Merz","doi":"10.1038/s41375-019-0634-2","elsevierAuthor":"Merz M.","publicationName":"Leukemia","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"April 2020","elsevierCitationCount":"1"},{"title":"Fit older adults with advanced myelodysplastic syndromes: who is most likely to benefit from transplant?","googleId":"bOMaYdpr9uEJ","googleLink":"https://www.nature.com/articles/s41375-020-01092-2","googleCitationCount":0,"googleAuthor":"DP Steensma","doi":"10.1038/s41375-020-01092-2","elsevierAuthor":"Abel G.A.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"2021","elsevierCitationCount":"0"},{"title":"Influence of obesity and gender on treatment outcomes in patients with chronic lymphocytic leukemia (CLL) undergoing rituximab-based chemoimmunotherapy","googleId":"of0lW1VIcvwJ","googleLink":"https://www.nature.com/articles/s41375-019-0630-6","googleCitationCount":2,"googleAuthor":"AM Fink","doi":"10.1038/s41375-019-0630-6","elsevierAuthor":"Fürstenau M.","publicationName":"Leukemia","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"April 2020","elsevierCitationCount":"1"},{"title":"PPM1D mutations appear in complete remission after exposure to chemotherapy without predicting emerging AML relapse","googleId":"Ck9f-w3IR54J","googleLink":"https://www.nature.com/articles/s41375-021-01155-y","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-021-01155-y","elsevierCitationCount":0},{"title":"Biomarkers associated with blinatumomab outcomes in acute lymphoblastic leukemia","googleId":"zYWjNv7FvKwJ","googleLink":"https://www.nature.com/articles/s41375-020-01089-x","googleCitationCount":0,"googleAuthor":"AH Wei","doi":"10.1038/s41375-020-01089-x","elsevierAuthor":"Wei A.H.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"2021","elsevierCitationCount":"0"},{"title":"Endemic Burkitt Lymphoma in second-degree relatives in Northern Uganda: in-depth genome-wide analysis suggests clues about genetic susceptibility","googleId":"-1BRXCByNVcJ","googleLink":"https://www.nature.com/articles/s41375-020-01052-w","googleCitationCount":0,"googleAuthor":"MH Gouveia","doi":"10.1038/s41375-020-01052-w","elsevierAuthor":"Gouveia M.H.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"2021","elsevierCitationCount":"0"},{"title":"Primary therapy and relative survival in classical Hodgkin lymphoma: a nationwide population-based study in the Netherlands, 1989–2017","googleId":"-6L2GdEYJDMJ","googleLink":"https://www.nature.com/articles/s41375-020-0875-0.pdf?origin=ppub","googleCitationCount":0,"googleAuthor":"JM Zijlstra","doi":"10.1038/s41375-020-0875-0","elsevierAuthor":"Driessen J.","publicationName":"Leukemia","elsevierCoverDate":"2021-02-01","elsevierCoverDisplayDate":"February 2021","elsevierCitationCount":"0"},{"title":"Lymphocyte doubling time in chronic lymphocytic leukemia modern era: a real-life study in 848 unselected patients","googleId":"sVZHekKmM0QJ","googleLink":"https://www.nature.com/articles/s41375-021-01149-w","googleCitationCount":0,"googleAuthor":"J Delgado","doi":"10.1038/s41375-021-01149-w","elsevierAuthor":"Baumann T.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"2021","elsevierCitationCount":"0"},{"title":"Selective targeting of α4β1 integrin attenuates murine graft versus host disease","googleId":"N8HCP3p2HBYJ","googleLink":"https://www.nature.com/articles/s41375-020-0786-0","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-020-0786-0","elsevierAuthor":"Alahmari B.","publicationName":"Leukemia","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"1 November 2020","elsevierCitationCount":"0"},{"title":"N-glycosylation of monoclonal light chains on routine MASS-FIX testing is a risk factor for MGUS progression","googleId":"qxXplU4ov10J","googleLink":"https://www.nature.com/articles/s41375-020-0940-8","googleCitationCount":2,"googleAuthor":"A Dispenzieri","doi":"10.1038/s41375-020-0940-8","elsevierAuthor":"Dispenzieri A.","publicationName":"Leukemia","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"1"},{"title":"Reply to: Second primary malignancies in myeloproliferative neoplasms and the role of aspirin","googleId":"xDG2uS0lcocJ","googleLink":"https://www.nature.com/articles/s41375-019-0616-4","googleCitationCount":2,"googleAuthor":"T Barbui","doi":"10.1038/s41375-019-0616-4","elsevierAuthor":"Barbui T.","publicationName":"Leukemia","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"April 2020","elsevierCitationCount":"1"},{"title":"Reduced red blood cell surface level of Factor H as a mechanism underlying paroxysmal nocturnal hemoglobinuria","googleId":"c3F-__pAq1cJ","googleLink":"https://www.nature.com/articles/s41375-020-1008-5","googleCitationCount":0,"googleAuthor":"L Zhang","doi":"10.1038/s41375-020-1008-5","elsevierAuthor":"Zhang L.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"A new pre-emptive TKIs strategy for preventing relapse based on BCR/ABL monitoring for Ph+ ALL undergoing allo-HCT: a prospective clinical cohort study","googleId":"AcGhh6fGYwMJ","googleLink":"https://www.nature.com/articles/s41375-020-01090-4?elqTrackId=e62e375c111240a584e971d89fe91509","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-020-01090-4","elsevierAuthor":"Liu H.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Impact of Nrf2 expression in reconstituting T-cells of allogeneic hematopoietic stem cell transplanted patients","googleId":"t4gt11JrciEJ","googleLink":"https://www.nature.com/articles/s41375-020-0956-0","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-020-0956-0","elsevierAuthor":"Karl F.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Quantitative phosphoproteomics uncovers synergy between DNA-PK and FLT3 inhibitors in acute myeloid leukaemia","googleId":"-NybXdCnW18J","googleLink":"https://www.nature.com/articles/s41375-020-01050-y","googleCitationCount":0,"googleAuthor":"HC Murray","doi":"10.1038/s41375-020-01050-y","elsevierAuthor":"Murray H.C.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Mutation landscape, clonal evolution pattern, and potential pathogenic pathways in B-lymphoblastic transformation of follicular lymphoma","googleId":"bZkbNp6H_iAJ","googleLink":"https://www.nature.com/articles/s41375-020-01014-2","googleCitationCount":0,"googleAuthor":"D Redmond","doi":"10.1038/s41375-020-01014-2","elsevierAuthor":"Nie K.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Optimal dosing of cytarabine in induction and post-remission therapy of acute myeloid leukemia","googleId":"9Al1D7mxlHkJ","googleLink":"https://www.nature.com/articles/s41375-020-01110-3","googleCitationCount":0,"googleAuthor":"FR Appelbaum","doi":"10.1038/s41375-020-01110-3","elsevierAuthor":"Walter R.B.","publicationName":"Leukemia","elsevierCoverDate":"2021-02-01","elsevierCoverDisplayDate":"February 2021","elsevierCitationCount":"0"},{"title":"Comprehensive genomic characterization of gene therapy-induced T-cell acute lymphoblastic leukemia","googleId":"lXGwac4DEGwJ","googleLink":"https://www.nature.com/articles/s41375-020-0779-z.pdf?origin=ppub","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-020-0779-z","elsevierAuthor":"Horak P.","publicationName":"Leukemia","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"0"},{"title":"MicroRNA-708 is a novel regulator of the Hoxa9 program in myeloid cells","googleId":"QAWUQUriOUgJ","googleLink":"https://www.nature.com/articles/s41375-019-0651-1","googleCitationCount":8,"googleAuthor":"","doi":"10.1038/s41375-019-0651-1","elsevierAuthor":"Schneider E.","publicationName":"Leukemia","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"2"},{"title":"EZH2 inactivation in RAS-driven myeloid neoplasms hyperactivates RAS-signaling and increases MEK inhibitor sensitivity","googleId":"C0GQeu-7ijAJ","googleLink":"https://www.nature.com/articles/s41375-021-01161-0","googleCitationCount":0,"googleAuthor":"A Reinisch","doi":"10.1038/s41375-021-01161-0","elsevierCitationCount":0},{"title":"Low CtBP2 expression is associated with a stem cell-like signature and adverse clinical outcome in childhood B-cell lymphoblastic leukemia","googleId":"LnowGIDTkXkJ","googleLink":"https://www.nature.com/articles/s41375-021-01151-2","googleCitationCount":0,"googleAuthor":"S Chun","doi":"10.1038/s41375-021-01151-2","elsevierCitationCount":0},{"title":"Phase II trial of CPX-351 in patients with acute myeloid leukemia at high risk for induction mortality","googleId":"ZiCNpTNpVPQJ","googleLink":"https://www.nature.com/articles/s41375-020-0916-8","googleCitationCount":1,"googleAuthor":"J Ning","doi":"10.1038/s41375-020-0916-8","elsevierAuthor":"Issa G.C.","publicationName":"Leukemia","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"1 November 2020","elsevierCitationCount":"1"},{"title":"Increased Incidence of IKZF1 deletions and IGH-CRLF2 translocations in B-ALL of Hispanic/Latino children—a novel health disparity","googleId":"er90x9i8QC0J","googleLink":"https://www.nature.com/articles/s41375-021-01133-4","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-021-01133-4","elsevierAuthor":"Raca G.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"2021","elsevierCitationCount":"0"},{"title":"New anti-IL-7Rα monoclonal antibodies show efficacy against T cell acute lymphoblastic leukemia in pre-clinical models","googleId":"Fa7OomGI-CMJ","googleLink":"https://www.nature.com/articles/s41375-019-0531-8","googleCitationCount":8,"googleAuthor":"JA Hixon","doi":"10.1038/s41375-019-0531-8","elsevierAuthor":"Hixon J.A.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"1 January 2020","elsevierCitationCount":"6"},{"title":"Impact of somatic mutations on response to lenalidomide in lower-risk non-del (5q) myelodysplastic syndromes patients","googleId":"fH8FXk0JfZIJ","googleLink":"https://www.nature.com/articles/s41375-020-0961-3","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-020-0961-3","elsevierAuthor":"Santini V.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Clinical and functional characterization of telomerase variants in patients with pediatric acute myeloid leukemia/myelodysplastic syndrome","googleId":"gZPDTPp3zIQJ","googleLink":"https://www.nature.com/articles/s41375-020-0835-8.pdf?origin=ppub","googleCitationCount":0,"googleAuthor":"CG Tomlinson","doi":"10.1038/s41375-020-0835-8","elsevierAuthor":"Tomlinson C.G.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"January 2021","elsevierCitationCount":"0"},{"title":"T cells redirected against Igβ for the immunotherapy of B cell lymphoma","googleId":"dKN-ZoUtlsMJ","googleLink":"https://www.nature.com/articles/s41375-019-0607-5","googleCitationCount":1,"googleAuthor":"","doi":"10.1038/s41375-019-0607-5","elsevierAuthor":"Jiang D.","publicationName":"Leukemia","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"1"},{"title":"Clinical and genetic characteristics of children with acute lymphoblastic leukemia and Li–Fraumeni syndrome","googleId":"noWmhP4eMkQJ","googleLink":"https://www.nature.com/articles/s41375-021-01163-y","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-021-01163-y","elsevierCitationCount":0},{"title":"Reduced CXCR4-expression on CD34-positive blood cells predicts outcomes of persons with primary myelofibrosis","googleId":"OWB1wR-T_MoJ","googleLink":"https://www.nature.com/articles/s41375-020-0926-6?elqTrackId=9464d8d8075143c49781a182b99d1465","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-020-0926-6","elsevierAuthor":"Barosi G.","publicationName":"Leukemia","elsevierCoverDate":"2021-02-01","elsevierCoverDisplayDate":"February 2021","elsevierCitationCount":"0"},{"title":"Generation and infusion of multi-antigen-specific T cells to prevent complications early after T-cell depleted allogeneic stem cell transplantation—a phase I/II study","googleId":"LmpUphUZxGUJ","googleLink":"https://www.nature.com/articles/s41375-019-0600-z","googleCitationCount":10,"googleAuthor":"","doi":"10.1038/s41375-019-0600-z","elsevierAuthor":"Roex M.C.J.","publicationName":"Leukemia","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"5"},{"title":"HDAC7 is a major contributor in the pathogenesis of infant t (4; 11) proB acute lymphoblastic leukemia","googleId":"Crk424ZGaF8J","googleLink":"https://www.nature.com/articles/s41375-020-01097-x","googleCitationCount":0,"googleAuthor":"O de Barrios","doi":"10.1038/s41375-020-01097-x","elsevierAuthor":"de Barrios O.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Light chain amyloidosis induced inflammatory changes in cardiomyocytes and adipose-derived mesenchymal stromal cells","googleId":"baIJ2JMDrc8J","googleLink":"https://www.nature.com/articles/s41375-019-0640-4","googleCitationCount":1,"googleAuthor":"TL Jordan","doi":"10.1038/s41375-019-0640-4","elsevierAuthor":"Jordan T.L.","publicationName":"Leukemia","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"1"},{"title":"Organ responses after highdose melphalan and stemcell transplantation in AL amyloidosis","googleId":"3BU2qnc3fkQJ","googleLink":"https://www.nature.com/articles/s41375-020-1006-7","googleCitationCount":2,"googleAuthor":"JM Sloan","doi":"10.1038/s41375-020-1006-7","elsevierAuthor":"Szalat R.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Therapy-related B-cell acute lymphoblastic leukemia in adults has unique genetic profile with frequent loss of TP53 and inferior outcome","googleId":"xhlCUEh-s9sJ","googleLink":"https://www.nature.com/articles/s41375-020-01061-9","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-020-01061-9","elsevierAuthor":"Barnea Slonim L.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Improving the identification of frail elderly newly diagnosed multiple myeloma patients","googleId":"--HCRsPGHsAJ","googleLink":"https://www.nature.com/articles/s41375-021-01162-z","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-021-01162-z","elsevierCitationCount":0},{"title":"Implication of PIGA genotype on erythrocytes phenotype in Paroxysmal Nocturnal Hemoglobinuria","googleId":"S93bjDr3PY0J","googleLink":"https://www.nature.com/articles/s41375-020-01113-0","googleCitationCount":0,"googleAuthor":"C Gurnari","doi":"10.1038/s41375-020-01113-0","elsevierAuthor":"Gurnari C.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"2021","elsevierCitationCount":"0"},{"title":"Altered expression of CSF3R splice variants impacts signal response and is associated with SRSF2 mutations","googleId":"QhnGlU-7JpYJ","googleLink":"https://www.nature.com/articles/s41375-019-0567-9","googleCitationCount":2,"googleAuthor":"","doi":"10.1038/s41375-019-0567-9","elsevierAuthor":"Lance A.","publicationName":"Leukemia","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"1 February 2020","elsevierCitationCount":"1"},{"title":"An Mb1-Cre-driven oncogenic Kras mutation results in a mouse model of T-acute lymphoblastic leukemia/lymphoma with short latency and high penetrance","googleId":"nrZuzScPgAYJ","googleLink":"https://www.nature.com/articles/s41375-020-01036-w","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-020-01036-w","elsevierAuthor":"Junco J.J.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Molecular status 36 months after TKI discontinuation in CML is highly predictive for subsequent loss of MMR—final report from AFTER-SKI","googleId":"w9aLB5uGNa0J","googleLink":"https://www.nature.com/articles/s41375-021-01173-w","googleCitationCount":0,"googleAuthor":"J Richter","doi":"10.1038/s41375-021-01173-w","elsevierCitationCount":0},{"title":"Flowcytometric evaluation of cerebrospinal fluid in childhood ALL identifies CNS involvement better then conventional cytomorphology","googleId":"diqy5E4FHlwJ","googleLink":"https://www.nature.com/articles/s41375-020-01029-9","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-020-01029-9","elsevierAuthor":"de Haas V.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"COVID-19 and myeloproliferative neoplasms: some considerations","googleId":"QB01yxBha2EJ","googleLink":"https://www.nature.com/articles/s41375-020-01070-8","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-020-01070-8","elsevierAuthor":"Kamaz B.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"January 2021","elsevierCitationCount":"0"},{"title":"Severe clinical relapse in an immunocompromised host with persistent SARS-CoV-2 infection","googleId":"dmYeO1cZhXIJ","googleLink":"https://www.nature.com/articles/s41375-021-01175-8","googleCitationCount":0,"googleAuthor":"A Stallmach","doi":"10.1038/s41375-021-01175-8","elsevierCitationCount":0},{"title":"Germline variants drive myelodysplastic syndrome in young adults","googleId":"INHS_FQjFQwJ","googleLink":"https://www.nature.com/articles/s41375-021-01137-0","googleCitationCount":0,"googleAuthor":"JE Churpek","doi":"10.1038/s41375-021-01137-0","elsevierAuthor":"Feurstein S.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"2021","elsevierCitationCount":"0"},{"title":"Long: molecular tracking of CML with bilineal inv (16) myeloid and del (9) lymphoid blast crisis and durable response to CD19-directed CAR-T therapy","googleId":"4JFMkPDhhdQJ","googleLink":"https://www.nature.com/articles/s41375-020-0983-x","googleCitationCount":1,"googleAuthor":"KS Casey","doi":"10.1038/s41375-020-0983-x","elsevierAuthor":"Venkataraman V.","publicationName":"Leukemia","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"1 November 2020","elsevierCitationCount":"0"},{"title":"Clonal trajectories and cellular dynamics of myeloid neoplasms with SF3B1 mutations","googleId":"96jSFRuKemAJ","googleLink":"https://www.nature.com/articles/s41375-021-01176-7","googleCitationCount":0,"googleAuthor":"H Awada","doi":"10.1038/s41375-021-01176-7","elsevierCitationCount":0},{"title":"Potential and pitfalls of whole transcriptome-based immunogenetic marker identification in acute lymphoblastic leukemia; a EuroMRD and EuroClonality-NGS …","googleId":"gdI0000aEy4J","googleLink":"https://www.nature.com/articles/s41375-021-01154-z","googleCitationCount":0,"googleAuthor":"G Cazzaniga","doi":"10.1038/s41375-021-01154-z","elsevierCitationCount":0},{"title":"Therapy-related leukaemias with balanced translocations can arise from pre-existing clonal haematopoiesis","googleId":"ENG02P_PC84J","googleLink":"https://www.nature.com/articles/s41375-021-01150-3","googleCitationCount":0,"googleAuthor":"R Dillon","doi":"10.1038/s41375-021-01150-3","elsevierAuthor":"Dillon R.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"2021","elsevierCitationCount":"0"},{"title":"Sensitive GATA1 mutation screening reliably identifies neonates with Down syndrome at risk for myeloid leukemia","googleId":"1uc1uZJIqVYJ","googleLink":"https://www.nature.com/articles/s41375-021-01128-1","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-021-01128-1","elsevierAuthor":"Goemans B.F.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"2021","elsevierCitationCount":"0"},{"title":"Pretransplant nivolumab further enhanced Treg expansion after posttransplant cyclophosphamide; another aspect for immune tolerance by PTCy after nivolumab","googleId":"l7LWOl9PBMAJ","googleLink":"https://www.nature.com/articles/s41375-021-01167-8","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-021-01167-8","elsevierCitationCount":0},{"title":"Proteomic analysis identifies mechanism (s) of overcoming bortezomib resistance via targeting ubiquitin receptor Rpn13","googleId":"RLcsfgTZ3QYJ","googleLink":"https://www.nature.com/articles/s41375-020-0865-2","googleCitationCount":1,"googleAuthor":"T Du","doi":"10.1038/s41375-020-0865-2","elsevierAuthor":"Du T.","publicationName":"Leukemia","elsevierCoverDate":"2021-02-01","elsevierCoverDisplayDate":"February 2021","elsevierCitationCount":"1"},{"title":"Sorafenib or placebo in patients with newly diagnosed acute myeloid leukaemia: long-term follow-up of the randomized controlled SORAML trial","googleId":"I2tnaFJKOFIJ","googleLink":"https://www.nature.com/articles/s41375-021-01148-x","googleCitationCount":0,"googleAuthor":"C Röllig","doi":"10.1038/s41375-021-01148-x","elsevierCitationCount":0},{"title":"Toxic iron species in lower-risk myelodysplastic syndrome patients: course of disease and effects on outcome","googleId":"F3xfiLMOEtYJ","googleLink":"https://www.nature.com/articles/s41375-020-01022-2","googleCitationCount":0,"googleAuthor":"T Bagguley","doi":"10.1038/s41375-020-01022-2","elsevierAuthor":"Hoeks M.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Conditional relative survival among adult patients with chronic myeloid leukemia in the tyrosine kinase inhibitor era: a population-based study in the Netherlands","googleId":"dV8gFL1AvGYJ","googleLink":"https://www.nature.com/articles/s41375-021-01174-9","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-021-01174-9","elsevierCitationCount":0},{"title":"ERBB2/HER2 mutations are transforming and therapeutically targetable in leukemia","googleId":"nTh8sNq6YwAJ","googleLink":"https://www.nature.com/articles/s41375-020-0844-7","googleCitationCount":2,"googleAuthor":"D Bottomly","doi":"10.1038/s41375-020-0844-7","elsevierAuthor":"Joshi S.K.","publicationName":"Leukemia","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"1"},{"title":"Phase 1b study of tirabrutinib in combination with idelalisib or entospletinib in previously treated B-cell lymphoma","googleId":"P1INVKBx-TwJ","googleLink":"https://www.nature.com/articles/s41375-020-01108-x","googleCitationCount":0,"googleAuthor":"AV Danilov","doi":"10.1038/s41375-020-01108-x","elsevierAuthor":"Morschhauser F.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Early detection of myeloproliferative neoplasms in a Danish general population study","googleId":"qvbFyO5OM-AJ","googleLink":"https://www.nature.com/articles/s41375-021-01159-8","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-021-01159-8","elsevierCitationCount":0},{"title":"BCR signaling contributes to autophagy regulation in chronic lymphocytic leukemia","googleId":"39C8ekZwCe8J","googleLink":"https://www.nature.com/articles/s41375-019-0557-y","googleCitationCount":2,"googleAuthor":"MD Blunt","doi":"10.1038/s41375-019-0557-y","elsevierAuthor":"Smith L.D.","publicationName":"Leukemia","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"1 February 2020","elsevierCitationCount":"1"},{"title":"Prediction of immunomodulatory drugs (IMiDs) sensitivity in myeloma via determination of baseline anti-oxidative stress capacity","googleId":"QhpP4qp4BqwJ","googleLink":"https://www.nature.com/articles/s41375-020-0881-2","googleCitationCount":0,"googleAuthor":"S Sebastian","doi":"10.1038/s41375-020-0881-2","elsevierAuthor":"Mountjoy L.","publicationName":"Leukemia","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"1 November 2020","elsevierCitationCount":"0"},{"title":"Comparison of clinical and molecular characteristics of patients with acute myeloid leukemia and either TP73 or TP53 mutations","googleId":"5fpSTZHQxDQJ","googleLink":"https://www.nature.com/articles/s41375-020-1007-6","googleCitationCount":0,"googleAuthor":"AS Mims","doi":"10.1038/s41375-020-1007-6","elsevierAuthor":"Mims A.S.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"KIT pathway upregulation predicts dasatinib efficacy in acute myeloid leukemia","googleId":"XqwWw_r9Z5kJ","googleLink":"https://www.nature.com/articles/s41375-020-0978-7","googleCitationCount":0,"googleAuthor":"D Malani","doi":"10.1038/s41375-020-0978-7","elsevierAuthor":"Malani D.","publicationName":"Leukemia","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"0"},{"title":"Benzene induces rapid leukemic transformation after prolonged hematotoxicity in a murine model","googleId":"YZGu2W2z7pkJ","googleLink":"https://www.nature.com/articles/s41375-020-0894-x","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-020-0894-x","elsevierAuthor":"Zhao J.","publicationName":"Leukemia","elsevierCoverDate":"2021-02-01","elsevierCoverDisplayDate":"February 2021","elsevierCitationCount":"0"},{"title":"Post-induction MRD by FCM and GATA1-PCR are significant prognostic factors for myeloid leukemia of Down syndrome","googleId":"uWmsr1cA9mgJ","googleLink":"https://www.nature.com/articles/s41375-021-01157-w","googleCitationCount":0,"googleAuthor":"S Tanaka","doi":"10.1038/s41375-021-01157-w","elsevierCitationCount":0},{"title":"High incidence of MYD88 and KMT2D mutations in Chinese with chronic lymphocytic leukemia","googleId":"BNDZeeOde1YJ","googleLink":"https://www.nature.com/articles/s41375-021-01124-5","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-021-01124-5","elsevierAuthor":"Yi S.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"2021","elsevierCitationCount":"0"},{"title":"Reduction in the rate and improvement in the prognosis of COVID-19 in haematological patients over time","googleId":"4RMLiGoxk0wJ","googleLink":"https://www.nature.com/articles/s41375-020-01015-1","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-020-01015-1","elsevierAuthor":"Cattaneo C.","publicationName":"Leukemia","elsevierCoverDate":"2021-02-01","elsevierCoverDisplayDate":"February 2021","elsevierCitationCount":"0"},{"title":"Evaluation of ERK as a therapeutic target in acute myelogenous leukemia","googleId":"KQ0u_byDmpUJ","googleLink":"https://www.nature.com/articles/s41375-019-0552-3","googleCitationCount":3,"googleAuthor":"","doi":"10.1038/s41375-019-0552-3","elsevierAuthor":"Weisberg E.","publicationName":"Leukemia","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"0"},{"title":"RFWD2 induces cellular proliferation and selective proteasome inhibitor resistance by mediating P27 ubiquitination in multiple myeloma","googleId":"FTdT57T_JXcJ","googleLink":"https://www.nature.com/articles/s41375-020-01033-z","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-020-01033-z","elsevierAuthor":"Gu C.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Notch blockade overcomes endothelial cell-mediated resistance of FLT3/ITD-positive AML progenitors to AC220 treatment","googleId":"pbz6ihjBGYgJ","googleLink":"https://www.nature.com/articles/s41375-020-0893-y","googleCitationCount":0,"googleAuthor":"B Hadland","doi":"10.1038/s41375-020-0893-y","elsevierAuthor":"Le Q.","publicationName":"Leukemia","elsevierCoverDate":"2021-02-01","elsevierCoverDisplayDate":"February 2021","elsevierCitationCount":"0"},{"title":"SHP1 regulates a STAT6–ITGB3 axis in FLT3ITD-positive AML cells","googleId":"9QkY90GLdSUJ","googleLink":"https://www.nature.com/articles/s41375-019-0676-5","googleCitationCount":1,"googleAuthor":"R Bauer","doi":"10.1038/s41375-019-0676-5","elsevierAuthor":"Reich D.","publicationName":"Leukemia","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"1"},{"title":"Dynamic clonal hematopoiesis and functional T-cell immunity in a supercentenarian","googleId":"CZZ09xFbf_UJ","googleLink":"https://www.nature.com/articles/s41375-020-01086-0","googleCitationCount":1,"googleAuthor":"S Makrodimitris","doi":"10.1038/s41375-020-01086-0","elsevierAuthor":"van den Akker E.B.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Detection of subclonal SETBP1 and JAK3 mutations in juvenile myelomonocytic leukemia using droplet digital PCR","googleId":"xkfAMKOrYT8J","googleLink":"https://www.nature.com/articles/s41375-020-0817-x","googleCitationCount":0,"googleAuthor":"Y Okuno","doi":"10.1038/s41375-020-0817-x","elsevierAuthor":"Wakamatsu M.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"January 2021","elsevierCitationCount":"0"},{"title":"Novel invariant features of Good syndrome","googleId":"n2PyWMVpUIIJ","googleLink":"https://www.nature.com/articles/s41375-020-01114-z","googleCitationCount":0,"googleAuthor":"C Gurnari","doi":"10.1038/s41375-020-01114-z","elsevierAuthor":"Gurnari C.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"2021","elsevierCitationCount":"0"},{"title":"Gata2− 77 enhancer regulates adult hematopoietic stem cell survival","googleId":"YQvtqCztTvcJ","googleLink":"https://www.nature.com/articles/s41375-020-0942-6","googleCitationCount":0,"googleAuthor":"X You","doi":"10.1038/s41375-020-0942-6","elsevierAuthor":"You X.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Comparison of minimal residual disease levels in bone marrow and peripheral blood in adult acute lymphoblastic leukemia","googleId":"zxy2g1JgkqAJ","googleLink":"https://www.nature.com/articles/s41375-019-0599-1","googleCitationCount":2,"googleAuthor":"M Kotrova","doi":"10.1038/s41375-019-0599-1","elsevierAuthor":"Kotrova M.","publicationName":"Leukemia","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"April 2020","elsevierCitationCount":"2"},{"title":"Randomized phase 2 trial of pevonedistat plus azacitidine versus azacitidine for higher-risk MDS/CMML or low-blast AML","googleId":"OWJYQbCzxsEJ","googleLink":"https://www.nature.com/articles/s41375-021-01125-4","googleCitationCount":0,"googleAuthor":"MA Sekeres","doi":"10.1038/s41375-021-01125-4","elsevierAuthor":"Sekeres M.A.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"2021","elsevierCitationCount":"0"},{"title":"Characteristics of cells with engraftment capacity within CD34+ cell population upon G-CSF and Plerixafor mobilization","googleId":"b3aU8CpZC6sJ","googleLink":"https://www.nature.com/articles/s41375-020-0982-y","googleCitationCount":1,"googleAuthor":"","doi":"10.1038/s41375-020-0982-y","elsevierAuthor":"Mombled M.","publicationName":"Leukemia","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"0"},{"title":"Obinutuzumab plus fludarabine and cyclophosphamide in previously untreated, fit patients with chronic lymphocytic leukemia: a subgroup analysis of the …","googleId":"x4m478TTmJAJ","googleLink":"https://www.nature.com/articles/s41375-019-0554-1","googleCitationCount":2,"googleAuthor":"F Bosch","doi":"10.1038/s41375-019-0554-1","elsevierAuthor":"Bosch F.","publicationName":"Leukemia","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"1 February 2020","elsevierCitationCount":"1"},{"title":"Knockout of the RAS endoprotease RCE1 accelerates myeloid leukemia by downregulating GADD45b","googleId":"wJS8pgmjhLgJ","googleLink":"https://www.nature.com/articles/s41375-020-0859-0","googleCitationCount":0,"googleAuthor":"MK Akula","doi":"10.1038/s41375-020-0859-0","elsevierAuthor":"Karlsson C.","publicationName":"Leukemia","elsevierCoverDate":"2021-02-01","elsevierCoverDisplayDate":"February 2021","elsevierCitationCount":"0"},{"title":"Shwachman–Bodian–Diamond syndrome (SBDS) protein is a direct inhibitor of protein phosphatase 2A (PP2A) activity and overexpressed in acute myeloid …","googleId":"EdefofpfVSIJ","googleLink":"https://www.nature.com/articles/s41375-020-0814-0","googleCitationCount":0,"googleAuthor":"MD Dun","doi":"10.1038/s41375-020-0814-0","elsevierAuthor":"Dun M.D.","publicationName":"Leukemia","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"0"},{"title":"Identification of the SRC-family tyrosine kinase HCK as a therapeutic target in mantle cell lymphoma","googleId":"H49zmlg70aIJ","googleLink":"https://www.nature.com/articles/s41375-020-0934-6","googleCitationCount":1,"googleAuthor":"","doi":"10.1038/s41375-020-0934-6","elsevierAuthor":"Lantermans H.C.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"New treatments for acute myeloid leukemia: how much has changed?","googleId":"3SJuutaXSE8J","googleLink":"https://www.nature.com/articles/s41375-020-01084-2","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-020-01084-2","elsevierAuthor":"Estey E.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"January 2021","elsevierCitationCount":"0"},{"title":"Allogeneic hematopoietic stem cell transplantation in elderly patients with acute myeloid leukemia or myelodysplastic syndromes: myth and reality","googleId":"1_pXLhAZITIJ","googleLink":"https://www.nature.com/articles/s41375-020-1004-9","googleCitationCount":0,"googleAuthor":"E Raffoux","doi":"10.1038/s41375-020-1004-9","elsevierAuthor":"Del Galy A.S.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"2021","elsevierCitationCount":"0"},{"title":"Systemic mastocytosis with acute myeloid leukemia occurs from mutually exclusive clones expressing KIT D816V and FLT3-ITD","googleId":"RbznNvUnr9AJ","googleLink":"https://www.nature.com/articles/s41375-020-01073-5","googleCitationCount":0,"googleAuthor":"JM Capo-Chichi","doi":"10.1038/s41375-020-01073-5","elsevierAuthor":"Capo-Chichi J.M.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"January 2021","elsevierCitationCount":"0"},{"title":"T (6; 14)(q25; q32) involves BCL11B and is highly associated with mixed-phenotype acute leukemia, T/myeloid","googleId":"eZNSAEj3He0J","googleLink":"https://www.nature.com/articles/s41375-020-0761-9","googleCitationCount":0,"googleAuthor":"W Wang","doi":"10.1038/s41375-020-0761-9","elsevierAuthor":"Wang W.","publicationName":"Leukemia","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"0"},{"title":"Preclinical efficacy of gemcitabine in MLL-rearranged infant acute lymphoblastic leukemia","googleId":"xfR_lLRNitwJ","googleLink":"https://www.nature.com/articles/s41375-020-0895-9","googleCitationCount":0,"googleAuthor":"L Jones","doi":"10.1038/s41375-020-0895-9","elsevierAuthor":"Wander P.","publicationName":"Leukemia","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"1 November 2020","elsevierCitationCount":"0"},{"title":"Prognostic value of monocyte subset distribution in chronic myelomonocytic leukemia: results of a multicenter study","googleId":"pr2zbsBO1NYJ","googleLink":"https://www.nature.com/articles/s41375-020-0955-1","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-020-0955-1","elsevierAuthor":"Jestin M.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"POEMS syndrome remains a mystery after 40 years","googleId":"sOjpBDLiXSIJ","googleLink":"https://www.nature.com/articles/s41375-021-01168-7","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-021-01168-7","elsevierCitationCount":0},{"title":"Salvage second transplantation in relapsed multiple myeloma","googleId":"5MR8HISF0bEJ","googleLink":"https://www.nature.com/articles/s41375-020-1005-8.pdf?origin=ppub","googleCitationCount":0,"googleAuthor":"B Dhakal","doi":"10.1038/s41375-020-1005-8","elsevierAuthor":"Dhakal B.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Disease escape with the selective loss of the Philadelphia chromosome after tyrosine kinase inhibitor exposure in Ph-positive acute lymphoblastic leukemia","googleId":"VSI__w8v_uAJ","googleLink":"https://www.nature.com/articles/s41375-020-0715-2.pdf?origin=ppub","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-020-0715-2","elsevierAuthor":"Gazeau N.","publicationName":"Leukemia","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"0"},{"title":"FAM122A is required for hematopoietic stem cell function","googleId":"0DZdRagpzcoJ","googleLink":"https://www.nature.com/articles/s41375-020-01099-9","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-020-01099-9","elsevierAuthor":"Liu M.H.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"A 9-gene score for risk stratification in B-cell acute lymphoblastic leukemia","googleId":"PTCZCFXaJsgJ","googleLink":"https://www.nature.com/articles/s41375-020-0888-8","googleCitationCount":0,"googleAuthor":"F Yan","doi":"10.1038/s41375-020-0888-8","elsevierAuthor":"Yan F.","publicationName":"Leukemia","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"1 November 2020","elsevierCitationCount":"0"},{"title":"Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative …","googleId":"O5V3iYGX4N0J","googleLink":"https://www.nature.com/articles/s41375-020-0945-3","googleCitationCount":0,"googleAuthor":"C Fuchs","doi":"10.1038/s41375-020-0945-3","elsevierAuthor":"Stegelmann F.","publicationName":"Leukemia","elsevierCoverDate":"2021-02-01","elsevierCoverDisplayDate":"February 2021","elsevierCitationCount":"0"},{"title":"Antimicrobial use before chronic lymphocytic leukemia: a retrospective cohort study","googleId":"ieWTVsFOT7EJ","googleLink":"https://www.nature.com/articles/s41375-020-0980-0","googleCitationCount":1,"googleAuthor":"MA Andersen","doi":"10.1038/s41375-020-0980-0","elsevierAuthor":"Andersen M.A.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Impact of using leader primers for IGHV mutational status assessment in chronic lymphocytic leukemia","googleId":"-x4dG9NPMVsJ","googleLink":"https://www.nature.com/articles/s41375-020-0716-1.pdf?origin=ppub","googleCitationCount":0,"googleAuthor":""},{"title":"Erythrocytosis with JAK2 GGCC_46/1 haplotype and without JAK2 V617F mutation is associated with CALR rs1049481_G allele","googleId":"KbsXFBaUKgMJ","googleLink":"https://www.nature.com/articles/s41375-020-0847-4","googleCitationCount":0,"googleAuthor":"A Minervini","doi":"10.1038/s41375-020-0847-4","elsevierAuthor":"Anelli L.","publicationName":"Leukemia","elsevierCoverDate":"2021-02-01","elsevierCoverDisplayDate":"February 2021","elsevierCitationCount":"0"},{"title":"Bone marrow stromal cell-mediated degradation of CD20 leads to primary rituximab resistance in mantle cell lymphoma","googleId":"yP0j_ylvwTAJ","googleLink":"https://www.nature.com/articles/s41375-020-01035-x","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-020-01035-x","elsevierAuthor":"Kuroda Y.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Acute lymphoblastic leukemia and down syndrome: 6-mercaptopurine and methotrexate metabolites during maintenance therapy","googleId":"zUvq6HXIrUkJ","googleLink":"https://www.nature.com/articles/s41375-020-0946-2","googleCitationCount":0,"googleAuthor":"M Degn","doi":"10.1038/s41375-020-0946-2","elsevierAuthor":"Østergaard A.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"European recommendations and quality assurance for cytogenomic analysis of haematological neoplasms: reponse to the comments from the Francophone …","googleId":"DXSwwfHEUOcJ","googleLink":"https://www.nature.com/articles/s41375-020-0736-x.pdf?origin=ppub","googleCitationCount":0,"googleAuthor":"E Van den Berg"},{"title":"In Ph+ BCR-ABL1 P210+ acute lymphoblastic leukemia the e13a2 (B2A2) transcript is prevalent","googleId":"o1Rn0PvDxxAJ","googleLink":"https://www.nature.com/articles/s41375-019-0591-9","googleCitationCount":1,"googleAuthor":"","doi":"10.1038/s41375-019-0591-9","elsevierAuthor":"Baccarani M.","publicationName":"Leukemia","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"1"},{"title":"In vitro-generated alloantigen-specific Th9 cells mediate antileukemia cytotoxicity in the absence of graft-versus-host disease","googleId":"I2EcUV8ZxhYJ","googleLink":"https://www.nature.com/articles/s41375-020-0731-2","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-020-0731-2","elsevierAuthor":"Reisser T.","publicationName":"Leukemia","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"0"},{"title":"In vivo efficacy of mutant IDH1 inhibitor HMS-101 and structural resolution of distinct binding site","googleId":"w4YSp8mOCkQJ","googleLink":"https://www.nature.com/articles/s41375-019-0582-x","googleCitationCount":6,"googleAuthor":"","doi":"10.1038/s41375-019-0582-x","elsevierAuthor":"Chaturvedi A.","publicationName":"Leukemia","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"1 February 2020","elsevierCitationCount":"4"},{"title":"Chromosome 21 gain is dispensable for transient myeloproliferative disorder driven by a novel GATA1 mutation","googleId":"qNimMry7eZ4J","googleLink":"https://www.nature.com/articles/s41375-020-0769-1","googleCitationCount":1,"googleAuthor":"","doi":"10.1038/s41375-020-0769-1","elsevierAuthor":"Lukes J.","publicationName":"Leukemia","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"0"},{"title":"Targetability of STAT3-JAK2 fusions: implications for T-cell lymphoproliferative disorders of the gastrointestinal tract","googleId":"Dn08lNx_CV8J","googleLink":"https://www.nature.com/articles/s41375-019-0678-3","googleCitationCount":1,"googleAuthor":"G Hu","doi":"10.1038/s41375-019-0678-3","elsevierAuthor":"Hu G.","publicationName":"Leukemia","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"1"},{"title":"Fusion of the CRM1 nuclear export receptor to AF10 causes leukemia and transcriptional activation of HOXA genes","googleId":"P-cVeO7gN2EJ","googleLink":"https://www.nature.com/articles/s41375-020-0998-3","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-020-0998-3","elsevierAuthor":"Aumann W.K.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Good prognosis or poor prognosis, dose-intensive or less intensive: who decides for adults with T-lymphoblastic lymphoma/leukemia","googleId":"mKvIGz3NQNkJ","googleLink":"https://www.nature.com/articles/s41375-020-0861-6","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-020-0861-6","elsevierAuthor":"Young K.H.","publicationName":"Leukemia","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"1 November 2020","elsevierCitationCount":"0"},{"title":"Results of a national UK physician reported survey of COVID-19 infection in patients with a myeloproliferative neoplasm","googleId":"tfloTboO42IJ","googleLink":"https://www.nature.com/articles/s41375-021-01143-2","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-021-01143-2","elsevierCitationCount":0},{"title":"Quantitative distribution of patient-derived leukemia clones in murine xenografts revealed by cellular barcodes","googleId":"OSLduS9jqIgJ","googleLink":"https://www.nature.com/articles/s41375-019-0695-2","googleCitationCount":2,"googleAuthor":"E Zwart","doi":"10.1038/s41375-019-0695-2","elsevierAuthor":"Jacobs S.","publicationName":"Leukemia","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"0"},{"title":"Functional and clinical characterization of the alternatively spliced isoform AML1-ETO9a in adult patients with translocation t (8; 21)(q22; q22. 1) acute myeloid …","googleId":"ZUEvXgYo1t4J","googleLink":"https://www.nature.com/articles/s41375-019-0551-4","googleCitationCount":1,"googleAuthor":"M Agrawal","doi":"10.1038/s41375-019-0551-4","elsevierAuthor":"Agrawal M.","publicationName":"Leukemia","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"1 February 2020","elsevierCitationCount":"0"},{"title":"Soluble SLAMF7 is a predictive biomarker for elotuzumab therapy","googleId":"LHBowOZ4fmcJ","googleLink":"https://www.nature.com/articles/s41375-020-0860-7.pdf?origin=ppub","googleCitationCount":0,"googleAuthor":""},{"title":"Leukemic cells expressing NCOR1-LYN are sensitive to dasatinib in vivo in a patient-derived xenograft mouse model","googleId":"YpDLTzDQLB8J","googleLink":"https://www.nature.com/articles/s41375-020-01091-3","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-020-01091-3","elsevierAuthor":"Tomii T.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19","googleId":"Gt4_-QGoynwJ","googleLink":"https://www.nature.com/articles/s41375-020-01038-8","googleCitationCount":8,"googleAuthor":"A Gozzetti","doi":"10.1038/s41375-020-01038-8","elsevierAuthor":"Gozzetti A.","publicationName":"Leukemia","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"5"},{"title":"Revised 15-item MDS-specific frailty scale maintains prognostic potential","googleId":"TP1YfNT8q8UJ","googleLink":"https://www.nature.com/articles/s41375-020-01026-y","googleCitationCount":0,"googleAuthor":"A Nazha","doi":"10.1038/s41375-020-01026-y","elsevierAuthor":"Wan B.A.","publicationName":"Leukemia","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"0"},{"title":"Second cancers in adults with acute promyelocytic leukemia treated with or without arsenic trioxide: a SEER-medicare analysis","googleId":"DY0ffgu37vYJ","googleLink":"https://www.nature.com/articles/s41375-020-0905-y","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-020-0905-y","elsevierAuthor":"Norsworthy K.J.","publicationName":"Leukemia","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"1 November 2020","elsevierCitationCount":"0"},{"title":"Molecular-defined clonal evolution in patients with chronic myeloid leukemia who were exposed to ionizing radiation following the Chernobyl nuclear disaster","googleId":"chZRcrEwLQUJ","googleLink":"https://www.nature.com/articles/s41375-019-0679-2","googleCitationCount":1,"googleAuthor":"I Dmytrenko","doi":"10.1038/s41375-019-0679-2","elsevierAuthor":"Ernst T.","publicationName":"Leukemia","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"1 February 2020","elsevierCitationCount":"1"},{"title":"Despite mutation acquisition in hematopoietic stem cells, JMML-propagating cells are not always restricted to this compartment","googleId":"uCK52nIC_hAJ","googleLink":"https://www.nature.com/articles/s41375-019-0662-y","googleCitationCount":3,"googleAuthor":"K Rouault-Pierre","doi":"10.1038/s41375-019-0662-y","elsevierAuthor":"Caye A.","publicationName":"Leukemia","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"0"},{"title":"Targeting BCL-W and BCL-XL as a therapeutic strategy for Hodgkin lymphoma","googleId":"TsyR5jQHFlMJ","googleLink":"https://www.nature.com/articles/s41375-019-0611-9","googleCitationCount":2,"googleAuthor":"R Mitra","doi":"10.1038/s41375-019-0611-9","elsevierAuthor":"Adams C.M.","publicationName":"Leukemia","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"1"},{"title":"Roger Herschel Herzig: younger half of the dynamic duo which advanced leukaemia therapy and transplants: January 4, 1946 to July 18, 2020","googleId":"AEBrV6xFFIkJ","googleLink":"https://www.nature.com/articles/s41375-020-01027-x","googleCitationCount":0,"googleAuthor":"RP Gale","doi":"10.1038/s41375-020-01027-x","elsevierAuthor":"Gale R.P.","publicationName":"Leukemia","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"0"},{"title":"Treatment and outcome of IG-MYC+ neoplasms with precursor B-cell phenotype in childhood and adolescence","googleId":"JkYLeT0F964J","googleLink":"https://www.nature.com/articles/s41375-019-0606-6","googleCitationCount":1,"googleAuthor":"S Mueller","doi":"10.1038/s41375-019-0606-6","elsevierAuthor":"Herbrueggen H.","publicationName":"Leukemia","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"0"},{"title":"MRMR-BAT-HS: a clinical decision support system for cancer diagnosis","googleId":"MqzjFhzem1EJ","googleLink":"https://www.academia.edu/download/63972585/IJAST__JUNE202020200720-11243-wjw5ox.pdf","googleCitationCount":1,"googleAuthor":"A Panigrahi"},{"title":"Leukemia evolving from paroxysmal nocturnal hemoglobinuria","googleId":"F0gJyZy2ge0J","googleLink":"https://www.nature.com/articles/s41375-019-0555-0","googleCitationCount":2,"googleAuthor":"H Awada","doi":"10.1038/s41375-019-0555-0","elsevierAuthor":"Awada H.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"1 January 2020","elsevierCitationCount":"0"},{"title":"Need for routine examination of left ventricular ejection fraction in patients with AML","googleId":"VLg5cf05aBkJ","googleLink":"https://www.nature.com/articles/s41375-019-0637-z","googleCitationCount":1,"googleAuthor":"","doi":"10.1038/s41375-019-0637-z","elsevierAuthor":"Khan H.M.","publicationName":"Leukemia","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"April 2020","elsevierCitationCount":"0"},{"title":"Donor-derived acute promyelocytic leukemia presenting as myeloid sarcoma in a transplanted kidney","googleId":"Mn2gOe-mLooJ","googleLink":"https://www.nature.com/articles/s41375-020-0903-0","googleCitationCount":0,"googleAuthor":"S Akilesh","doi":"10.1038/s41375-020-0903-0","elsevierAuthor":"Wong R.L.","publicationName":"Leukemia","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"0"},{"title":"Staging challenges in extranasal and juvenile extranodal NK/T-cell lymphoma","googleId":"rE0rjDsxyaEJ","googleLink":"https://www.nature.com/articles/s41375-020-0975-x","googleCitationCount":0,"googleAuthor":"P Guan","doi":"10.1038/s41375-020-0975-x","elsevierAuthor":"Guan P.","publicationName":"Leukemia","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"0"},{"title":"Hematopoietic stem cell transplantation for children with acute myeloid leukemia—results of the AML SCT-BFM 2007 trial","googleId":"IpXwjuXqTIAJ","googleLink":"https://www.nature.com/articles/s41375-019-0584-8","googleCitationCount":4,"googleAuthor":"","doi":"10.1038/s41375-019-0584-8","elsevierAuthor":"Sauer M.G.","publicationName":"Leukemia","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"0"},{"title":"Recommendations for cytogenomic analysis of hematologic malignancies: comments from the Francophone Group of Hematological Cytogenetics (GFCH)","googleId":"XE5WPJK738oJ","googleLink":"https://www.nature.com/articles/s41375-019-0696-1","googleCitationCount":1,"googleAuthor":"","doi":"10.1038/s41375-019-0696-1","elsevierAuthor":"Nguyen-Khac F.","publicationName":"Leukemia","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"0"},{"title":"Clara Bloomfield MD: Queen of AML. Dare to cross her at your risk (May 15, 1942 to March 1, 2020)","googleId":"H_hWnV7MePUJ","googleLink":"https://www.nature.com/articles/s41375-020-0807-z","googleCitationCount":0,"googleAuthor":"RP Gale","doi":"10.1038/s41375-020-0807-z","elsevierAuthor":"Gale R.P.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Academician Andrey Ivanovich Vorobiev, 1 November 1928 to 15 June 2020: founder of modern Soviet/Russian haematology","googleId":"9t292HjSw38J","googleLink":"https://www.nature.com/articles/s41375-020-0985-8","googleCitationCount":0,"googleAuthor":"RP Gale","doi":"10.1038/s41375-020-0985-8","elsevierAuthor":"Shklovskiy-Kordi N.E.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Correction: High-risk additional chromosomal abnormalities at low blast counts herald death by CML (Leukemia,(2020), 34, 8,(2074-2086), 10.1038/s41375 …","googleId":"zHusNTJ-DHQJ","googleLink":"https://research.vumc.nl/en/publications/correction-high-risk-additional-chromosomal-abnormalities-at-low-","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-020-01039-7","elsevierAuthor":"Hehlmann R.","publicationName":"Leukemia","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"0"},{"title":"Prognostic impact of eosinophils in mastocytosis: analysis of 2350 patients collected in the ECNM Registry","googleId":"eq60jSmOsMsJ","googleLink":"https://www.nature.com/articles/s41375-019-0632-4","googleCitationCount":4,"googleAuthor":"","doi":"10.1038/s41375-019-0632-4","elsevierAuthor":"Kluin-Nelemans H.C.","publicationName":"Leukemia","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"April 2020","elsevierCitationCount":"4"},{"title":"Go nka","googleId":"BiEnT9onvo8J","googleLink":"https://search.proquest.com/openview/40c27d19bc2d58c8118ed17b497d9d22/1?pq-origsite=gscholar&cbl=2032341","googleCitationCount":0,"googleAuthor":"","doi":"10.3390/ijms22030988","elsevierAuthor":"Bukowska-Strakova K.","publicationName":"International Journal of Molecular Sciences","elsevierCoverDate":"2021-02-01","elsevierCoverDisplayDate":"1 February 2021","elsevierCitationCount":"0"},{"title":"Redirecting proteoxicity","googleId":"5c0x6mC2bM8J","googleLink":"https://www.nature.com/articles/s41375-020-01028-w","googleCitationCount":0,"googleAuthor":"G Merlini","doi":"10.1038/s41375-020-01028-w","elsevierAuthor":"Nuvolone M.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"A transcriptomic continuum of differentiation arrest identifies myeloid interface acute leukemias with poor prognosis","googleId":"jDrhtOcLdQEJ","googleLink":"https://www.nature.com/articles/s41375-020-0965-z","googleCitationCount":0,"googleAuthor":"J Bond","doi":"10.1038/s41375-020-0965-z","elsevierAuthor":"Bond J.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Inhibition of Slug effectively targets leukemia stem cells via the Slc13a3/ROS signaling pathway","googleId":"A0eWgWo3pGAJ","googleLink":"https://www.nature.com/articles/s41375-019-0566-x","googleCitationCount":1,"googleAuthor":"Z Zhang","doi":"10.1038/s41375-019-0566-x","elsevierAuthor":"Zhang Z.","publicationName":"Leukemia","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"1 February 2020","elsevierCitationCount":"1"},{"title":"Circulating tumor cells for comprehensive and multiregional non-invasive genetic characterization of multiple myeloma","googleId":"nJ7FtEePTD4J","googleLink":"https://www.nature.com/articles/s41375-020-0883-0","googleCitationCount":0,"googleAuthor":"JJ Garcés","doi":"10.1038/s41375-020-0883-0","elsevierAuthor":"Garcés J.J.","publicationName":"Leukemia","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"1 November 2020","elsevierCitationCount":"0"},{"title":"Quantitative chimerism in CD3-negative mononuclear cells predicts prognosis in acute myeloid leukemia patients after hematopoietic stem cell transplantation","googleId":"D746e6uFqR4J","googleLink":"https://www.nature.com/articles/s41375-019-0624-4","googleCitationCount":0,"googleAuthor":"J Riou","doi":"10.1038/s41375-019-0624-4","elsevierAuthor":"Bouvier A.","publicationName":"Leukemia","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"0"},{"title":"Randomized assessment of delayed intensification and two methods for parenteral methotrexate delivery in childhood B-ALL: Children's Oncology Group Studies …","googleId":"LRFYTXMGwPUJ","googleLink":"https://www.nature.com/articles/s41375-019-0642-2","googleCitationCount":3,"googleAuthor":"M Devidas","doi":"10.1038/s41375-019-0642-2","elsevierAuthor":"Winick N.","publicationName":"Leukemia","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"April 2020","elsevierCitationCount":"2"},{"title":"Two unique HLA-A* 0201 restricted peptides derived from cyclin E as immunotherapeutic targets in leukemia","googleId":"oxiMwlylO-sJ","googleLink":"https://www.nature.com/articles/s41375-019-0698-z","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-019-0698-z","elsevierAuthor":"He H.","publicationName":"Leukemia","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"0"},{"title":"Hematopoietic stem cell transplantation for adults with T-cell lymphoblastic lymphoma: can we successfully step into the era of precision medicine?","googleId":"ccj9eezoadcJ","googleLink":"https://www.nature.com/articles/s41375-019-0608-4","googleCitationCount":1,"googleAuthor":"","doi":"10.1038/s41375-019-0608-4","elsevierAuthor":"Young K.H.","publicationName":"Leukemia","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"April 2020","elsevierCitationCount":"0"},{"title":"BRAF inhibitor treatment in classic hairy cell leukemia: a long-term follow-up study of patients treated outside clinical trials","googleId":"EMV3QQNlajkJ","googleLink":"https://www.nature.com/articles/s41375-019-0646-y","googleCitationCount":2,"googleAuthor":"T Roider","doi":"10.1038/s41375-019-0646-y","elsevierAuthor":"Liebers N.","publicationName":"Leukemia","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"1"},{"title":"Residual abdominal lymphadenopathy after intensive frontline chemoimmunotherapy is associated with inferior outcome independently of minimal residual disease …","googleId":"8cG4llKwrPQJ","googleLink":"https://www.nature.com/articles/s41375-019-0597-3","googleCitationCount":0,"googleAuthor":"AM Fink","doi":"10.1038/s41375-019-0597-3","elsevierAuthor":"Fürstenau M.","publicationName":"Leukemia","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"0"},{"title":"Minimal spatial heterogeneity in chronic lymphocytic leukemia at diagnosis","googleId":"3PyOFZNT6ucJ","googleLink":"https://www.nature.com/articles/s41375-020-0730-3","googleCitationCount":0,"googleAuthor":"F Nadeu","doi":"10.1038/s41375-020-0730-3","elsevierAuthor":"Nadeu F.","publicationName":"Leukemia","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"0"},{"title":"Impact of interferon on a triple positive polycythemia vera","googleId":"tL8Fuboa7ysJ","googleLink":"https://www.nature.com/articles/s41375-019-0636-0","googleCitationCount":1,"googleAuthor":"","doi":"10.1038/s41375-019-0636-0","elsevierAuthor":"Campario H.","publicationName":"Leukemia","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"April 2020","elsevierCitationCount":"0"},{"title":"Insights on mechanisms of clonal evolution in chronic neutrophilic leukemia on ruxolitinib therapy","googleId":"prRLubuehcQJ","googleLink":"https://www.nature.com/articles/s41375-019-0688-1","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-019-0688-1","elsevierAuthor":"Stoner R.C.","publicationName":"Leukemia","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"0"},{"title":"Carfilzomib-induced reticulocytosis in patients with multiple myeloma is caused by impaired terminal erythroid maturation","googleId":"CTF26IGE4eUJ","googleLink":"https://www.nature.com/articles/s41375-019-0565-y","googleCitationCount":0,"googleAuthor":"D Pepe","doi":"10.1038/s41375-019-0565-y","elsevierAuthor":"Kint N.G.","publicationName":"Leukemia","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"1 February 2020","elsevierCitationCount":"0"},{"title":"Decreased cell stiffness enhances leukemia development and progression","googleId":"GN4L5Veq0dUJ","googleLink":"https://www.nature.com/articles/s41375-020-0763-7","googleCitationCount":0,"googleAuthor":"F Ni","doi":"10.1038/s41375-020-0763-7","elsevierAuthor":"Hu L.","publicationName":"Leukemia","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"0"},{"title":"Rolf Neth (October 6, 1926 to March 17, 2020)","googleId":"1qE4FRdsRukJ","googleLink":"https://www.nature.com/articles/s41375-020-0829-6","googleCitationCount":0,"googleAuthor":"RP Gale","doi":"10.1038/s41375-020-0829-6","elsevierAuthor":"Hehlmann R.","publicationName":"Leukemia","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"0"},{"title":"Genomic characterization of diffuse large B-cell lymphoma transformation of nodular lymphocyte-predominant Hodgkin lymphoma","googleId":"q9Fw3hfaMXQJ","googleLink":"https://www.nature.com/articles/s41375-020-0739-7","googleCitationCount":0,"googleAuthor":"JY Song","doi":"10.1038/s41375-020-0739-7","elsevierAuthor":"Song J.Y.","publicationName":"Leukemia","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"0"},{"title":"Tissue Expression of ETS-Related Gene in Gastric Carcinomas","googleId":"Xw7-b8lkzH8J","googleLink":"https://jag.journalagent.com/z4/download_fulltext.asp?pdir=forbes&plng=eng&un=FJM-43153","googleCitationCount":0,"googleAuthor":""},{"title":"Archived bone marrow smears are an excellent source for NGS-based mutation detection in acute myeloid leukemia","googleId":"lj71B88TCwQJ","googleLink":"https://www.nature.com/articles/s41375-020-0744-x","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-020-0744-x","elsevierAuthor":"Al Hinai A.S.A.","publicationName":"Leukemia","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"0"},{"title":"Complete remission with incomplete count recovery (CRi) prior to allogeneic HCT for acute myeloid leukaemia is associated with a high non-relapse mortality","googleId":"0FPHh_HadfMJ","googleLink":"https://www.nature.com/articles/s41375-019-0572-z","googleCitationCount":0,"googleAuthor":"RM Szydlo","doi":"10.1038/s41375-019-0572-z","elsevierAuthor":"Innes A.J.","publicationName":"Leukemia","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"1 February 2020","elsevierCitationCount":"0"},{"title":"Primary therapy and relative survival among elderly patients with chronic myeloid leukemia: a population-based study in the Netherlands, 1989–2017","googleId":"LhLjnXQ8XqgJ","googleLink":"https://www.nature.com/articles/s41375-020-0902-1","googleCitationCount":1,"googleAuthor":"","doi":"10.1038/s41375-020-0902-1","elsevierAuthor":"Ector G.I.C.G.","publicationName":"Leukemia","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"0"},{"title":"Unexpected variation in leukemia stem cell frequency and genetic heterogeneity in two murine leukemia models initiated by AML1/ETO9a and CALM/AF10","googleId":"2fLww7D4lOUJ","googleLink":"https://www.nature.com/articles/s41375-019-0657-8","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-019-0657-8","elsevierAuthor":"Desai R.","publicationName":"Leukemia","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"0"},{"title":"Impact of upfront chemotherapy on overall survival in isolated myeloid sarcoma","googleId":"8pZ8InJxL5sJ","googleLink":"https://www.nature.com/articles/s41375-020-01017-z","googleCitationCount":0,"googleAuthor":"K Lontos","doi":"10.1038/s41375-020-01017-z","elsevierAuthor":"Lontos K.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"On the road to molecular prognostication in SMM","googleId":"NJBPe-oeDUcJ","googleLink":"https://www.nature.com/articles/s41375-019-0627-1","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-019-0627-1","elsevierAuthor":"Manier S.","publicationName":"Leukemia","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"1 February 2020","elsevierCitationCount":"0"},{"title":"Correction: Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS (Leukemia,(2020), 34, 7,(1751-1759), 10.1038 …","googleId":"MEP1OH76X4wJ","googleLink":"https://research.vumc.nl/en/publications/correction-lenalidomide-added-to-standard-intensive-treatment-for","googleCitationCount":0,"googleAuthor":"G Stuessi","doi":"10.1038/s41375-020-0994-7","elsevierAuthor":"Ossenkoppele G.J.","publicationName":"Leukemia","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"0"},{"title":"Prognostic value of minimal residual disease measured by flow-cytometry in two cohorts of infants with acute lymphoblastic leukemia treated according to either MLL …","googleId":"zE0_gD7wHZYJ","googleLink":"https://www.nature.com/articles/s41375-020-0912-z","googleCitationCount":2,"googleAuthor":"","doi":"10.1038/s41375-020-0912-z","elsevierAuthor":"Popov A.","publicationName":"Leukemia","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"1 November 2020","elsevierCitationCount":"0"},{"title":"Correction: Role of growth arrest-specific gene 6-mer axis in multiple myeloma","googleId":"tumz1BK8k8wJ","googleLink":"https://www.nature.com/articles/s41375-020-0781-5","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-020-0781-5","elsevierAuthor":"Waizenegger J.S.","publicationName":"Leukemia","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"0"},{"title":"Correction: Epidemiology of bloodstream infections in patients with chronic lymphocytic leukemia: a longitudinal nation-wide cohort study","googleId":"1-Dem1WrcuIJ","googleLink":"https://www.nature.com/articles/s41375-020-0992-9","googleCitationCount":0,"googleAuthor":"MA Andersen","doi":"10.1038/s41375-020-0992-9","elsevierAuthor":"Andersen M.A.","publicationName":"Leukemia","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"0"},{"title":"Color-Based Hybrid Modeling to Classify the Acute Lymphoblastic Leukemia","googleId":"mSMel-9LELYJ","googleLink":"http://www.inass.org/2020/2020083136.pdf","googleCitationCount":0,"googleAuthor":"A Muntasa"},{"title":"Correction: CD93 is expressed on chronic myeloid leukemia stem cells and identifies a quiescent population which persists after tyrosine kinase inhibitor therapy","googleId":"EkyuDtOmOp8J","googleLink":"https://www.nature.com/articles/s41375-020-0721-4","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-020-0721-4","elsevierAuthor":"Kinstrie R.","publicationName":"Leukemia","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"0"},{"title":"Correction: Evaluation of ERK as a therapeutic target in acute myelogenous leukemia","googleId":"hz1Vo9FdinsJ","googleLink":"https://www.nature.com/articles/s41375-020-0782-4","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-020-0782-4","elsevierAuthor":"Weisberg E.","publicationName":"Leukemia","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"0"},{"title":"Development of CAR-T Cell Therapies for Multiple Myeloma","googleId":"YlJTBrdpn0wJ","googleLink":"https://www.ncbi.nlm.nih.gov/pubmed/32572190","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-020-0930-x,","elsevierAuthor":"Gagelmann N.","publicationName":"Leukemia","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"8"},{"title":"Correction: CRISPR/Cas9-edited NSG mice as PDX models of human leukemia to address the role of niche-derived SPARC","googleId":"WANRBxhhiQ0J","googleLink":"https://pubmed.ncbi.nlm.nih.gov/33262529/","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-020-01071-7,","elsevierAuthor":"Tirado-Gonzalez I.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"January 2021","elsevierCitationCount":"0"},{"title":"Correction: Outcomes in first relapsed-refractory younger patients with mantle cell lymphoma: results from the MANTLE-FIRST study (Leukemia,(2020), 10.1038 …","googleId":"xIBlCTzwrJoJ","googleLink":"https://moh-it.pure.elsevier.com/en/publications/correction-outcomes-in-first-relapsed-refractory-younger-patients","googleCitationCount":0,"googleAuthor":"C Visco","doi":"10.1038/s41375-020-01119-8","elsevierAuthor":"Visco C.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"2021","elsevierCitationCount":"0"},{"title":"Correction: A six-gene leukemic stem cell score identifies high risk pediatric acute myeloid leukemia","googleId":"b9KVDI5zU8cJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/32300185/","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-020-0822-0,","elsevierAuthor":"Elsayed A.H.","publicationName":"Leukemia","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"0"},{"title":"Author Correction: Fit older adults with advanced myelodysplastic syndromes: who is most likely to benefit from transplant?","googleId":"4CQ4FijFZEoJ","googleLink":"https://www.nature.com/articles/s41375-021-01138-z","googleCitationCount":0,"googleAuthor":"DP Steensma","doi":"10.1038/s41375-021-01138-z","elsevierAuthor":"Abel G.A.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"2021","elsevierCitationCount":"0"},{"title":"Correction: S100A6 is a critical regulator of hematopoietic stem cells","googleId":"PwniHYJ5KkoJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/32665696/","googleCitationCount":0,"googleAuthor":"THM Grahn","doi":"10.1038/s41375-020-0971-1,","elsevierAuthor":"Grahn T.H.M.","publicationName":"Leukemia","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"0"},{"title":"Osteoarticular infections in paediatric sickle cell disease: in the era of multidrugresistant bacteria","googleId":"ORL6NjTPo5kJ","googleLink":"https://www.researchgate.net/profile/Paula_Kjollerstrom/publication/339804275_Osteoarticular_infections_in_paediatric_sickle_cell_disease_in_the_era_of_multidrugresistant_bacteria/links/5ef0ab56a6fdcc73be944e9f/Osteoarticular-infections-in-paediatric-sickle-cell-disease-in-the-era-of-multidrugresistant-bacteria.pdf","googleCitationCount":0,"googleAuthor":"A Orazi"},{"title":"Correction: Despite mutation acquisition in hematopoietic stem cells, JMML-propagating cells are not always restricted to this compartment","googleId":"RTjCP11bgPYJ","googleLink":"https://www.nature.com/articles/s41375-020-0720-5","googleCitationCount":0,"googleAuthor":"K Rouault-Pierre","doi":"10.1038/s41375-020-0720-5","elsevierAuthor":"Caye A.","publicationName":"Leukemia","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"0"},{"title":"Immunoglobulin Gene Analysis in Chronic Lymphocytic Leukemia in the Era of Next Generation Sequencing","googleId":"BUhKRKF0T3sJ","googleLink":"https://www.ncbi.nlm.nih.gov/pubmed/32561841","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-020-0923-9,","elsevierAuthor":"Davi F.","publicationName":"Leukemia","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"2"},{"title":"Risk factors for grade 3/4 transaminase elevation in patients with chronic lymphocytic leukemia treated with idelalisib","googleId":"tG7JRH-7qDYJ","googleLink":"https://www.nature.com/articles/s41375-020-0974-y","googleCitationCount":2,"googleAuthor":"A Mato","doi":"10.1038/s41375-020-0974-y","elsevierAuthor":"Brown J.R.","publicationName":"Leukemia","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"1"},{"title":"Corrections: Reinstated p53 response and high anti-T-cell leukemia activity by the novel alkylating deacetylase inhibitor tinostamustine","googleId":"GPCtX1_z4YwJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/33097839/","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-020-01067-3,","elsevierAuthor":"Pützer S.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"January 2021","elsevierCitationCount":"0"},{"title":"Correction: Frequency of infections in 948 MPN patients: a prospective multicenter patient-reported pilot study","googleId":"pWZPYOUbjj8J","googleLink":"https://pubmed.ncbi.nlm.nih.gov/32651539/","googleCitationCount":0,"googleAuthor":"S Koschmieder","doi":"10.1038/s41375-020-0970-2,","elsevierAuthor":"Crodel C.C.","publicationName":"Leukemia","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"1 November 2020","elsevierCitationCount":"0"},{"title":"Correction: Minimal residual disease quantification by flow cytometry provides reliable risk stratification in T-cell acute lymphoblastic leukemia","googleId":"ZKvJZdyVBZIJ","googleLink":"https://www.nature.com/articles/s41375-019-0672-9","googleCitationCount":0,"googleAuthor":"S Rosthøj","doi":"10.1038/s41375-019-0672-9","elsevierAuthor":"Modvig S.","publicationName":"Leukemia","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"0"},{"title":"Ablin. AR Managing the problem of hyperleukocytosis in acute","googleId":"mNxIa_LdEogJ","googleLink":"https://journals.lww.com/jpho-online/Citation/1984/00640/AUTHOR_INDEX.14.aspx","googleCitationCount":0,"googleAuthor":""},{"title":"Correction: Bidirectional linkage between the B-cell receptor and NOTCH1 in chronic lymphocytic leukemia and in Richter's syndrome: therapeutic implications","googleId":"jsSDe-oGnyQJ","googleLink":"https://www.nature.com/articles/s41375-019-0680-9","googleCitationCount":0,"googleAuthor":"T Vaisitti","doi":"10.1038/s41375-019-0680-9","elsevierAuthor":"Arruga F.","publicationName":"Leukemia","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"0"},{"title":"New Cancer-Related Medicines in Development for Children","googleId":"YJHjj64esVAJ","googleLink":"https://journals.lww.com/oncology-times/Fulltext/2002/08000/New_Cancer_Related_Medicines_in_Development_for.13.aspx","googleCitationCount":0,"googleAuthor":"","doi":"10.1097/01.COT.0000289941.69753.d3","elsevierCitationCount":0},{"title":"Correction: Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL) by …","googleId":"h7AdmPeoWXMJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/31937894/?otool=icznmelib","googleCitationCount":0,"googleAuthor":"G Cazzaniga","doi":"10.1038/s41375-020-0707-2,","elsevierAuthor":"Pfeifer H.","publicationName":"Leukemia","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"0"},{"title":"Correction: Dependency on the TYK2/STAT1/MCL1 axis in anaplastic large cell lymphoma","googleId":"f0xQnnWosVIJ","googleLink":"https://www.nature.com/articles/s41375-020-0968-9","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-020-0968-9","elsevierAuthor":"Prutsch N.","publicationName":"Leukemia","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"1 November 2020","elsevierCitationCount":"0"},{"title":"Correction: The acetyltransferase GCN5 maintains ATRA-resistance in non-APL AML","googleId":"1dspofwjeJwJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/31949266/","googleCitationCount":0,"googleAuthor":"A Brioli","doi":"10.1038/s41375-020-0706-3,","elsevierAuthor":"Kahl M.","publicationName":"Leukemia","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"0"},{"title":"Correction: Quantitative distribution of patient-derived leukemia clones in murine xenografts revealed by cellular barcodes","googleId":"KUWwobXIrecJ","googleLink":"https://www.nature.com/articles/s41375-020-0722-3","googleCitationCount":0,"googleAuthor":"E Zwart","doi":"10.1038/s41375-020-0722-3","elsevierAuthor":"Jacobs S.","publicationName":"Leukemia","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"0"},{"title":"Retraction Note: LAMP2 expression dictates azacytidine response and prognosis in MDS/AML","googleId":"SiRhpvebc9QJ","googleLink":"https://www.nature.com/articles/s41375-020-0969-8","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-020-0969-8","elsevierAuthor":"Dubois A.","publicationName":"Leukemia","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"0"},{"title":"Correction: Hematopoietic Stem Cell Transplantation for Children With Acute Myeloid Leukemia-Results of the AML SCT-BFM 2007 Trial","googleId":"qMMFzfgQPw8J","googleLink":"https://pubmed.ncbi.nlm.nih.gov/31768014/","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-019-0648-9,","elsevierAuthor":"Sauer M.G.","publicationName":"Leukemia","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"0"},{"title":"Grønbæk Group","googleId":"iLut0rRJn-4J","googleLink":"https://www.bric.ku.dk/people/groenbek-group/?pure=en%2Fpublications%2Fclinical-impact-of-clonal-hematopoiesis-in-patients-with-lymphoma-undergoing-asct(be29c6de-7a2a-4fc9-806a-259b778fde79)%2Fexport.html","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-020-0795-z","elsevierAuthor":"Husby S.","publicationName":"Leukemia","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"7"},{"title":"Correction: Transient Stabilization, Rather Than Inhibition, of MYC Amplifies Extrinsic Apoptosis and Therapeutic Responses in Refractory B-cell Lymphoma","googleId":"wYYR246HKGgJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/31758088/","googleCitationCount":0,"googleAuthor":"E Sotillo","doi":"10.1038/s41375-019-0650-2,","elsevierAuthor":"Harrington C.T.","publicationName":"Leukemia","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"0"},{"title":"Retraction Note: Disruption of the Bcr-Abl/Hsp90 protein complex: a possible mechanism to inhibit Bcr-Abl-positive human leukemic blasts by novobiocin","googleId":"UNgx4EMgE98J","googleLink":"https://www.nature.com/articles/s41375-020-0823-z","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-020-0823-z","elsevierAuthor":"Wu L.X.","publicationName":"Leukemia","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"0"},{"title":"Author Correction to: Endemic Burkitt lymphoma in second-degree relatives in Northern Uganda: in-depth genome-wide analysis suggests clues about genetic …","googleId":"NaKo7VfkVfkJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/33526862/","googleCitationCount":0,"googleAuthor":"MH Gouveia","doi":"10.1038/s41375-021-01140-5,","elsevierAuthor":"Gouveia M.H.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"2021","elsevierCitationCount":"0"},{"title":"Correction: Flow cytometric detection of leukemic blasts in cerebrospinal fluid predicts risk of relapse in childhood acute lymphoblastic leukemia: a Nordic Society of …","googleId":"vwJt8TpVkdoJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/32269320/","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-020-0821-1,","elsevierAuthor":"Thastrup M.","publicationName":"Leukemia","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"0"},{"title":"Correction: Bone marrow plasma cells 20% or greater discriminate presentation, response, and survival in AL amyloidosis (Leukemia,(2020), 34, 4,(1135-1143) …","googleId":"Rvkt98v53HUJ","googleLink":"https://mayoclinic.pure.elsevier.com/en/publications/correction-bone-marrow-plasma-cells-20-or-greater-discriminate-pr","googleCitationCount":0,"googleAuthor":"E Muchtar","doi":"10.1038/s41375-020-0993-8","elsevierAuthor":"Muchtar E.","publicationName":"Leukemia","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"0"},{"title":"Acute leukemia in the time of COVID-19","googleId":"ff7udVKAC0MJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/pmc7138175/","googleCitationCount":28,"googleAuthor":"O Spertini","doi":"10.1016/j.leukres.2020.106353","elsevierAuthor":"Gavillet M.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"May 2020","elsevierCitationCount":"22"},{"title":"Venetoclax combination therapy in relapsed/refractory acute myeloid leukemia: a single institution experience","googleId":"IHa5jrz_RN0J","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212620300199","googleCitationCount":16,"googleAuthor":"","doi":"10.1016/j.leukres.2020.106314","elsevierAuthor":"Gaut D.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"March 2020","elsevierCitationCount":"11"},{"title":"Covid-19 infection in therapy-naive patients with B-cell chronic lymphocytic leukemia","googleId":"oo4ou9oqXKQJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7192083/","googleCitationCount":15,"googleAuthor":"P Moss","doi":"10.1016/j.leukres.2020.106366","elsevierAuthor":"Paneesha S.","publicationName":"Leukemia research","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"1 June 2020","elsevierCitationCount":"13"},{"title":"Role of cancer immunology in chronic myelogenous leukemia","googleId":"bXUdJzZsF9gJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212619307180","googleCitationCount":10,"googleAuthor":"","doi":"10.1016/j.leukres.2019.106273","elsevierAuthor":"Ureshino H.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"January 2020","elsevierCitationCount":"6"},{"title":"Impact of minimal residual disease status in patients with relapsed/refractory acute lymphoblastic leukemia treated with inotuzumab ozogamicin in the phase …","googleId":"l6JcrEFVuT0J","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212619307283","googleCitationCount":14,"googleAuthor":"","doi":"10.1016/j.leukres.2019.106283","elsevierAuthor":"Jabbour E.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"January 2020","elsevierCitationCount":"9"},{"title":"Camidanlumab tesirine, an antibody-drug conjugate, in relapsed/refractory CD25-positive acute myeloid leukemia or acute lymphoblastic leukemia: a phase I study","googleId":"iyfarx8Xu3UJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212620300904","googleCitationCount":6,"googleAuthor":"AD Goldberg","doi":"10.1016/j.leukres.2020.106385","elsevierAuthor":"Goldberg A.D.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"August 2020","elsevierCitationCount":"6"},{"title":"A phase I study of panobinostat and ruxolitinib in patients with primary myelofibrosis (PMF) and post-polycythemia vera/essential thrombocythemia myelofibrosis (post …","googleId":"OTYCLylkWT0J","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212619307179","googleCitationCount":8,"googleAuthor":"","doi":"10.1016/j.leukres.2019.106272","elsevierAuthor":"Mascarenhas J.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"January 2020","elsevierCitationCount":"6"},{"title":"Cannabinoid CP55940 selectively induces apoptosis in Jurkat cells and in ex vivo T-cell acute lymphoblastic leukemia through H2O2 signaling mechanism","googleId":"P7qdhYcfSssJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212620300941","googleCitationCount":3,"googleAuthor":"","doi":"10.1016/j.leukres.2020.106389","elsevierAuthor":"Soto-Mercado V.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"August 2020","elsevierCitationCount":"2"},{"title":"Advances in non-intensive chemotherapy treatment options for adults diagnosed with acute myeloid leukemia","googleId":"cRCVxekHmdcJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212620300448","googleCitationCount":3,"googleAuthor":"NS Chandhok","doi":"10.1016/j.leukres.2020.106339","elsevierAuthor":"Griffiths E.A.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"April 2020","elsevierCitationCount":"2"},{"title":"A452, HDAC6-selective inhibitor synergistically enhances the anticancer activity of immunomodulatory drugs in IMiDs-resistant multiple myeloma","googleId":"mWbGoIzifksJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S014521262030103X","googleCitationCount":3,"googleAuthor":"","doi":"10.1016/j.leukres.2020.106398","elsevierAuthor":"Kim G.W.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"August 2020","elsevierCitationCount":"3"},{"title":"Disulfiram/cytarabine eradicates a subset of acute myeloid leukemia stem cells with high aldehyde dehydrogenase expression","googleId":"IVbAZ-odI88J","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212620300564","googleCitationCount":3,"googleAuthor":"","doi":"10.1016/j.leukres.2020.106351","elsevierAuthor":"Yang W.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"May 2020","elsevierCitationCount":"3"},{"title":"Novel therapeutic approaches in chronic myeloid leukemia","googleId":"xtZq2Wmk8_wJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212620300424","googleCitationCount":2,"googleAuthor":"AE Eşkazan","doi":"10.1016/j.leukres.2020.106337","elsevierAuthor":"Özgür Yurttaş N.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"April 2020","elsevierCitationCount":"0"},{"title":"Comparative effectiveness of rasburicase versus allopurinol for cancer patients with renal dysfunction and hyperuricemia","googleId":"xkNurs-Eu58J","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212620300035","googleCitationCount":5,"googleAuthor":"","doi":"10.1016/j.leukres.2020.106298","elsevierAuthor":"Martens K.L.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"February 2020","elsevierCitationCount":"5"},{"title":"Ibrutinib restores immune cell numbers and function in first-line and relapsed/refractory chronic lymphocytic leukemia","googleId":"fOmbGtisYPAJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212620301375","googleCitationCount":3,"googleAuthor":"TJ Kipps","doi":"10.1016/j.leukres.2020.106432","elsevierAuthor":"Solman I.G.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"October 2020","elsevierCitationCount":"1"},{"title":"The specificity of asciminib, a potential treatment for chronic myeloid leukemia, as a myristate-pocket binding ABL inhibitor and analysis of its interactions with mutant …","googleId":"V1fm8vUpIykJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212620301636","googleCitationCount":3,"googleAuthor":"","doi":"10.1016/j.leukres.2020.106458","elsevierAuthor":"Manley P.W.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"November 2020","elsevierCitationCount":"2"},{"title":"Syrbactin proteasome inhibitor TIR-199 overcomes bortezomib chemoresistance and inhibits multiple myeloma tumor growth in vivo","googleId":"TB-SOentENIJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212619307167","googleCitationCount":4,"googleAuthor":"","doi":"10.1016/j.leukres.2019.106271","elsevierAuthor":"Pierce M.R.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"January 2020","elsevierCitationCount":"2"},{"title":"Clinical features and treatment outcomes in patients with T-cell large granular lymphocytic leukemia: A single-institution experience","googleId":"zaE0tHu0-VYJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212620300047","googleCitationCount":2,"googleAuthor":"","doi":"10.1016/j.leukres.2020.106299","elsevierAuthor":"Zhu Y.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"March 2020","elsevierCitationCount":"2"},{"title":"Peripheral T-cell lymphoma with gastrointestinal involvement and indolent T-lymphoproliferative disorders of the gastrointestinal tract","googleId":"MpcSqQNULvkJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212620300412","googleCitationCount":2,"googleAuthor":"","doi":"10.1016/j.leukres.2020.106336","elsevierAuthor":"Kohri M.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"April 2020","elsevierCitationCount":"2"},{"title":"Outcomes of HIV-associated Burkitt Lymphoma in Brazil: High treatment toxicity and refractoriness rates–A multicenter cohort study","googleId":"LqMXMOi-18wJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212619307325","googleCitationCount":7,"googleAuthor":"","doi":"10.1016/j.leukres.2019.106287","elsevierAuthor":"Silva W.F.d.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"February 2020","elsevierCitationCount":"4"},{"title":"Plerixafor in combination with chemotherapy and/or hematopoietic cell transplantation to treat acute leukemia: A systematic review and metanalysis of preclinical and …","googleId":"1RVzDN8l3PcJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212620301478","googleCitationCount":3,"googleAuthor":"R Shorr","doi":"10.1016/j.leukres.2020.106442","elsevierAuthor":"Maganti H.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"October 2020","elsevierCitationCount":"2"},{"title":"Plasma proteomics of biomarkers for inflammation or cancer cannot predict relapse in chronic myeloid leukaemia patients stopping tyrosine kinase inhibitor therapy","googleId":"ctOkc-F7gTcJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212620300151","googleCitationCount":2,"googleAuthor":"","doi":"10.1016/j.leukres.2020.106310","elsevierAuthor":"Söderlund S.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"March 2020","elsevierCitationCount":"0"},{"title":"MN1, FOXP1 and hsa-miR-181a-5p as prognostic markers in acute myeloid leukemia patients treated with intensive induction chemotherapy and autologous stem cell …","googleId":"3yT66-EXBcUJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212620300011","googleCitationCount":5,"googleAuthor":"","doi":"10.1016/j.leukres.2020.106296","elsevierAuthor":"Seipel K.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"February 2020","elsevierCitationCount":"2"},{"title":"Treatment outcomes of patients with acute promyelocytic leukaemia between 2000 and 2017, a retrospective, single centre experience","googleId":"3mb92AU9rMQJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212620300631","googleCitationCount":2,"googleAuthor":"C Varghese","doi":"10.1016/j.leukres.2020.106358","elsevierAuthor":"Chien N.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"June 2020","elsevierCitationCount":"1"},{"title":"Cutaneous extranodal natural killer (NK)/T-cell lymphoma: A comprehensive clinical features and outcomes analysis of 71 cases","googleId":"I8Z1Y9UBsOYJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212619307295","googleCitationCount":4,"googleAuthor":"","doi":"10.1016/j.leukres.2019.106284","elsevierAuthor":"Jiang L.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"January 2020","elsevierCitationCount":"2"},{"title":"Pregnancy outcomes, risk factors, and cell count trends in pregnant women with essential thrombocythemia","googleId":"quuhFAaedfEJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212620301648","googleCitationCount":2,"googleAuthor":"O Leiva","doi":"10.1016/j.leukres.2020.106459","elsevierAuthor":"How J.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"November 2020","elsevierCitationCount":"2"},{"title":"Cytofluorimetric and immunohistochemical comparison for detecting bone marrow infiltration in non-Hodgkin lymphomas: a study of 354 patients","googleId":"w2qKU4d88x0J","googleLink":"https://www.sciencedirect.com/science/article/pii/S014521261930712X","googleCitationCount":3,"googleAuthor":"","doi":"10.1016/j.leukres.2019.106267","elsevierAuthor":"Statuto T.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"January 2020","elsevierCitationCount":"2"},{"title":"IL-33/IL1RL1 axis regulates cell survival through the p38 MAPK pathway in acute myeloid leukemia","googleId":"x1lhItLKj5AJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212620301144","googleCitationCount":1,"googleAuthor":"","doi":"10.1016/j.leukres.2020.106409","elsevierAuthor":"Wang Y.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"September 2020","elsevierCitationCount":"1"},{"title":"Comparison of frontline treatment with intensive immunosuppression therapy and HLA-haploidentical hematopoietic stem cell transplantation for young patients with …","googleId":"mGQLZd6lLWsJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212619307118","googleCitationCount":4,"googleAuthor":"","doi":"10.1016/j.leukres.2019.106266","elsevierAuthor":"Geng C.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"January 2020","elsevierCitationCount":"3"},{"title":"The incidence of non-Hodgkin lymphoma is increased in patients with obstructive sleep apnea","googleId":"YR_xCGjfzN8J","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212620301600","googleCitationCount":1,"googleAuthor":"JH Cho","doi":"10.1016/j.leukres.2020.106455","elsevierAuthor":"Choi J.H.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"November 2020","elsevierCitationCount":"1"},{"title":"PRIMA-1MET cytotoxic effect correlates with p53 protein reduction in TP53-mutated chronic lymphocytic leukemia cells","googleId":"kre84ZNIz34J","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212619307337","googleCitationCount":2,"googleAuthor":"","doi":"10.1016/j.leukres.2019.106288","elsevierAuthor":"Jaskova Z.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"February 2020","elsevierCitationCount":"1"},{"title":"Rigosertib in combination with azacitidine in patients with myelodysplastic syndromes or acute myeloid leukemia: Results of a phase 1 study","googleId":"-y6Xny4KDnUJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212620300746","googleCitationCount":1,"googleAuthor":"G Garcia-Manero","doi":"10.1016/j.leukres.2020.106369","elsevierAuthor":"Navada S.C.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"July 2020","elsevierCitationCount":"1"},{"title":"Prognosis of haploidentical hematopoietic stem cell transplantation in non-infant children with t (v; 11q23)/MLL-rearranged B-cell acute lymphoblastic leukemia","googleId":"9evB49BzSikJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212620300382","googleCitationCount":1,"googleAuthor":"","doi":"10.1016/j.leukres.2020.106333","elsevierAuthor":"Bai L.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"April 2020","elsevierCitationCount":"1"},{"title":"Outcome of elderly patients with classical Hodgkin's lymphoma","googleId":"COrU0lLVwdEJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212620300163","googleCitationCount":2,"googleAuthor":"","doi":"10.1016/j.leukres.2020.106311","elsevierAuthor":"Sykorova A.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"March 2020","elsevierCitationCount":"1"},{"title":"Iron overload regulate the cytokine of mesenchymal stromal cells through ROS/HIF-1α pathway in Myelodysplastic syndromes","googleId":"NQdUB9upw9MJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S014521262030059X","googleCitationCount":1,"googleAuthor":"","doi":"10.1016/j.leukres.2020.106354","elsevierAuthor":"Hu J.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"June 2020","elsevierCitationCount":"1"},{"title":"Untargeted adductomics of newborn dried blood spots identifies modifications to human serum albumin associated with childhood leukemia","googleId":"4XAam0HQubEJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212619307131","googleCitationCount":4,"googleAuthor":"H Grigoryan","doi":"10.1016/j.leukres.2019.106268","elsevierAuthor":"Yano Y.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"January 2020","elsevierCitationCount":"1"},{"title":"Improved Post remission survival of non-favorable risk Acute Myelogenous Leukemia (AML) patients following initial remission induction therapy with FLAG+ …","googleId":"iWXeDWyGel8J","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212620300230","googleCitationCount":1,"googleAuthor":"","doi":"10.1016/j.leukres.2020.106318","elsevierAuthor":"Solh M.M.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"June 2020","elsevierCitationCount":"1"},{"title":"Metformin suppresses the growth of leukemia cells partly through downregulation of AXL receptor tyrosine kinase","googleId":"iSMmWSc6zVsJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212620300886","googleCitationCount":1,"googleAuthor":"","doi":"10.1016/j.leukres.2020.106383","elsevierAuthor":"Saito T.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"July 2020","elsevierCitationCount":"1"},{"title":"Impact of long-term ibrutinib treatment on circulating immune cells in previously untreated chronic lymphocytic leukemia","googleId":"qxxy7VQ2qJEJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212621000217","googleCitationCount":0,"googleAuthor":"JA Burger","doi":"10.1016/j.leukres.2021.106520","elsevierCitationCount":0},{"title":"Patient and physician perceptions about blood transfusions in the myelodysplastic syndromes","googleId":"WyGGzLLFW-sJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212620301302","googleCitationCount":1,"googleAuthor":"","doi":"10.1016/j.leukres.2020.106425","elsevierAuthor":"King D.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"September 2020","elsevierCitationCount":"1"},{"title":"Characterization of a 4 lncRNAs-based prognostic risk scoring system in adults with acute myeloid leukemia","googleId":"R39R2kp7u0IJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212619307064","googleCitationCount":2,"googleAuthor":"","doi":"10.1016/j.leukres.2019.106261","elsevierAuthor":"Zeng H.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"January 2020","elsevierCitationCount":"2"},{"title":"Assessment of Azithromycin as an Anticancer Agent for Treatment of Imatinib Sensitive and Resistant CML Cells","googleId":"WMUvwAeMrYcJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212621000242","googleCitationCount":0,"googleAuthor":"","doi":"10.1016/j.leukres.2021.106523","elsevierCitationCount":0},{"title":"Clinical, inflammatory and immunohistochemical features in a cohort of Peruvian patients with diffuse large B-cell lymphoma","googleId":"cwLp-SAU9rkJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S014521262100014X","googleCitationCount":0,"googleAuthor":"","doi":"10.1016/j.leukres.2021.106513","elsevierAuthor":"Castro D.","publicationName":"Leukemia Research","elsevierCoverDate":"2021-03-01","elsevierCoverDisplayDate":"March 2021","elsevierCitationCount":"0"},{"title":"Expression of putative leukemia stem cell targets in genetically-defined acute myeloid leukemia subtypes","googleId":"WxRAibTzZuMJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S014521262030182X","googleCitationCount":0,"googleAuthor":"T Karantanos","doi":"10.1016/j.leukres.2020.106477","elsevierAuthor":"Yanagisawa B.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"0"},{"title":"Efficacy of 10-Day Decitabine in Acute Myeloid Leukemia","googleId":"SRLOEBpzQHUJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212621000254","googleCitationCount":0,"googleAuthor":"","doi":"10.1016/j.leukres.2021.106524","elsevierCitationCount":0},{"title":"Type I Interferon Upregulation and Deregulation of Genes Involved in Monopoiesis in Chronic Myelomonocytic Leukemia","googleId":"sNWwROBaFmYJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212621000126","googleCitationCount":0,"googleAuthor":"F Darbaniyan","doi":"10.1016/j.leukres.2021.106511","elsevierAuthor":"Montalban-Bravo G.","publicationName":"Leukemia Research","elsevierCoverDate":"2021-02-01","elsevierCoverDisplayDate":"February 2021","elsevierCitationCount":"0"},{"title":"Safety profile and impact on survival of tyrosine kinase inhibitors versus conventional therapy in relapse or refractory FLT3 positive acute myeloid leukemia patients","googleId":"bdniVR8acO0J","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212620302022","googleCitationCount":0,"googleAuthor":"G Marconi","doi":"10.1016/j.leukres.2020.106497","elsevierAuthor":"Marconi G.","publicationName":"Leukemia Research","elsevierCoverDate":"2021-02-01","elsevierCoverDisplayDate":"February 2021","elsevierCitationCount":"0"},{"title":"Acute undifferentiated leukemia: data on incidence and outcomes from a large population-based database","googleId":"QBWe2u2w6YAJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212620300060","googleCitationCount":1,"googleAuthor":"A Qasrawi","doi":"10.1016/j.leukres.2020.106301","elsevierAuthor":"Qasrawi A.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"February 2020","elsevierCitationCount":"0"},{"title":"Clinical Implications of Copy Number Alteration Detection using Panel-Based Next-Generation Sequencing Data in Myelodysplastic Syndrome","googleId":"lOVecE74QToJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212621000412","googleCitationCount":0,"googleAuthor":"SH Jung","doi":"10.1016/j.leukres.2021.106540","elsevierCitationCount":0},{"title":"Efficacy and predictive factors of venetoclax combined with azacitidine as salvage therapy in advanced acute myeloid leukemia patients: A multicenter retrospective …","googleId":"dmP8yqNrobsJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/32092584/","googleCitationCount":3,"googleAuthor":"Y Lou","doi":"10.1016/j.leukres.2020.106317,","elsevierAuthor":"Lou Y.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"April 2020","elsevierCitationCount":"2"},{"title":"Clonal hematopoiesis: Molecular basis and clinical relevance","googleId":"mbrmXpUAwasJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212620301624","googleCitationCount":0,"googleAuthor":"","doi":"10.1016/j.leukres.2020.106457","elsevierAuthor":"Kunimoto H.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"November 2020","elsevierCitationCount":"0"},{"title":"Naquotinib exerts antitumor activity in activated B-cell-like diffuse large B-cell lymphoma","googleId":"-v0wMa4AaBwJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212619307313","googleCitationCount":1,"googleAuthor":"H Tanaka","doi":"10.1016/j.leukres.2019.106286","elsevierAuthor":"Tanaka H.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"January 2020","elsevierCitationCount":"0"},{"title":"Diminished expression of 5hmc in Reed-Sternberg cells in classical Hodgkin lymphoma is a common epigenetic marker","googleId":"2GCaEBaRB3wJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212620301132","googleCitationCount":0,"googleAuthor":"","doi":"10.1016/j.leukres.2020.106408","elsevierAuthor":"Siref A.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"September 2020","elsevierCitationCount":"0"},{"title":"Hemorrhage in acute promyelocytic leukemia: Can it be predicted and prevented?","googleId":"PG0SriRxTHQJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212620300618","googleCitationCount":0,"googleAuthor":"","doi":"10.1016/j.leukres.2020.106356","elsevierAuthor":"Naymagon L.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"July 2020","elsevierCitationCount":"0"},{"title":"Evidence that knock down of GSK-3β in Chronic Myelogenous Leukemia cells augments IFN-γ-induced apoptosis","googleId":"QVeCnZY519oJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212620301697","googleCitationCount":0,"googleAuthor":"S Nazemidashtarjandi","doi":"10.1016/j.leukres.2020.106464","elsevierAuthor":"Kauffman M.R.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"0"},{"title":"The association of leukocyte immunoglobulin-like receptor subfamily B-4 expression in acute myeloid leukemia and central nervous system involvement","googleId":"PZ3flsHyXXAJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212620301855","googleCitationCount":0,"googleAuthor":"S Dahiya","doi":"10.1016/j.leukres.2020.106480","elsevierAuthor":"Bergstrom C.P.","publicationName":"Leukemia Research","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"January 2021","elsevierCitationCount":"0"},{"title":"Venous thromboembolic events in T-cell lymphoma patients: Incidence, risk factors and clinical features","googleId":"zBOuh1z0wc4J","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212621000382","googleCitationCount":0,"googleAuthor":"","doi":"10.1016/j.leukres.2021.106537","elsevierCitationCount":0},{"title":"Antihistamines are synergistic with Bruton's tyrosine kinase inhibiter ibrutinib mediated by lysosome disruption in chronic lymphocytic leukemia (CLL) cells","googleId":"DGKPY1o_3-QJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212620301284","googleCitationCount":0,"googleAuthor":"","doi":"10.1016/j.leukres.2020.106423","elsevierAuthor":"Chanas-Larue A.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"September 2020","elsevierCitationCount":"0"},{"title":"Prevalence and characteristics of myeloproliferative neoplasms with concomitant monoclonal gammopathy","googleId":"xmwsXJE6GdkJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212620301594","googleCitationCount":0,"googleAuthor":"","doi":"10.1016/j.leukres.2020.106454","elsevierAuthor":"Javorniczky N.R.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"November 2020","elsevierCitationCount":"0"},{"title":"Runt-related transcription factor 2 influences cell adhesion-mediated drug resistance and cell proliferation in B-cell non-Hodgkin's lymphoma and multiple myeloma","googleId":"ro-nNcLb31MJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S014521262030045X","googleCitationCount":0,"googleAuthor":"","doi":"10.1016/j.leukres.2020.106340","elsevierAuthor":"Zhang P.P.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"May 2020","elsevierCitationCount":"0"},{"title":"The outcome of Ph-negative acute lymphoblastic leukemia presenting during pregnancy and treated on the Russian prospective multicenter trial RALL-2009","googleId":"FgKgEbGb9coJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212621000370","googleCitationCount":0,"googleAuthor":"","doi":"10.1016/j.leukres.2021.106536","elsevierCitationCount":0},{"title":"Diagnostic Performance of F-18 FDG PET/CT in the Detection of Bone Marrow Involvement in Paediatric Hodgkin Lymphoma: A Meta-analysis","googleId":"ZtJVc0v4kMcJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212621000266","googleCitationCount":0,"googleAuthor":"","doi":"10.1016/j.leukres.2021.106525","elsevierCitationCount":0},{"title":"Direct comparison of diagnostic accuracies of F-18 FDG PET and MRI for detection of bone marrow involvement in lymphoma patients; A meta-analysis","googleId":"RycGZjAlTpsJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212620301806","googleCitationCount":0,"googleAuthor":"","doi":"10.1016/j.leukres.2020.106475","elsevierAuthor":"Kim K.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"0"},{"title":"Analysis of estimated clinical benefit of newly approved drugs for US patients with acute myeloid leukemia","googleId":"2-IHM2NcWdoJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212620301259","googleCitationCount":1,"googleAuthor":"AA Tran","doi":"10.1016/j.leukres.2020.106420","elsevierAuthor":"Tran A.A.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"September 2020","elsevierCitationCount":"0"},{"title":"Association of Insurance Disparities and Survival in Adults with Multiple Myeloma: A Non-Concurrent Cohort Study","googleId":"T_kUgQwlWuUJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212621000436","googleCitationCount":0,"googleAuthor":"","doi":"10.1016/j.leukres.2021.106542","elsevierCitationCount":0},{"title":"Low serum cholesterol levels predict inferior prognosis and improve prognostic index scoring for peripheral T-cell lymphoma, unspecified","googleId":"dJ0jVIbrxWoJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212621000357","googleCitationCount":0,"googleAuthor":"","doi":"10.1016/j.leukres.2021.106534","elsevierCitationCount":0},{"title":"Impact of High Dose Cytarabine Dosing Strategies in Obese Patients with Acute Myeloid Leukemia","googleId":"IdsKCwXqA2UJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212621000187","googleCitationCount":0,"googleAuthor":"AJ Perissinotti","doi":"10.1016/j.leukres.2021.106517","elsevierAuthor":"Ochs M.A.","publicationName":"Leukemia Research","elsevierCoverDate":"2021-03-01","elsevierCoverDisplayDate":"March 2021","elsevierCitationCount":"0"},{"title":"Vancomycin-resistant enterococci infection and predisposing factors for infection and mortality in patients with acute leukaemia and febrile neutropenia","googleId":"rWmZaFZDyGUJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212620301685","googleCitationCount":1,"googleAuthor":"O Kirkizlar","doi":"10.1016/j.leukres.2020.106463","elsevierAuthor":"Kirkizlar T.A.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"0"},{"title":"Impact of age and treatment institution type on outcomes of patients treated for chronic lymphocytic leukemia in British Columbia, Canada","googleId":"bmX1_NqnXv8J","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212621000394","googleCitationCount":0,"googleAuthor":"AS Gerrie","doi":"10.1016/j.leukres.2021.106538","elsevierCitationCount":0},{"title":"A strategy to reduce cumulative anthracycline exposure in low-risk pediatric acute myeloid leukemia while maintaining favorable outcomes","googleId":"363br0b3MFkJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212620301260","googleCitationCount":0,"googleAuthor":"HS Sabnis","doi":"10.1016/j.leukres.2020.106421","elsevierAuthor":"Sabnis H.S.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"September 2020","elsevierCitationCount":"1"},{"title":"High serum levels of IL-2R, IL-6, and TNF-α are associated with higher tumor burden and poorer outcome of follicular lymphoma patients in the rituximab era","googleId":"FpjKvuefidQJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S014521262030076X","googleCitationCount":0,"googleAuthor":"P Mozas","doi":"10.1016/j.leukres.2020.106371","elsevierAuthor":"Mozas P.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"July 2020","elsevierCitationCount":"0"},{"title":"Myelo-deception: Luspatercept & TGF-Beta ligand traps in myeloid diseases & anemia","googleId":"DvrVkcJfnQ8J","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212620301351","googleCitationCount":1,"googleAuthor":"","doi":"10.1016/j.leukres.2020.106430","elsevierAuthor":"Feld J.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"October 2020","elsevierCitationCount":"1"},{"title":"The effect bulky mass on prognosis in diffuse large B-cell lymphoma: still poor?","googleId":"HMFUe7Tm5wcJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212621000229","googleCitationCount":0,"googleAuthor":"M Bakırtaş","doi":"10.1016/j.leukres.2021.106521","elsevierAuthor":"Başcı S.","publicationName":"Leukemia Research","elsevierCoverDate":"2021-03-01","elsevierCoverDisplayDate":"March 2021","elsevierCitationCount":"0"},{"title":"Decitabine induction with myeloablative conditioning and allogeneic hematopoietic stem cell transplantation in high-risk patients with myeloid malignancies is …","googleId":"rhBXykuIdcAJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212620301247","googleCitationCount":0,"googleAuthor":"","doi":"10.1016/j.leukres.2020.106419","elsevierAuthor":"D'Angelo C.R.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"September 2020","elsevierCitationCount":"0"},{"title":"MECOM rearrangement involving the MYC locus: Two additional patients with the rare translocation, t (3; 8)(q26. 2; q24), and molecular review","googleId":"2-47GeZs_vkJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212620300928","googleCitationCount":0,"googleAuthor":"BJ Dave","doi":"10.1016/j.leukres.2020.106387","elsevierAuthor":"Smith S.C.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"August 2020","elsevierCitationCount":"0"},{"title":"Terminal deoxynucleotidyl transferase (TdT) expression is associated with FLT3-ITD mutations in Acute Myeloid Leukemia","googleId":"r6PnuU31b9cJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212620301673","googleCitationCount":0,"googleAuthor":"","doi":"10.1016/j.leukres.2020.106462","elsevierAuthor":"De Bellis E.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"0"},{"title":"Myeloid/lymphoid neoplasms with eosinophilia and FLT3 rearrangement","googleId":"-9XJLXjhcZIJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S014521262030165X","googleCitationCount":1,"googleAuthor":"W Wang","doi":"10.1016/j.leukres.2020.106460","elsevierAuthor":"Shao H.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"0"},{"title":"Examination of clinically-derived p210 BCR/ABL1 RhoGEF mutations in a murine bone marrow transplantation model of CML","googleId":"xkheUEQ7AZ4J","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212620301454","googleCitationCount":0,"googleAuthor":"","doi":"10.1016/j.leukres.2020.106440","elsevierAuthor":"Ciccarelli B.T.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"October 2020","elsevierCitationCount":"0"},{"title":"Targeted Therapy for Treatment of Patients with Classical Hairy Cell Leukemia","googleId":"wiB2If3gRjgJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212621000230","googleCitationCount":0,"googleAuthor":"AM Baran","doi":"10.1016/j.leukres.2021.106522","elsevierAuthor":"Moore J.E.","publicationName":"Leukemia Research","elsevierCoverDate":"2021-03-01","elsevierCoverDisplayDate":"March 2021","elsevierCitationCount":"0"},{"title":"Hybrid chemotherapy regimen (FLAG-IDA-vincristine-prednisone) for acute leukemia with mixed-phenotype blasts","googleId":"7OXpYL03M0MJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212621000400","googleCitationCount":0,"googleAuthor":"JH Reid","doi":"10.1016/j.leukres.2021.106539","elsevierCitationCount":0},{"title":"Sweet's syndrome associated with hematological malignancies","googleId":"4M2JzRQdtsEJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212620301661","googleCitationCount":0,"googleAuthor":"A Bigness","doi":"10.1016/j.leukres.2020.106461","elsevierAuthor":"Maller B.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"0"},{"title":"Acute myeloid leukemia or myelodysplastic syndrome with chromosome 17 abnormalities and long-term outcomes with or without hematopoietic stem cell …","googleId":"N_YxtxDinnoJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212620301077","googleCitationCount":0,"googleAuthor":"GR Mohyuddin","doi":"10.1016/j.leukres.2020.106402","elsevierAuthor":"Britt A.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"August 2020","elsevierCitationCount":"0"},{"title":"Comparison of real-world treatment patterns in chronic lymphocytic leukemia management before and after availability of ibrutinib in the province of British Columbia …","googleId":"Noa66iLr-JEJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212620300400","googleCitationCount":1,"googleAuthor":"AS Gerrie","doi":"10.1016/j.leukres.2020.106335","elsevierAuthor":"Huang S.J.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"April 2020","elsevierCitationCount":"0"},{"title":"Murine double minute 2 inhibition alone or with cytarabine in acute myeloid leukemia: Results from an idasanutlin phase 1/1b study⋆","googleId":"_gvIWLTzm7EJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212620301946","googleCitationCount":0,"googleAuthor":"","doi":"10.1016/j.leukres.2020.106489","elsevierAuthor":"Yee K.","publicationName":"Leukemia Research","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"January 2021","elsevierCitationCount":"0"},{"title":"Synergy of FLT3 inhibitors and the small molecule inhibitor of LIM kinase1/2 CEL_Amide in FLT3-ITD mutated Acute Myeloblastic Leukemia (AML) cells","googleId":"ZxvuIKYT0FAJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212620301958","googleCitationCount":0,"googleAuthor":"","doi":"10.1016/j.leukres.2020.106490","elsevierAuthor":"Djamai H.","publicationName":"Leukemia Research","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"January 2021","elsevierCitationCount":"0"},{"title":"MR 4log and low levels of NK cells are associated with higher molecular relapse after imatinib discontinuation: results of a prospective trial","googleId":"M0OhTFLZmN8J","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212621000175","googleCitationCount":0,"googleAuthor":"","doi":"10.1016/j.leukres.2021.106516","elsevierAuthor":"Seguro F.S.","publicationName":"Leukemia Research","elsevierCoverDate":"2021-02-01","elsevierCoverDisplayDate":"February 2021","elsevierCitationCount":"0"},{"title":"Plasma sIL-2Rα Levels Are Associated With Disease Progression in Myelofibrosis With JAK2 V617F but Not CALR Mutation","googleId":"QjWGWlgusk4J","googleLink":"https://pubmed.ncbi.nlm.nih.gov/32081398/","googleCitationCount":2,"googleAuthor":"","doi":"10.1016/j.leukres.2020.106319,","elsevierAuthor":"Barosi G.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"March 2020","elsevierCitationCount":"1"},{"title":"Acute myeloid leukemia with 11q23 rearrangements: A study of therapy-related disease and therapeutic outcomes","googleId":"o3mFVsDQxcoJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212620301582","googleCitationCount":0,"googleAuthor":"","doi":"10.1016/j.leukres.2020.106453","elsevierAuthor":"Menghrajani K.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"November 2020","elsevierCitationCount":"0"},{"title":"Deletions and amplifications of the IGH variable and constant regions: a novel prognostic parameter in patients with multiple myeloma","googleId":"vQNApgVDci0J","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212620301818","googleCitationCount":0,"googleAuthor":"","doi":"10.1016/j.leukres.2020.106476","elsevierAuthor":"Rabani H.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"0"},{"title":"Performance of prognostic scoring systems in elderly patients with acute myeloid leukaemia on intensive chemotherapy: A PETHEMA registry study","googleId":"P0Wh0iv2xSEJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212620300576","googleCitationCount":0,"googleAuthor":"","doi":"10.1016/j.leukres.2020.106352","elsevierAuthor":"Rodríguez-Medina C.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"September 2020","elsevierCitationCount":"0"},{"title":"The prognostic importance of BCR-ABL transcripts in Chronic Myeloid Leukemia: A systematic review and meta-analysis.","googleId":"jpx4vFlaOPIJ","googleLink":"https://europepmc.org/article/med/33524640","googleCitationCount":0,"googleAuthor":"OK Ghalesardi"},{"title":"Impact of tyrosine kinase inhibitors on the statural growth in children with acute lymphoblastic leukemia","googleId":"aX-9OPfnHKAJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212620301107","googleCitationCount":0,"googleAuthor":"","doi":"10.1016/j.leukres.2020.106405","elsevierAuthor":"Zheng F.y.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"August 2020","elsevierCitationCount":"0"},{"title":"Efficacy of mitoxantrone-based salvage therapies in relapsed or refractory acute myeloid leukemia in the Mayo Clinic Cancer Center: analysis of survival after 'CLAG …","googleId":"tuNx4rWRZScJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212620300059","googleCitationCount":3,"googleAuthor":"","doi":"10.1016/j.leukres.2020.106300","elsevierAuthor":"Scheckel C.J.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"March 2020","elsevierCitationCount":"3"},{"title":"Strategy for identification of a potential inherited leukemia predisposition in a 299 patient's cohort with tumor-only sequencing data","googleId":"A4SJAesBR70J","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212620300916","googleCitationCount":0,"googleAuthor":"A Aguilera-Diaz","doi":"10.1016/j.leukres.2020.106386","elsevierAuthor":"Aguilera-Diaz A.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"August 2020","elsevierCitationCount":"0"},{"title":"t (3; 14)(p14. 1; q32)/FOXP1-IGH translocation in thyroid extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)","googleId":"CBPd_AEwNhoJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212620301041","googleCitationCount":0,"googleAuthor":"","doi":"10.1016/j.leukres.2020.106399","elsevierAuthor":"Sasaki Y.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"August 2020","elsevierCitationCount":"0"},{"title":"Management of patients with acute lymphoblastic leukemia in routine clinical practice: Minimal residual disease testing, treatment patterns and clinical …","googleId":"O4Yn1sIpx8EJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212620300394","googleCitationCount":1,"googleAuthor":"","doi":"10.1016/j.leukres.2020.106334","elsevierAuthor":"Deeren D.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"April 2020","elsevierCitationCount":"0"},{"title":"GATA1 downregulation in prefibrotic and fibrotic stages of primary myelofibrosis and in the myelofibrotic progression of other myeloproliferative neoplasms","googleId":"9dGsEyvcuhkJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212620302009","googleCitationCount":0,"googleAuthor":"Z Chen","doi":"10.1016/j.leukres.2020.106495","elsevierAuthor":"Sangiorgio V.F.I.","publicationName":"Leukemia Research","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"January 2021","elsevierCitationCount":"0"},{"title":"SVILE regimen, a combination of dexamethasone, vindesine, ifosfamide, pegaspargase, and etoposide, for treating relapsed/refractory extranodal natural killer/T-cell …","googleId":"MMvsWJjr9nsJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212620301272","googleCitationCount":0,"googleAuthor":"L Wang","doi":"10.1016/j.leukres.2020.106422","elsevierAuthor":"Wei L.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"0"},{"title":"Unraveling clonal heterogeneity at the stem cell level in myelodysplastic syndrome: In pursuit of cell subsets driving disease progression","googleId":"AAfWWdbjZNIJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/32334198/","googleCitationCount":2,"googleAuthor":"","doi":"10.1016/j.leukres.2020.106350,","elsevierAuthor":"Simonsen A.T.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"May 2020","elsevierCitationCount":"1"},{"title":"Inpatient versus outpatient hypomethylating agent induction for acute myeloid leukemia as a predictor for survival","googleId":"7LB_jBnG7T4J","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212621000345","googleCitationCount":0,"googleAuthor":"C Jeurkar","doi":"10.1016/j.leukres.2021.106533","elsevierCitationCount":0},{"title":"MYD88 L265P mutation detected by digital PCR as a prognostic factor in patients with diffuse large B-cell lymphoma in rituximab era","googleId":"V-t7kYJVlzcJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212620301314","googleCitationCount":0,"googleAuthor":"K Takeuchi","doi":"10.1016/j.leukres.2020.106426","elsevierAuthor":"Nishimura N.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"October 2020","elsevierCitationCount":"0"},{"title":"Additional flow cytometric studies for differential diagnosis between Burkitt lymphoma/leukemia and B-cell precursor acute lymphoblastic leukemia","googleId":"3mNMMRUTSoEJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S014521262030196X","googleCitationCount":0,"googleAuthor":"","doi":"10.1016/j.leukres.2020.106491","elsevierAuthor":"Demina I.","publicationName":"Leukemia Research","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"January 2021","elsevierCitationCount":"0"},{"title":"IPS-3 Validation in 1012 cases with classical hodgkin lymphoma","googleId":"483Q8i3wYKUJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212621000205","googleCitationCount":0,"googleAuthor":"S Paydas","doi":"10.1016/j.leukres.2021.106519","elsevierAuthor":"Paydas S.","publicationName":"Leukemia Research","elsevierCoverDate":"2021-03-01","elsevierCoverDisplayDate":"March 2021","elsevierCitationCount":"0"},{"title":"Plasmablastic lymphoma–single centre experience with infusional EPOCH chemotherapy","googleId":"PxlCgc8HCl8J","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212620300965","googleCitationCount":0,"googleAuthor":"P Karunakaran","doi":"10.1016/j.leukres.2020.106391","elsevierAuthor":"Jayachandran P.K.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"August 2020","elsevierCitationCount":"0"},{"title":"Low-dose radiotherapy (2× 2 g) versus low doses and rituximab in the treatment of marginal zone b-cell lymphoma previously untreated","googleId":"ULaZe5lvqVoJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S014521262030148X","googleCitationCount":0,"googleAuthor":"","doi":"10.1016/j.leukres.2020.106443","elsevierAuthor":"Aviles A.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"November 2020","elsevierCitationCount":"0"},{"title":"Characteristics and outcome of multiple myeloma patients presenting with anaemia only: A retrospective multi-centre study","googleId":"vxcYBNr28O0J","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212620302034","googleCitationCount":1,"googleAuthor":"","doi":"10.1016/j.leukres.2020.106498","elsevierAuthor":"Shragai T.","publicationName":"Leukemia Research","elsevierCoverDate":"2021-02-01","elsevierCoverDisplayDate":"February 2021","elsevierCitationCount":"0"},{"title":"Lymphocyte-depleting chemotherapy for aggressive hematologic malignancies in two patients with positive SARS-CoV-2 PCR","googleId":"OXZdECWPwxoJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/pmc7664342/","googleCitationCount":0,"googleAuthor":"A Pandita","doi":"10.1016/j.leukres.2020.106473","elsevierAuthor":"Pelcovits A.","publicationName":"Leukemia Research","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"January 2021","elsevierCitationCount":"0"},{"title":"The impact of lockdown during the COVID-19 pandemic on newly acute myeloid leukemia patients: Single-centre comparative study between 2019 and 2020 …","googleId":"BwTSBhiSNjIJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/pmc7839831/","googleCitationCount":0,"googleAuthor":"","doi":"10.1016/j.leukres.2021.106518","elsevierAuthor":"Martín-Moro F.","publicationName":"Leukemia Research","elsevierCoverDate":"2021-02-01","elsevierCoverDisplayDate":"February 2021","elsevierCitationCount":"0"},{"title":"Osteopontin-c is overexpressed in KMT2A-AFF1 positive pediatric B-cell lymphoblastic leukemia when compared to those with ETV6-RUNX1","googleId":"eXl3c3LgAukJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/32114371/","googleCitationCount":1,"googleAuthor":"","doi":"10.1016/j.leukres.2020.106316,","elsevierAuthor":"da Fonseca Bastos A.C.S.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"April 2020","elsevierCitationCount":"1"},{"title":"Evolution of clonal dynamics and differential response to targeted therapy in a case of systemic mastocytosis with associated myelodysplastic syndrome","googleId":"6E4CBVcGw70J","googleLink":"https://pubmed.ncbi.nlm.nih.gov/32569927/","googleCitationCount":1,"googleAuthor":"ML Antony","doi":"10.1016/j.leukres.2020.106404,","elsevierAuthor":"Yun H.D.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"August 2020","elsevierCitationCount":"1"},{"title":"Reinfection versus failure of viral clearance in a COVID-19 patient with hematologic malignancy","googleId":"HV0jTNDT42AJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817416/","googleCitationCount":0,"googleAuthor":"M Ibrahim","doi":"10.1016/j.leukres.2021.106514","elsevierAuthor":"Ibrahim M.","publicationName":"Leukemia Research","elsevierCoverDate":"2021-02-01","elsevierCoverDisplayDate":"February 2021","elsevierCitationCount":"0"},{"title":"Immunosuppression in hematological cancer patients with Covid-19–uncomplicated infections but delayed viral clearance?","googleId":"R17e1T_TXIMJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326457/","googleCitationCount":0,"googleAuthor":"","doi":"10.1016/j.leukres.2020.106407","elsevierAuthor":"Boyd K.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"September 2020","elsevierCitationCount":"0"},{"title":"Disturbed MAPK pathway in early bilateral testicular extramedullary relapse of multiple myeloma","googleId":"y2lpQgAqWwEJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/32569928/","googleCitationCount":1,"googleAuthor":"","doi":"10.1016/j.leukres.2020.106403,","elsevierAuthor":"Huang H.F.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"August 2020","elsevierCitationCount":"1"},{"title":"DNMT3A alterations associated with myeloid malignancies dictate differential responses to hypomethylating agents","googleId":"IhHiv3Ml_1QJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/32445940/","googleCitationCount":1,"googleAuthor":"K Venugopal","doi":"10.1016/j.leukres.2020.106372,","elsevierAuthor":"Casellas Román H.L.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"July 2020","elsevierCitationCount":"1"},{"title":"An exemplar population-based study to predict up-take of non-intensive therapies in acute myeloid leukaemia","googleId":"e9KBazEndm0J","googleLink":"https://discovery.dundee.ac.uk/en/publications/an-exemplar-population-based-study-to-predict-up-take-of-non-inte","googleCitationCount":0,"googleAuthor":"","doi":"10.1016/j.leukres.2020.106348","elsevierAuthor":"Ip K.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"May 2020","elsevierCitationCount":"0"},{"title":"Venetoclax and hypomethylating agent combination therapy in acute myeloid leukemia secondary to a myeloproliferative neoplasm","googleId":"X6DLRUj8dTEJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/33002673/","googleCitationCount":2,"googleAuthor":"D Tremblay","doi":"10.1016/j.leukres.2020.106456,","elsevierAuthor":"Tremblay D.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"November 2020","elsevierCitationCount":"1"},{"title":"Comparison of induction strategies and responses for acute myeloid leukemia patients after resistance to hypomethylating agents for antecedent myeloid malignancy","googleId":"QI7zHxF3K5MJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212620300722","googleCitationCount":1,"googleAuthor":"AD Goldberg","doi":"10.1016/j.leukres.2020.106367","elsevierAuthor":"Talati C.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"June 2020","elsevierCitationCount":"0"},{"title":"The impact of anti-bacterial prophylaxis on the outcome of patients treated with venetoclax-based regimens for relapsed/refractory plasma cell dyscrasias: Real-life …","googleId":"z9glBYhS-_cJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/32861018/?otool=iiltaulib","googleCitationCount":1,"googleAuthor":"","doi":"10.1016/j.leukres.2020.106429,","elsevierAuthor":"Avivi I.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"October 2020","elsevierCitationCount":"0"},{"title":"Outcomes of the Cyclophosphamide, Vincristine, Prednisone (CVP)+/-Rituximab (R-CVP) Regimen in Older Patients With Newly Diagnosed Ph-Acute Lymphoblastic …","googleId":"5gQemdSVxdgJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/31935625/","googleCitationCount":1,"googleAuthor":"J Blachly","doi":"10.1016/j.leukres.2020.106297,","elsevierAuthor":"Saygin C.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"February 2020","elsevierCitationCount":"0"},{"title":"WITHDRAWN: Cost-effectiveness analysis of daratumumab plus bortezomib, melphalan and prednisone for newly diagnosed multiple myeloma ineligible for stem cell …","googleId":"ssFk9YtIfyIJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212620301491","googleCitationCount":0,"googleAuthor":"","doi":"10.1016/j.leukres.2020.106444","elsevierCitationCount":0},{"title":"Esssential thrombocythaemia and pregnancy-A need for prospective study and a consensus on its management.","googleId":"hU09ZiZejdcJ","googleLink":"https://europepmc.org/article/med/33556743","googleCitationCount":0,"googleAuthor":"K Burbury"},{"title":"Haploinsufficiency of multiple del (5q) genes induce B cell abnormalities in mice","googleId":"6PDvJR3FQT4J","googleLink":"https://pubmed.ncbi.nlm.nih.gov/32739655/","googleCitationCount":0,"googleAuthor":"CL Shirai","doi":"10.1016/j.leukres.2020.106428,","elsevierAuthor":"Liu T.","publicationName":"Leukemia Research","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"January 2021","elsevierCitationCount":"0"},{"title":"High expression of c-Myc in chronic lymphocytic leukaemia with t (8; 14)(q24. 1; q32): A case report","googleId":"j5BeON2-OLsJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/32721643/","googleCitationCount":0,"googleAuthor":"","doi":"10.1016/j.leukres.2020.106424,","elsevierAuthor":"Nagaharu K.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"September 2020","elsevierCitationCount":"0"},{"title":"Metastatic lung adenocarcinoma mimicking Richter transformation in a patient with chronic lymphocytic leukemia","googleId":"nPwGk9zDcEAJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/32937250/","googleCitationCount":0,"googleAuthor":"N Jain","doi":"10.1016/j.leukres.2020.106445,","elsevierAuthor":"Cherng H.J.J.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"November 2020","elsevierCitationCount":"0"},{"title":"Reducing Venous Thrombosis With Antithrombin Supplementation in Patients Undergoing Treatment for ALL With Peg-asparaginase-A Real World Study","googleId":"EIKp4M8p0H8J","googleLink":"https://pubmed.ncbi.nlm.nih.gov/32442786/","googleCitationCount":0,"googleAuthor":"","doi":"10.1016/j.leukres.2020.106368,","elsevierAuthor":"George G.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"July 2020","elsevierCitationCount":"1"},{"title":"A simplified prognostic index for chronic lymphocytic leukemia treated with ibrutinib: Results from a multicenter retrospective cohort study","googleId":"ek33dnudJPgJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/31982152/","googleCitationCount":1,"googleAuthor":"","doi":"10.1016/j.leukres.2020.106302,","elsevierAuthor":"Gordon M.J.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"February 2020","elsevierCitationCount":"0"},{"title":"The predictive value of intracellular imatinib levels in newly diagnosed chronic myeloid leukemia","googleId":"bo6_3jd8OqgJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/31846781/","googleCitationCount":0,"googleAuthor":"CM Hillis","doi":"10.1016/j.leukres.2019.106285,","elsevierAuthor":"Hillis C.M.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"January 2020","elsevierCitationCount":"0"},{"title":"A fatal case of TEMPI syndrome, refractory to proteasome inhibitors and autologous stem cell transplantation","googleId":"Eyc5th7oNlUJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/32861019/","googleCitationCount":0,"googleAuthor":"R Renso","doi":"10.1016/j.leukres.2020.106441,","elsevierAuthor":"Diral E.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"October 2020","elsevierCitationCount":"0"},{"title":"Genetic characterization of acute myeloid leukemia patients with mutations in IDH1/2 genes","googleId":"z87C3J9sd3QJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/33494038/","googleCitationCount":0,"googleAuthor":"P Acha","doi":"10.1016/j.leukres.2020.106492,","elsevierAuthor":"Acha P.","publicationName":"Leukemia Research","elsevierCoverDate":"2021-02-01","elsevierCoverDisplayDate":"February 2021","elsevierCitationCount":"0"},{"title":"What's germane in the germline? Finding clinically relevant germline variants in myeloid neoplasms from tumor only screening","googleId":"5m3_YWmW3RcJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/32771235/","googleCitationCount":0,"googleAuthor":"AL Brown","doi":"10.1016/j.leukres.2020.106431,","elsevierAuthor":"Brown A.L.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"September 2020","elsevierCitationCount":"0"},{"title":"Corrigendum to\" Haploinsufficiency of multiple del (5q) genes induce B cell abnormalities in mice\"","googleId":"4USI_DL7powJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/33288274/","googleCitationCount":0,"googleAuthor":"CL Shirai","doi":"10.1016/j.leukres.2020.106478,","elsevierAuthor":"Liu T.","publicationName":"Leukemia Research","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"January 2021","elsevierCitationCount":"0"},{"title":"Dasatinib discontinuation in patients with chronic-phase chronic myeloid leukemia and stable deep molecular response: the DASFREE study","googleId":"TcsX1GNb9bUJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2019.1675879","googleCitationCount":28,"googleAuthor":"","doi":"10.1080/10428194.2019.1675879","elsevierAuthor":"Shah N.P.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-02-23","elsevierCoverDisplayDate":"23 February 2020","elsevierCitationCount":"17"},{"title":"Development of Classic Hodgkin Lymphoma after successful treatment of primary mediastinal large b-cell lymphoma: results from a well-defined database","googleId":"gJgiLY6Zsz8J","googleLink":"https://pubmed.ncbi.nlm.nih.gov/33285316/","googleCitationCount":0,"googleAuthor":"TP Vassilakopoulos","doi":"10.1016/j.leukres.2020.106479,","elsevierAuthor":"Vassilakopoulos T.P.","publicationName":"Leukemia Research","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"January 2021","elsevierCitationCount":"0"},{"title":"Corrigendum to\" STAT5b-RARa-positive Acute Myeloid Leukemia: Diagnostic and Therapeutic Challenges of a Rare AML Subtype\"","googleId":"_tUXZsniEagJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/32381305/","googleCitationCount":0,"googleAuthor":"C Gurnari","doi":"10.1016/j.leukres.2019.04.014,","elsevierAuthor":"Ciangola G.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"June 2020","elsevierCitationCount":"0"},{"title":"A case of Burkitt Leukemia: Revisiting the prognostic value of lactate dehydrogenase","googleId":"l-XUFMU-EcoJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/31924584/","googleCitationCount":0,"googleAuthor":"B Zhang","doi":"10.1016/j.leukres.2019.106295,","elsevierAuthor":"Bodrog A.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"February 2020","elsevierCitationCount":"0"},{"title":"Outcome of lower-risk myelodysplastic syndrome with ring sideroblasts (MDS-RS) after failure of erythropoiesis-stimulating agents","googleId":"cj6I84BA-oEJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/33212326/","googleCitationCount":0,"googleAuthor":"","doi":"10.1016/j.leukres.2020.106472,","elsevierAuthor":"Park S.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"0"},{"title":"Peyronie's disease in patients with Hodgkin lymphoma","googleId":"-dCkxjWz8n4J","googleLink":"https://pubmed.ncbi.nlm.nih.gov/32763627/","googleCitationCount":0,"googleAuthor":"G Massini","doi":"10.1016/j.leukres.2020.106427,","elsevierAuthor":"Autore F.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"September 2020","elsevierCitationCount":"0"},{"title":"Corrigendum to\" Performance of prognostic scoring systems in elderly patients with acute myeloid leukaemia on intensive chemotherapy: A PETHEMA registry study\" …","googleId":"3u_hFGgm15gJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/32680618/","googleCitationCount":0,"googleAuthor":"","doi":"10.1016/j.leukres.2020.106388,","elsevierAuthor":"Rodríguez-Medina C.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"September 2020","elsevierCitationCount":"0"},{"title":"Corrigendum to\" SVILE regimen, a combination of dexamethasone, vindesine, ifosfamide, pegaspargase, and etoposide, for treating relapsed/refractory extranodal …","googleId":"V8ITy60zIRgJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/32981756/","googleCitationCount":0,"googleAuthor":"","doi":"10.1016/j.leukres.2020.106446,","elsevierAuthor":"Wei L.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"0"},{"title":"Letter to the Editor on the Original Article\" A Systematic Review of Patient Reported Outcomes in Phase II or III Clinical Trials of Myelodysplastic Syndromes and Acute …","googleId":"FenwEItuAxYJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/32387759/","googleCitationCount":0,"googleAuthor":"EN Oliva","doi":"10.1016/j.leukres.2020.106355,","elsevierAuthor":"Oliva E.N.","publicationName":"Leukemia Research","elsevierCoverDate":"2020-06-01","elsevierCoverDisplayDate":"June 2020","elsevierCitationCount":"0"},{"title":"Gene name","googleId":"vJVk028E4u4J","googleLink":"https://pdfs.semanticscholar.org/861b/cf57f9c2e30fd34ee3be7d2dd432bf7c3d66.pdf","googleCitationCount":0,"googleAuthor":""},{"title":"Real-World Minimal Residual Disease (MRD) Assessment and Trends Using clonoSEQ® in Acute Lymphoblastic Leukemia and Multiple Myeloma","googleId":"ooAGV2Q016UJ","googleLink":"https://www.nccn.org/professionals/meetings/2020/pdf/092_GPS_NCCNac20.pdf","googleCitationCount":0,"googleAuthor":""},{"title":"Hematological Malignancies Pattern among Bangladeshi Adults","googleId":"joe1C26YEtkJ","googleLink":"http://216.10.240.19/v8-i5/2%20jmscr.pdf","googleCitationCount":0,"googleAuthor":"S Selim"},{"title":"Epstein-Barr virus NK and T cell lymphoproliferative disease: report of a 2018 international meeting","googleId":"9FWC9K_kNZsJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2019.1699080","googleCitationCount":14,"googleAuthor":"","doi":"10.1080/10428194.2019.1699080","elsevierAuthor":"Cohen J.I.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-03-20","elsevierCoverDisplayDate":"20 March 2020","elsevierCitationCount":"8"},{"title":"CPX-351 (vyxeos) in AML","googleId":"LP_5cTeTjvAJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2019.1660970","googleCitationCount":16,"googleAuthor":"M Alfayez","doi":"10.1080/10428194.2019.1660970","elsevierAuthor":"Parisio K.","publicationName":"Pediatric Blood and Cancer","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"1 July 2020","elsevierCitationCount":"0"},{"title":"Venetoclax in acute myeloid leukemia–current and future directions","googleId":"Qxt06K6Aly0J","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1719098","googleCitationCount":7,"googleAuthor":"C Lachowiez","doi":"10.1080/10428194.2020.1719098","elsevierAuthor":"Lachowiez C.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-05-11","elsevierCoverDisplayDate":"11 May 2020","elsevierCitationCount":"3"},{"title":"Direct-acting antivirals in relapsed or refractory hepatitis C virus-associated diffuse large B-cell lymphoma","googleId":"mhLERd09TwQJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1755859","googleCitationCount":8,"googleAuthor":"I Defrancesco","doi":"10.1080/10428194.2020.1755859","elsevierAuthor":"Merli M.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-07-28","elsevierCoverDisplayDate":"28 July 2020","elsevierCitationCount":"4"},{"title":"Selinexor in combination with decitabine in patients with acute myeloid leukemia: results from a phase 1 study","googleId":"f5kuUEIiNWUJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2019.1665664","googleCitationCount":11,"googleAuthor":"B Bhatnagar","doi":"10.1080/10428194.2019.1665664","elsevierAuthor":"Bhatnagar B.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-01-28","elsevierCoverDisplayDate":"28 January 2020","elsevierCitationCount":"8"},{"title":"Association of provider experience and clinical outcomes in patients with myelodysplastic syndromes receiving hypomethylating agents","googleId":"Rd3HDUp0XkwJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2019.1663423","googleCitationCount":9,"googleAuthor":"AM Zeidan","doi":"10.1080/10428194.2019.1663423","elsevierAuthor":"Zeidan A.M.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-01-28","elsevierCoverDisplayDate":"28 January 2020","elsevierCitationCount":"7"},{"title":"Patterns of care and clinical outcomes of patients with newly diagnosed acute myeloid leukemia presenting with hyperleukocytosis who do not receive intensive …","googleId":"xhZhCbv_nzoJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1728753","googleCitationCount":7,"googleAuthor":"M Stahl","doi":"10.1080/10428194.2020.1728753","elsevierAuthor":"Shallis R.M.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-04-15","elsevierCoverDisplayDate":"15 April 2020","elsevierCitationCount":"6"},{"title":"The role of MYC in the transformation and aggressiveness of 'indolent'B-cell malignancies","googleId":"0en0HV4_wbQJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2019.1675877","googleCitationCount":9,"googleAuthor":"M Mraz","doi":"10.1080/10428194.2019.1675877","elsevierAuthor":"Filip D.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-02-23","elsevierCoverDisplayDate":"23 February 2020","elsevierCitationCount":"9"},{"title":"Health-related quality of life results from the IFM 2009 trial: treatment with lenalidomide, bortezomib, and dexamethasone in transplant-eligible patients with newly …","googleId":"x2HGhr4o7gYJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1719091","googleCitationCount":6,"googleAuthor":"A Perrot","doi":"10.1080/10428194.2020.1719091","elsevierAuthor":"Roussel M.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-05-11","elsevierCoverDisplayDate":"11 May 2020","elsevierCitationCount":"3"},{"title":"CD8+ T-cells of CLL-bearing mice acquire a transcriptional program of T-cell activation and exhaustion","googleId":"DdlyvaUP0bwJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2019.1660972","googleCitationCount":10,"googleAuthor":"BS Hanna","doi":"10.1080/10428194.2019.1660972","elsevierAuthor":"Llaó Cid L.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-01-28","elsevierCoverDisplayDate":"28 January 2020","elsevierCitationCount":"8"},{"title":"Anti-CD19 chimeric antigen receptor T-cells induce durable remission in relapsed Philadelphia chromosome-positive ALL with T315I mutation","googleId":"ubUhVVWZdoEJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2019.1663417","googleCitationCount":9,"googleAuthor":"","doi":"10.1080/10428194.2019.1663417","elsevierAuthor":"Yang F.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-01-28","elsevierCoverDisplayDate":"28 January 2020","elsevierCitationCount":"3"},{"title":"Management of myelofibrosis after ruxolitinib failure","googleId":"L0N0sx20u_gJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1749606","googleCitationCount":4,"googleAuthor":"","doi":"10.1080/10428194.2020.1749606","elsevierAuthor":"Bose P.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-07-02","elsevierCoverDisplayDate":"2 July 2020","elsevierCitationCount":"2"},{"title":"Identification of microRNAs modulated by DNA hypomethylating drugs in extranodal NK/T-cell lymphoma","googleId":"xcmvo5Vrqc8J","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2019.1654096","googleCitationCount":8,"googleAuthor":"PJ Kim","doi":"10.1080/10428194.2019.1654096","elsevierAuthor":"Go H.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-01-02","elsevierCoverDisplayDate":"2 January 2020","elsevierCitationCount":"5"},{"title":"Efficacy and toxicity of reduced vs. standard dose pegylated asparaginase in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia","googleId":"KX4Ybxl97zQJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2019.1680839","googleCitationCount":10,"googleAuthor":"BA Derman","doi":"10.1080/10428194.2019.1680839","elsevierAuthor":"Derman B.A.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-02-23","elsevierCoverDisplayDate":"23 February 2020","elsevierCitationCount":"8"},{"title":"Quality of life in patients with relapsed/refractory multiple myeloma during ixazomib-thalidomide-dexamethasone induction and ixazomib maintenance therapy and …","googleId":"oBw7nWUhlKEJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2019.1666381","googleCitationCount":8,"googleAuthor":"A Egle","doi":"10.1080/10428194.2019.1666381","elsevierAuthor":"Ludwig H.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-01-28","elsevierCoverDisplayDate":"28 January 2020","elsevierCitationCount":"2"},{"title":"Mechanisms of intrinsic and acquired resistance to venetoclax in B-cell lymphoproliferative disease","googleId":"BRRirN0tzpAJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2019.1660974","googleCitationCount":6,"googleAuthor":"","doi":"10.1080/10428194.2019.1660974","elsevierAuthor":"Blombery P.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-01-28","elsevierCoverDisplayDate":"28 January 2020","elsevierCitationCount":"3"},{"title":"Pembrolizumab monotherapy in patients with primary refractory classical hodgkin lymphoma who relapsed after salvage autologous stem cell transplantation and/or …","googleId":"3dzv31UOeuYJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2019.1702178","googleCitationCount":6,"googleAuthor":"PL Zinzani","doi":"10.1080/10428194.2019.1702178","elsevierAuthor":"Zinzani P.L.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-03-20","elsevierCoverDisplayDate":"20 March 2020","elsevierCitationCount":"3"},{"title":"Monocytic myeloid-derived suppressor cells in chronic lymphocytic leukemia patients: a single center experience","googleId":"QhwfiiVbP9AJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1728747","googleCitationCount":5,"googleAuthor":"AM Zahran","doi":"10.1080/10428194.2020.1728747","elsevierAuthor":"Zahran A.M.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-06-06","elsevierCoverDisplayDate":"6 June 2020","elsevierCitationCount":"4"},{"title":"Asparaginase activities during intensified treatment with pegylated E. coli asparaginase in adults with newly-diagnosed acute lymphoblastic leukemia","googleId":"R6L21VLBmZMJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2019.1658099","googleCitationCount":6,"googleAuthor":"","doi":"10.1080/10428194.2019.1658099","elsevierAuthor":"Lanvers-Kaminsky C.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-01-02","elsevierCoverDisplayDate":"2 January 2020","elsevierCitationCount":"3"},{"title":"Interrogation of molecular profiles can help in differentiating between MDS and AML with MDS-related changes","googleId":"dkZ2UGNUH8EJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1719089","googleCitationCount":4,"googleAuthor":"T Badar","doi":"10.1080/10428194.2020.1719089","elsevierAuthor":"Badar T.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-05-11","elsevierCoverDisplayDate":"11 May 2020","elsevierCitationCount":"3"},{"title":"Routine next generation sequencing of lymphoid malignancies: clinical utility and challenges from a 3-Year practical experience","googleId":"Kb79Jc69s6sJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1786560","googleCitationCount":3,"googleAuthor":"","doi":"10.1080/10428194.2020.1786560","elsevierAuthor":"Pillonel V.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-09-18","elsevierCoverDisplayDate":"November 2020","elsevierCitationCount":"3"},{"title":"Hypomethylating agent (HMA) therapy use and survival in older adults with refractory anemia with excess blasts (RAEB) in the United States (USA): a large propensity …","googleId":"jTQa2_DVb9IJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2019.1703970","googleCitationCount":5,"googleAuthor":"X Hu","doi":"10.1080/10428194.2019.1703970","elsevierAuthor":"Davidoff A.J.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-04-15","elsevierCoverDisplayDate":"15 April 2020","elsevierCitationCount":"5"},{"title":"Waldenstrom's macroglobulinemia in the era of immunotherapy","googleId":"gvoIl5tlYC8J","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1711901","googleCitationCount":4,"googleAuthor":"","doi":"10.1080/10428194.2020.1711901","elsevierAuthor":"Vaxman I.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-05-11","elsevierCoverDisplayDate":"11 May 2020","elsevierCitationCount":"1"},{"title":"Open-Label, phase 2 study of blinatumomab as second salvage therapy in adults with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma","googleId":"GQQYS77_kdYJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1759055","googleCitationCount":9,"googleAuthor":"A Rambaldi","doi":"10.1080/10428194.2020.1759055","elsevierAuthor":"Coyle L.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-07-28","elsevierCoverDisplayDate":"28 July 2020","elsevierCitationCount":"6"},{"title":"Optimal sequence of daratumumab and elotuzumab in relapsed and refractory multiple myeloma","googleId":"QVVwwph9AsYJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2019.1688324","googleCitationCount":7,"googleAuthor":"AJ Perissinotti","doi":"10.1080/10428194.2019.1688324","elsevierAuthor":"Hoylman E.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-02-23","elsevierCoverDisplayDate":"23 February 2020","elsevierCitationCount":"6"},{"title":"Burkitt lymphoma: bridging the gap between advances in molecular biology and therapy","googleId":"p6qFLCkq6I0J","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1747068","googleCitationCount":5,"googleAuthor":"AJ Olszewski","doi":"10.1080/10428194.2020.1747068","elsevierAuthor":"Zayac A.S.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-07-02","elsevierCoverDisplayDate":"2 July 2020","elsevierCitationCount":"2"},{"title":"Risk factors for infections and secondary malignancies in patients with a myeloproliferative neoplasm treated with ruxolitinib: a dual-center, propensity score-matched …","googleId":"fkc1yaa5SE8J","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2019.1688323","googleCitationCount":7,"googleAuthor":"D Tremblay","doi":"10.1080/10428194.2019.1688323","elsevierAuthor":"Tremblay D.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-02-23","elsevierCoverDisplayDate":"23 February 2020","elsevierCitationCount":"5"},{"title":"Rewriting the rules for care of MDS and AML patients in the time of COVID-19","googleId":"eMJTiVwu1MYJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S2213048920300078","googleCitationCount":7,"googleAuthor":"","doi":"10.1016/j.lrr.2020.100201","elsevierAuthor":"Raza A.","publicationName":"Leukemia Research Reports","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"5"},{"title":"The clinical outcomes of rituximab biosimilar CT-P10 (Truxima®) with CHOP as first-line treatment for patients with diffuse large B-cell lymphoma: real-world …","googleId":"V1RCtfElqFcJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1742906","googleCitationCount":3,"googleAuthor":"","doi":"10.1080/10428194.2020.1742906","elsevierAuthor":"Lee K.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-06-06","elsevierCoverDisplayDate":"6 June 2020","elsevierCitationCount":"3"},{"title":"Comparison of acalabrutinib plus obinutuzumab, ibrutinib plus obinutuzumab and venetoclax plus obinutuzumab for untreated CLL: a network meta-analysis","googleId":"AY4Kdq92KWgJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1811271","googleCitationCount":3,"googleAuthor":"","doi":"10.1080/10428194.2020.1811271","elsevierAuthor":"Sheng Z.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"2"},{"title":"A comprehensive clinical study of integrins in acute lymphoblastic leukemia indicates a role of α6/CD49f in persistent minimal residual disease and α5 in the …","googleId":"Un8hPUOJD9MJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1731500","googleCitationCount":4,"googleAuthor":"","doi":"10.1080/10428194.2020.1731500","elsevierAuthor":"Shah Scharff B.F.S.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-06-06","elsevierCoverDisplayDate":"6 June 2020","elsevierCitationCount":"4"},{"title":"Venetoclax and hypomethylating agent therapy in high risk myelodysplastic syndromes: a retrospective evaluation of a real-world experience","googleId":"SHnh3Z_sQ-UJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1775214","googleCitationCount":3,"googleAuthor":"A Ediriwickrema","doi":"10.1080/10428194.2020.1775214","elsevierAuthor":"Azizi A.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-09-18","elsevierCoverDisplayDate":"November 2020","elsevierCitationCount":"1"},{"title":"Checkpoint inhibition therapy as possible frontline therapy for Hodgkin lymphoma","googleId":"-QcwcHSMPP4J","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2019.1709832","googleCitationCount":4,"googleAuthor":"A Khurana","doi":"10.1080/10428194.2019.1709832","elsevierAuthor":"Khurana A.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-04-15","elsevierCoverDisplayDate":"15 April 2020","elsevierCitationCount":"2"},{"title":"Selinexor for advanced hematologic malignancies","googleId":"Z_tN4b1JnrgJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1775210","googleCitationCount":2,"googleAuthor":"R Garzon","doi":"10.1080/10428194.2020.1775210","elsevierAuthor":"Walker J.S.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-08-23","elsevierCoverDisplayDate":"23 August 2020","elsevierCitationCount":"2"},{"title":"Comparison of complication rates and incidences associated with different peripherally inserted central catheters (PICC) in patients with hematological malignancies …","googleId":"UgCrTsmMhXoJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2019.1646908","googleCitationCount":7,"googleAuthor":"","doi":"10.1080/10428194.2019.1646908","elsevierAuthor":"Scrivens N.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-01-02","elsevierCoverDisplayDate":"2 January 2020","elsevierCitationCount":"1"},{"title":"Persistent mediastinal FDG uptake on PET-CT after frontline therapy for Hodgkin lymphoma: biopsy, treat or observe?","googleId":"mua3QC3Dhn8J","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2019.1663422","googleCitationCount":5,"googleAuthor":"","doi":"10.1080/10428194.2019.1663422","elsevierAuthor":"Novo M.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-01-28","elsevierCoverDisplayDate":"28 January 2020","elsevierCitationCount":"2"},{"title":"Convalescent hyperimmune plasma for chemo-immunotherapy induced immunodeficiency in COVID-19 patients with hematological malignancies","googleId":"6XvUHJx2tlsJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2021.1872070","googleCitationCount":2,"googleAuthor":"A Rambaldi","doi":"10.1080/10428194.2021.1872070","elsevierAuthor":"Ferrari S.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"2021","elsevierCitationCount":"0"},{"title":"Time from first symptom onset to the final diagnosis of multiple myeloma (MM)–possible risks and future solutions: retrospective and prospective 'Deutsche …","googleId":"zi98LpOqiDEJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2019.1695051","googleCitationCount":5,"googleAuthor":"G Graziani","doi":"10.1080/10428194.2019.1695051","elsevierAuthor":"Graziani G.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-03-20","elsevierCoverDisplayDate":"20 March 2020","elsevierCitationCount":"3"},{"title":"Comparison of salvage chemotherapy regimens and prognostic significance of minimal residual disease in relapsed/refractory acute myeloid leukemia","googleId":"5RW_w506x5oJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1821009","googleCitationCount":2,"googleAuthor":"MU Mushtaq","doi":"10.1080/10428194.2020.1821009","elsevierAuthor":"Mushtaq M.U.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"2021","elsevierCitationCount":"0"},{"title":"The prognostic value of the controlling nutritional status score in patients with multiple myeloma","googleId":"pb5OwL7HWsUJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1749608","googleCitationCount":3,"googleAuthor":"","doi":"10.1080/10428194.2020.1749608","elsevierAuthor":"Kamiya T.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-07-02","elsevierCoverDisplayDate":"2 July 2020","elsevierCitationCount":"2"},{"title":"Retreatment with brentuximab vedotin in patients with relapsed/refractory classical Hodgkin lymphoma or systemic anaplastic large-cell lymphoma: a multicenter …","googleId":"TFiIBxSHdj8J","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2019.1654100","googleCitationCount":7,"googleAuthor":"","doi":"10.1080/10428194.2019.1654100","elsevierAuthor":"Fukuhara N.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-01-02","elsevierCoverDisplayDate":"2 January 2020","elsevierCitationCount":"3"},{"title":"A single-center retrospective cohort analysis of venetoclax in relapsed/refractory multiple myeloma","googleId":"OjVXO95mF00J","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2019.1709835","googleCitationCount":5,"googleAuthor":"CY Huang","doi":"10.1080/10428194.2019.1709835","elsevierAuthor":"Kambhampati S.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-04-15","elsevierCoverDisplayDate":"15 April 2020","elsevierCitationCount":"4"},{"title":"1q21 gain but not t (4; 14) indicates inferior outcomes in multiple myeloma treated with bortezomib","googleId":"C1_ZSpvIw3IJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2019.1700503","googleCitationCount":4,"googleAuthor":"","doi":"10.1080/10428194.2019.1700503","elsevierAuthor":"Du C.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-04-15","elsevierCoverDisplayDate":"15 April 2020","elsevierCitationCount":"3"},{"title":"Reconstitution of humoral immunity and decreased risk of infections in patients with chronic lymphocytic leukemia treated with Bruton tyrosine kinase inhibitors","googleId":"bokJS40WVu8J","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1772477","googleCitationCount":2,"googleAuthor":"S Desai","doi":"10.1080/10428194.2020.1772477","elsevierAuthor":"Pleyer C.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-08-23","elsevierCoverDisplayDate":"23 August 2020","elsevierCitationCount":"2"},{"title":"Health-related quality-of-life results from the phase 3 OPTIMISMM study: pomalidomide, bortezomib, and low-dose dexamethasone versus bortezomib and low-dose …","googleId":"zxWtdcHDJ0EJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1747066","googleCitationCount":3,"googleAuthor":"M Dimopoulos","doi":"10.1080/10428194.2020.1747066","elsevierAuthor":"Weisel K.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-07-02","elsevierCoverDisplayDate":"2 July 2020","elsevierCitationCount":"1"},{"title":"LILRB4 expression in chronic myelomonocytic leukemia and myelodysplastic syndrome based on response to hypomethylating agents","googleId":"avrsO_qBSOUJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1723014","googleCitationCount":4,"googleAuthor":"CA Class","doi":"10.1080/10428194.2020.1723014","elsevierAuthor":"Chien K.S.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-05-11","elsevierCoverDisplayDate":"11 May 2020","elsevierCitationCount":"3"},{"title":"Exposure-safety and exposure-efficacy analyses of polatuzumab vedotin in patients with relapsed or refractory diffuse large B-cell lymphoma","googleId":"Cc8OAivYhYAJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1795154","googleCitationCount":3,"googleAuthor":"T Lu","doi":"10.1080/10428194.2020.1795154","elsevierAuthor":"Lu T.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-10-14","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"4"},{"title":"Burden of disease progression in patients with multiple myeloma in the US","googleId":"2H0Or8j3BJ4J","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2019.1648802","googleCitationCount":7,"googleAuthor":"E Yucel","doi":"10.1080/10428194.2019.1648802","elsevierAuthor":"Hagiwara M.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-01-02","elsevierCoverDisplayDate":"2 January 2020","elsevierCitationCount":"2"},{"title":"Bleomycin use in the treatment of Hodgkin lymphoma (HL): toxicity and outcomes in the modern era","googleId":"mauZlCckfmIJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2019.1663419","googleCitationCount":5,"googleAuthor":"K Taparra","doi":"10.1080/10428194.2019.1663419","elsevierAuthor":"Taparra K.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-01-28","elsevierCoverDisplayDate":"28 January 2020","elsevierCitationCount":"1"},{"title":"Venetoclax is safe and efficacious in relapsed/refractory AML","googleId":"bUCPV9q32FMJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1761964","googleCitationCount":4,"googleAuthor":"O Wolach","doi":"10.1080/10428194.2020.1761964","elsevierAuthor":"Ganzel C.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-07-28","elsevierCoverDisplayDate":"28 July 2020","elsevierCitationCount":"4"},{"title":"Incidence and risk factors associated with a syndrome of persistent cytopenias after CAR-T cell therapy (PCTT)","googleId":"ty3PGIfDcYQJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2019.1697814","googleCitationCount":9,"googleAuthor":"KV Komanduri","doi":"10.1080/10428194.2019.1697814","elsevierAuthor":"Nahas G.R.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-03-20","elsevierCoverDisplayDate":"20 March 2020","elsevierCitationCount":"4"},{"title":"Acute lymphoblastic leukemia mortality in Hispanic Americans","googleId":"v4zk5wN_2_EJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1779260","googleCitationCount":2,"googleAuthor":"","doi":"10.1080/10428194.2020.1779260","elsevierAuthor":"Shoag J.M.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-09-18","elsevierCoverDisplayDate":"November 2020","elsevierCitationCount":"0"},{"title":"Evidence for separate transformation to acute myeloid leukemia and blastic plasmacytoid dendritic cell neoplasm from a shared ancestral hematopoietic clone","googleId":"D2T5kqpWVlIJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1755856","googleCitationCount":3,"googleAuthor":"AS Kim","doi":"10.1080/10428194.2020.1755856","elsevierAuthor":"Luskin M.R.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-07-28","elsevierCoverDisplayDate":"28 July 2020","elsevierCitationCount":"1"},{"title":"The efficacy of venetoclax and hypomethylating agents in acute myeloid leukemia with extramedullary involvement","googleId":"81-YhjN9NcYJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1742908","googleCitationCount":3,"googleAuthor":"","doi":"10.1080/10428194.2020.1742908","elsevierAuthor":"Otoukesh S.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-07-02","elsevierCoverDisplayDate":"2 July 2020","elsevierCitationCount":"2"},{"title":"Cost-effectiveness of polatuzumab vedotin in relapsed or refractory diffuse large B-cell lymphoma","googleId":"xRDiMr7dhxcJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1808208","googleCitationCount":2,"googleAuthor":"KK Patel","doi":"10.1080/10428194.2020.1808208","elsevierAuthor":"Patel K.K.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"2"},{"title":"Comparison of venetoclax plus rituximab with B-cell receptor inhibitors in patients with relapsed/refractory chronic lymphocytic leukemia: a systematic review and …","googleId":"jMQ5VSHBPacJ","googleLink":"https://www.tandfonline.com/doi/full/10.1080/10428194.2019.1691193","googleCitationCount":4,"googleAuthor":"D Giannarelli","doi":"10.1080/10428194.2019.1691193","elsevierAuthor":"Molica S.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-03-20","elsevierCoverDisplayDate":"20 March 2020","elsevierCitationCount":"2"},{"title":"Survivorship in AML–a landmark analysis on the outcomes of acute myelogenous leukemia patients after maintaining complete remission for at least 3 years","googleId":"9y9yR6VNwFEJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1802450","googleCitationCount":2,"googleAuthor":"K Sasaki","doi":"10.1080/10428194.2020.1802450","elsevierAuthor":"Major C.K.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"2"},{"title":"Chidamide in combination with chemotherapy in refractory and relapsed T lymphoblastic lymphoma/leukemia","googleId":"bX_vkdyYhZsJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2019.1691195","googleCitationCount":4,"googleAuthor":"","doi":"10.1080/10428194.2019.1691195","elsevierAuthor":"Guan W.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-03-20","elsevierCoverDisplayDate":"20 March 2020","elsevierCitationCount":"4"},{"title":"Venous thromboembolism following pegaspargase in adults receiving antithrombin supplementation","googleId":"YWbsbsofAxQJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1765239","googleCitationCount":2,"googleAuthor":"","doi":"10.1080/10428194.2020.1765239","elsevierAuthor":"Freyer C.W.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-07-28","elsevierCoverDisplayDate":"28 July 2020","elsevierCitationCount":"1"},{"title":"PET positivity–the agony of choice: response assessment and interpretation of increased FDG uptake of residual mediastinal tissue after frontline therapy in Hodgkin …","googleId":"8a5Mpu5oR7sJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2019.1711076","googleCitationCount":3,"googleAuthor":"","doi":"10.1080/10428194.2019.1711076","elsevierAuthor":"Gillessen S.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-01-28","elsevierCoverDisplayDate":"28 January 2020","elsevierCitationCount":"2"},{"title":"Curative outcomes following blinatumomab in adults with minimal residual disease B-cell precursor acute lymphoblastic leukemia","googleId":"r5g3lBkT29oJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1780583","googleCitationCount":3,"googleAuthor":"","doi":"10.1080/10428194.2020.1780583","elsevierAuthor":"Gökbuget N.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-09-18","elsevierCoverDisplayDate":"November 2020","elsevierCitationCount":"2"},{"title":"Comparison of mutational profiles and clinical outcomes in patients with acute myeloid leukemia with mutated RUNX1 versus acute myeloid leukemia with myelodysplasia …","googleId":"IH9Nsk1BOugJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1723016","googleCitationCount":2,"googleAuthor":"S Yun","doi":"10.1080/10428194.2020.1723016","elsevierAuthor":"Nguyen L.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-05-11","elsevierCoverDisplayDate":"11 May 2020","elsevierCitationCount":"2"},{"title":"Dexamethasone, oxaliplatin and cytarabine (R-DHAOx) as salvage and stem cells mobilizing therapy in relapsed/refractory diffuse large B cell lymphomas","googleId":"Ge3U-_84kJgJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2019.1658102","googleCitationCount":6,"googleAuthor":"","doi":"10.1080/10428194.2019.1658102","elsevierAuthor":"Manconi L.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-01-02","elsevierCoverDisplayDate":"2 January 2020","elsevierCitationCount":"2"},{"title":"Daratumumab as successful initial therapy for AL amyloidosis with nerve involvement","googleId":"BOMudxEfwRYJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1737688","googleCitationCount":3,"googleAuthor":"A Dispenzieri","doi":"10.1080/10428194.2020.1737688","elsevierAuthor":"Deshpande S.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-06-06","elsevierCoverDisplayDate":"6 June 2020","elsevierCitationCount":"3"},{"title":"Treatment strategies and risk of central nervous system recurrence in high-grade B-cell and Burkitt lymphoma","googleId":"uX1w8FRkgVwJ","googleLink":"https://www.tandfonline.com/doi/full/10.1080/10428194.2019.1654097","googleCitationCount":7,"googleAuthor":"","doi":"10.1080/10428194.2019.1654097","elsevierAuthor":"Decker D.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-01-02","elsevierCoverDisplayDate":"2 January 2020","elsevierCitationCount":"4"},{"title":"Pretreatment SUVmax may influence the clinical benefit of BR over R-CHOP in patients with previously untreated FL","googleId":"4ZTPVb7J7dEJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1716221","googleCitationCount":2,"googleAuthor":"P Strati","doi":"10.1080/10428194.2020.1716221","elsevierAuthor":"Strati P.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-05-11","elsevierCoverDisplayDate":"11 May 2020","elsevierCitationCount":"1"},{"title":"Differentiation of acute myeloid leukemia (AML) cells with ATRA reduces 18F-FDG uptake and increases sensitivity towards ABT-737-induced apoptosis","googleId":"ZdSXmRY0v5MJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1839648","googleCitationCount":1,"googleAuthor":"","doi":"10.1080/10428194.2020.1839648","elsevierAuthor":"Buschner G.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"1"},{"title":"Modified CLL international prognostic index (CLL-LIPI) using lymphocyte doubling time (LDT) in place of IgHV mutation status in resource-limited settings predicts time …","googleId":"m3uCJbTzpfMJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1719099","googleCitationCount":5,"googleAuthor":"","doi":"10.1080/10428194.2020.1719099","elsevierAuthor":"Lad D.P.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-05-11","elsevierCoverDisplayDate":"11 May 2020","elsevierCitationCount":"4"},{"title":"A phase 1, open-label, single-dose study of the pharmacokinetics of zanubrutinib in subjects with varying degrees of hepatic impairment","googleId":"qGx-qtCI6MMJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1719097","googleCitationCount":3,"googleAuthor":"","doi":"10.1080/10428194.2020.1719097","elsevierAuthor":"Ou Y.C.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-05-11","elsevierCoverDisplayDate":"11 May 2020","elsevierCitationCount":"4"},{"title":"STAT3, tumor microenvironment, and microvessel density in diffuse large B cell lymphomas","googleId":"el8M2d2JdqcJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2019.1678154","googleCitationCount":4,"googleAuthor":"G Ingravallo","doi":"10.1080/10428194.2019.1678154","elsevierAuthor":"Tamma R.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-02-23","elsevierCoverDisplayDate":"23 February 2020","elsevierCitationCount":"2"},{"title":"Prolonged administration of low-dose cytarabine and thioguanine in elderly patients with acute myeloid leukaemia (AML) achieves high complete remission rates and …","googleId":"_XQiCuikdnIJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2019.1697876","googleCitationCount":3,"googleAuthor":"","doi":"10.1080/10428194.2019.1697876","elsevierAuthor":"Arthur C.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-03-20","elsevierCoverDisplayDate":"20 March 2020","elsevierCitationCount":"2"},{"title":"Long-term outcomes of patients treated with an EPOCHL regimen as first-line chemotherapy for newly diagnosed extranodal natural killer/T-cell lymphoma: a …","googleId":"ZlcBnKvBRM0J","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2019.1663421","googleCitationCount":5,"googleAuthor":"","doi":"10.1080/10428194.2019.1663421","elsevierAuthor":"Wei L.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-01-28","elsevierCoverDisplayDate":"28 January 2020","elsevierCitationCount":"5"},{"title":"Clinical outcomes of adults with hemophagocytic lymphohistiocytosis treated with the HLH-04 protocol: a retrospective analysis","googleId":"sz9ldfIMBvcJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1737684","googleCitationCount":3,"googleAuthor":"","doi":"10.1080/10428194.2020.1737684","elsevierAuthor":"Bubik R.J.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-06-06","elsevierCoverDisplayDate":"6 June 2020","elsevierCitationCount":"1"},{"title":"Induction of leukemic stem cell differentiation by aryl hydrocarbon receptor agonist and synergy with gilteritinib in FLT3-ITD+ acute myeloid leukemia","googleId":"UctdrlNnpGMJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1747062","googleCitationCount":3,"googleAuthor":"","doi":"10.1080/10428194.2020.1747062","elsevierAuthor":"Han H.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-07-02","elsevierCoverDisplayDate":"2 July 2020","elsevierCitationCount":"1"},{"title":"Impact of intensifying primary antibiotic prophylaxis in at-home autologous stem cell transplantation program for lymphoma patients","googleId":"5dHUdnB_N9EJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1742901","googleCitationCount":3,"googleAuthor":"LG Rodríguez-Lobato","doi":"10.1080/10428194.2020.1742901","elsevierAuthor":"Rodríguez-Lobato L.G.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-06-06","elsevierCoverDisplayDate":"6 June 2020","elsevierCitationCount":"2"},{"title":"Increased risk of osteoporosis following commonly used first-line treatments for lymphoma: a Danish Nationwide Cohort Study","googleId":"0fjg3PvJjl0J","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1723015","googleCitationCount":2,"googleAuthor":"J Baech","doi":"10.1080/10428194.2020.1723015","elsevierAuthor":"Baech J.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-05-11","elsevierCoverDisplayDate":"11 May 2020","elsevierCitationCount":"2"},{"title":"Survival improvement of patients with chronic lymphocytic leukemia (CLL) in routine care 1995–2017","googleId":"NrGoOzQv2jwJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2019.1680840","googleCitationCount":8,"googleAuthor":"","doi":"10.1080/10428194.2019.1680840","elsevierAuthor":"Weide R.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-02-23","elsevierCoverDisplayDate":"23 February 2020","elsevierCitationCount":"3"},{"title":"Incidence and risk of tumor lysis syndrome in patients with relapsed chronic lymphocytic leukemia (CLL) treated with venetoclax in routine clinical practice","googleId":"HT8D65j7ZtsJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1768384","googleCitationCount":3,"googleAuthor":"","doi":"10.1080/10428194.2020.1768384","elsevierAuthor":"Koehler A.B.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-08-23","elsevierCoverDisplayDate":"23 August 2020","elsevierCitationCount":"2"},{"title":"Efficacy and safety of single-agent pralatrexate for treatment of angioimmunoblastic T-cell lymphoma after failure of first line therapy: a pooled analysis","googleId":"cHDFkzjkFYMJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1765232","googleCitationCount":2,"googleAuthor":"","doi":"10.1080/10428194.2020.1765232","elsevierAuthor":"Zhu J.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-07-28","elsevierCoverDisplayDate":"28 July 2020","elsevierCitationCount":"2"},{"title":"Clinical outcomes with low dose anti-thymocyte globulin in patients undergoing matched unrelated donor allogeneic hematopoietic cell transplantation","googleId":"EQJDjEVOth4J","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1747067","googleCitationCount":2,"googleAuthor":"T Jain","doi":"10.1080/10428194.2020.1747067","elsevierAuthor":"Mountjoy L.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-07-02","elsevierCoverDisplayDate":"2 July 2020","elsevierCitationCount":"2"},{"title":"Lenalidomide maintenance after second autologous stem cell transplant improves overall survival in multiple myeloma","googleId":"RI5GCFeVoiYJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1749603","googleCitationCount":3,"googleAuthor":"D Modi","doi":"10.1080/10428194.2020.1749603","elsevierAuthor":"Modi D.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-07-02","elsevierCoverDisplayDate":"2 July 2020","elsevierCitationCount":"2"},{"title":"Risk factors for venous thromboembolism in hospitalized patients with hematological malignancy: an analysis of the National Inpatient Sample, 2011–2015","googleId":"2uGslHTsyy8J","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2019.1666380","googleCitationCount":4,"googleAuthor":"V Bakalov","doi":"10.1080/10428194.2019.1666380","elsevierAuthor":"Bakalov V.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-01-28","elsevierCoverDisplayDate":"28 January 2020","elsevierCitationCount":"3"},{"title":"Peripheral T-cell lymphomas as fingolimod-associated lymphoproliferative disorder for patients with multiple sclerosis-case report with literature review","googleId":"NZOZ2Z_QTzMJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2019.1691197","googleCitationCount":4,"googleAuthor":"","doi":"10.1080/10428194.2019.1691197","elsevierAuthor":"Kawai H.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-03-20","elsevierCoverDisplayDate":"20 March 2020","elsevierCitationCount":"1"},{"title":"Prevalence and effects of polypharmacy on overall survival in acute myeloid leukemia","googleId":"Emd0j0LFByIJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1737687","googleCitationCount":4,"googleAuthor":"P Dhakal","doi":"10.1080/10428194.2020.1737687","elsevierAuthor":"Dhakal P.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-06-06","elsevierCoverDisplayDate":"6 June 2020","elsevierCitationCount":"2"},{"title":"Incidence and characterization of fungal infections in chronic lymphocytic leukemia patients receiving ibrutinib","googleId":"-THfVvtkL7YJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1775215","googleCitationCount":2,"googleAuthor":"SL Aitken","doi":"10.1080/10428194.2020.1775215","elsevierAuthor":"Frei M.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-08-23","elsevierCoverDisplayDate":"23 August 2020","elsevierCitationCount":"2"},{"title":"A retrospective study on prephase therapy prior to definitive multiagent chemotherapy in aggressive lymphomas","googleId":"l2YSoaMlVhsJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1725505","googleCitationCount":2,"googleAuthor":"X Tan","doi":"10.1080/10428194.2020.1725505","elsevierAuthor":"Malpica L.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-05-11","elsevierCoverDisplayDate":"11 May 2020","elsevierCitationCount":"2"},{"title":"Refining patient selection for CAR T-cell therapy in aggressive large B-cell lymphoma","googleId":"Aj_KuaJlk-QJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2019.1691201","googleCitationCount":3,"googleAuthor":"","doi":"10.1080/10428194.2019.1691201","elsevierAuthor":"Cahill K.E.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-03-20","elsevierCoverDisplayDate":"20 March 2020","elsevierCitationCount":"1"},{"title":"Low absolute CD4+ T cell counts in peripheral blood predict poor prognosis in patients with newly diagnosed multiple myeloma","googleId":"y2u8ny-jDfgJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1751840","googleCitationCount":2,"googleAuthor":"X Qu","doi":"10.1080/10428194.2020.1751840","elsevierAuthor":"Gu Y.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-07-02","elsevierCoverDisplayDate":"2 July 2020","elsevierCitationCount":"2"},{"title":"Outcome of relapsed/refractory diffuse large B-cell lymphoma patients treated with polatuzumab vedotin-based therapy: real-life experience","googleId":"lJ_OTZjEHLYJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1824069","googleCitationCount":2,"googleAuthor":"","doi":"10.1080/10428194.2020.1824069","elsevierAuthor":"Segman Y.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"2021","elsevierCitationCount":"1"},{"title":"Radiation therapy for salivary gland MALT lymphoma: ultra-low dose treatment achieves encouraging early outcomes and spares salivary function","googleId":"6N97TdcUmQoJ","googleLink":"https://www.tandfonline.com/doi/full/10.1080/10428194.2019.1644333","googleCitationCount":4,"googleAuthor":"","doi":"10.1080/10428194.2019.1644333","elsevierAuthor":"Gunther J.R.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-01-02","elsevierCoverDisplayDate":"2 January 2020","elsevierCitationCount":"4"},{"title":"An effective early death scoring system for predicting early death risk in de novo acute promyelocytic leukemia","googleId":"BXq8Jn5PXoEJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1742910","googleCitationCount":2,"googleAuthor":"","doi":"10.1080/10428194.2020.1742910","elsevierAuthor":"Cai P.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-07-02","elsevierCoverDisplayDate":"2 July 2020","elsevierCitationCount":"2"},{"title":"Outcomes of patients with up to 6 years of follow-up from a phase 2 study of idelalisib for relapsed indolent lymphomas","googleId":"JeXKpzKLDZAJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1855344","googleCitationCount":1,"googleAuthor":"ND Wagner-Johnston","doi":"10.1080/10428194.2020.1855344","elsevierCitationCount":0},{"title":"Emerging role of histone deacetylase inhibitors in the treatment of diffuse large B-cell lymphoma","googleId":"OuBt_oO3y0IJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2019.1691194","googleCitationCount":3,"googleAuthor":"","doi":"10.1080/10428194.2019.1691194","elsevierAuthor":"Wang M.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-03-20","elsevierCoverDisplayDate":"20 March 2020","elsevierCitationCount":"2"},{"title":"Distinct clinical characteristics at diagnosis in patients with late relapses compared with early relapses of diffuse large B-cell lymphoma treated with R-CHOP","googleId":"YB8DC3_nNS4J","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2019.1709831","googleCitationCount":3,"googleAuthor":"JY Hong","doi":"10.1080/10428194.2019.1709831","elsevierAuthor":"Kang J.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-04-15","elsevierCoverDisplayDate":"15 April 2020","elsevierCitationCount":"2"},{"title":"Relative efficacy of treatment options in transplant-ineligible newly diagnosed multiple myeloma: results from a systematic literature review and network meta-analysis","googleId":"jBPBrSseb4UJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2019.1683736","googleCitationCount":3,"googleAuthor":"K Ramasamy","doi":"10.1080/10428194.2019.1683736","elsevierAuthor":"Ramasamy K.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-02-23","elsevierCoverDisplayDate":"23 February 2020","elsevierCitationCount":"2"},{"title":"A matching-adjusted indirect treatment comparison (MAIC) of daratumumab–bortezomib–melphalan–prednisone (D-VMP) versus lenalidomide–dexamethasone …","googleId":"e0H1ggE_9gAJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2019.1682571","googleCitationCount":3,"googleAuthor":"MA Dimopoulos","doi":"10.1080/10428194.2019.1682571","elsevierAuthor":"Dimopoulos M.A.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-02-23","elsevierCoverDisplayDate":"23 February 2020","elsevierCitationCount":"2"},{"title":"Supportive care medications coinciding with chemotherapy among children with hematologic malignancy","googleId":"T7gtOYkzE6cJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1749604","googleCitationCount":1,"googleAuthor":"EY Enioutina","doi":"10.1080/10428194.2020.1749604","elsevierAuthor":"Biltaji E.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-07-02","elsevierCoverDisplayDate":"2 July 2020","elsevierCitationCount":"0"},{"title":"The treatment of adolescents and young adults with acute lymphoblastic leukemia","googleId":"sWBZLNlrECwJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2019.1658103","googleCitationCount":3,"googleAuthor":"R Hanna","doi":"10.1080/10428194.2019.1658103","elsevierAuthor":"Advani A.S.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-01-02","elsevierCoverDisplayDate":"2 January 2020","elsevierCitationCount":"2"},{"title":"Consolidation outcomes in CPX-351 versus cytarabine/daunorubicin-treated older patients with high-risk/secondary acute myeloid leukemia","googleId":"CC9agv79kiMJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2019.1688320","googleCitationCount":5,"googleAuthor":"","doi":"10.1080/10428194.2019.1688320","elsevierAuthor":"Kolitz J.E.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-02-23","elsevierCoverDisplayDate":"23 February 2020","elsevierCitationCount":"2"},{"title":"Clinical outcomes with fixed-duration therapy (UK real-world data) compared with continuous lenalidomide and low-dose dexamethasone therapy (FIRST trial; MM …","googleId":"dAzlY7vnWlMJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2019.1683737","googleCitationCount":3,"googleAuthor":"F Djebbari","doi":"10.1080/10428194.2019.1683737","elsevierAuthor":"Sharpley F.A.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-02-23","elsevierCoverDisplayDate":"23 February 2020","elsevierCitationCount":"2"},{"title":"Hypomagnesemia is associated with an increased risk of early clinical failure in patients with Burkitt lymphoma","googleId":"CYuyOzseRNcJ","googleLink":"https://www.tandfonline.com/doi/full/10.1080/10428194.2020.1759056","googleCitationCount":2,"googleAuthor":"J Abeykoon","doi":"10.1080/10428194.2020.1759056","elsevierAuthor":"Gile J.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-07-28","elsevierCoverDisplayDate":"28 July 2020","elsevierCitationCount":"0"},{"title":"Blinatumomab+ ponatinib for relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia in adults","googleId":"oBK57OVriH8J","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1844198","googleCitationCount":1,"googleAuthor":"E Raffoux","doi":"10.1080/10428194.2020.1844198","elsevierAuthor":"Couturier M.A.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Efficacy and safety of weekly carfilzomib (70 mg/m2), dexamethasone, and daratumumab (KdD70) is comparable to twice-weekly KdD56 while being a more …","googleId":"ASnqzXGT6TAJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1832672","googleCitationCount":1,"googleAuthor":"M Beksac","doi":"10.1080/10428194.2020.1832672","elsevierAuthor":"Leleu X.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"2021","elsevierCitationCount":"0"},{"title":"Clinical outcomes and characteristics of patients with TP53-mutated acute myeloid leukemia or myelodysplastic syndromes: a single center experience","googleId":"ojLbZtJVgYwJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1759051","googleCitationCount":2,"googleAuthor":"JP Bewersdorf","doi":"10.1080/10428194.2020.1759051","elsevierAuthor":"Bewersdorf J.P.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-07-28","elsevierCoverDisplayDate":"28 July 2020","elsevierCitationCount":"0"},{"title":"New developments in the field of mastocytosis and mast cell activation syndromes: a summary of the Annual Meeting of the European Competence Network on …","googleId":"mKr9ue9H7LwJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2019.1703974","googleCitationCount":2,"googleAuthor":"","doi":"10.1080/10428194.2019.1703974","elsevierAuthor":"Arock M.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-04-15","elsevierCoverDisplayDate":"15 April 2020","elsevierCitationCount":"1"},{"title":"Following in the footsteps of acute myeloid leukemia: are we witnessing the start of a therapeutic revolution for higher-risk myelodysplastic syndromes?","googleId":"6AwlSefwPccJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1761968","googleCitationCount":2,"googleAuthor":"JP Bewersdorf","doi":"10.1080/10428194.2020.1761968","elsevierAuthor":"Bewersdorf J.P.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-08-23","elsevierCoverDisplayDate":"23 August 2020","elsevierCitationCount":"2"},{"title":"Concurrent chronic lymphocytic leukemia/small lymphocytic lymphoma and hairy cell leukemia: clinical, pathologic and molecular features","googleId":"PZ7Dfs3yjawJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1797007","googleCitationCount":1,"googleAuthor":"","doi":"10.1080/10428194.2020.1797007","elsevierAuthor":"Obiorah I.E.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"1"},{"title":"The triptych of mixed histiocytosis: a systematic review of 105 cases and proposed clinical classification","googleId":"pBxZrpChnZ8J","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1824070","googleCitationCount":1,"googleAuthor":"","doi":"10.1080/10428194.2020.1824070","elsevierAuthor":"Bonometti A.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"2021","elsevierCitationCount":"0"},{"title":"Management of multiple myeloma during COVID-19 pandemic","googleId":"DfRa8oFn6gUJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S2213048920300182","googleCitationCount":3,"googleAuthor":"R Fonseca","doi":"10.1016/j.lrr.2020.100212","elsevierAuthor":"Jethava Y.S.","publicationName":"Leukemia Research Reports","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"1"},{"title":"Richter's transformation in patients with chronic lymphocytic leukaemia: a Nationwide Epidemiological Study","googleId":"_qmCtRJOTzgJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1719092","googleCitationCount":3,"googleAuthor":"","doi":"10.1080/10428194.2020.1719092","elsevierAuthor":"Ben-Dali Y.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-05-11","elsevierCoverDisplayDate":"11 May 2020","elsevierCitationCount":"0"},{"title":"Higher infiltration of intratumoral CD25+ FOXP3+ lymphocytes correlates with a favorable prognosis in patients with diffuse large B-cell lymphoma","googleId":"wWLNG525oXEJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1817438","googleCitationCount":1,"googleAuthor":"LJ Medeiros","doi":"10.1080/10428194.2020.1817438","elsevierAuthor":"Chang C.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"2021","elsevierCitationCount":"1"},{"title":"Primary immunodeficiencies and lymphoma: a systematic review of literature","googleId":"t-DKFnIrTp0J","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2019.1672056","googleCitationCount":3,"googleAuthor":"","doi":"10.1080/10428194.2019.1672056","elsevierAuthor":"Herber M.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-01-28","elsevierCoverDisplayDate":"28 January 2020","elsevierCitationCount":"2"},{"title":"Lower vancomycin trough levels in adults undergoing unrelated cord blood transplantation","googleId":"3JgN6Xfs4YoJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1834096","googleCitationCount":1,"googleAuthor":"","doi":"10.1080/10428194.2020.1834096","elsevierAuthor":"Yasu T.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"2021","elsevierCitationCount":"1"},{"title":"The paradoxical prognostic role of 1q21 Gain/Amplification in multiple myeloma: every coin has two sides","googleId":"SmbhqVUT0hQJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1772473","googleCitationCount":1,"googleAuthor":"","doi":"10.1080/10428194.2020.1772473","elsevierAuthor":"Xu J.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-08-23","elsevierCoverDisplayDate":"23 August 2020","elsevierCitationCount":"1"},{"title":"Healthcare resource utilization in myeloproliferative neoplasms: a population-based study from Ontario, Canada","googleId":"ScAFaDpB5TIJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1749607","googleCitationCount":1,"googleAuthor":"J Iqbal","doi":"10.1080/10428194.2020.1749607","elsevierAuthor":"Bankar A.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-07-02","elsevierCoverDisplayDate":"2 July 2020","elsevierCitationCount":"1"},{"title":"Combination of the dual PIM/PI3-kinase inhibitor IBL-202 and venetoclax is effective in diffuse large B-cell lymphoma","googleId":"5YRe5D8Z-D8J","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1795156","googleCitationCount":1,"googleAuthor":"G Best","doi":"10.1080/10428194.2020.1795156","elsevierAuthor":"Gifford G.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"1"},{"title":"Safety and efficacy of four cycles of Brentuximab Vedotin as consolidation after autologous peripheral stem cell transplantation in relapsed/refractory Hodgkin …","googleId":"NGJrk_f52swJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1728755","googleCitationCount":2,"googleAuthor":"R Massoud","doi":"10.1080/10428194.2020.1728755","elsevierAuthor":"Kort J.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-06-06","elsevierCoverDisplayDate":"6 June 2020","elsevierCitationCount":"1"},{"title":"Cardiovascular mortality among chronic myeloid leukemia patients in the pre-tyrosine kinase inhibitor (TKI) and TKI eras: a Surveillance, Epidemiology and End …","googleId":"3hhYpSqhOtQJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2019.1711074","googleCitationCount":1,"googleAuthor":"Q Wang","doi":"10.1080/10428194.2019.1711074","elsevierAuthor":"Wang Q.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-04-15","elsevierCoverDisplayDate":"15 April 2020","elsevierCitationCount":"1"},{"title":"Development and validation of the AML-QOL: a quality of life instrument for patients with acute myeloid leukemia","googleId":"33iGkkbECUAJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2019.1709838","googleCitationCount":3,"googleAuthor":"","doi":"10.1080/10428194.2019.1709838","elsevierAuthor":"Buckley S.A.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-04-15","elsevierCoverDisplayDate":"15 April 2020","elsevierCitationCount":"3"},{"title":"A systematic review of outcomes after stem cell transplantation in acute lymphoblastic leukemia with or without measurable residual disease","googleId":"Ds3D-AYlbSsJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2019.1709834","googleCitationCount":1,"googleAuthor":"Z Cong","doi":"10.1080/10428194.2019.1709834","elsevierAuthor":"Shah S.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-04-15","elsevierCoverDisplayDate":"15 April 2020","elsevierCitationCount":"1"},{"title":"Autograft cellular composition and outcome in NHL patients: results of the prospective multicenter GOA study","googleId":"Apk0VVidSjUJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1762879","googleCitationCount":1,"googleAuthor":"","doi":"10.1080/10428194.2020.1762879","elsevierAuthor":"Turunen A.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-07-28","elsevierCoverDisplayDate":"28 July 2020","elsevierCitationCount":"1"},{"title":"No advantage of Imatinib in combination with hydroxyurea over Imatinib monotherapy: a study of the East German Study Group (OSHO) and the German CML study …","googleId":"efvVMp5ds90J","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1786556","googleCitationCount":1,"googleAuthor":"A Gil","doi":"10.1080/10428194.2020.1786556","elsevierAuthor":"Lange T.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"A low lymphocyte-to-monocyte ratio is an independent predictor of poorer survival and higher risk of histological transformation in follicular lymphoma","googleId":"-ydxN8OUx-EJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1821010","googleCitationCount":1,"googleAuthor":"P Mozas","doi":"10.1080/10428194.2020.1821010","elsevierAuthor":"Mozas P.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"2021","elsevierCitationCount":"1"},{"title":"Long noncoding RNA LINC00467 facilitates the progression of acute myeloid leukemia by targeting the miR-339/SKI pathway","googleId":"GxpGxT63xFkJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1832667","googleCitationCount":2,"googleAuthor":"","doi":"10.1080/10428194.2020.1832667","elsevierAuthor":"Lu J.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"2021","elsevierCitationCount":"0"},{"title":"Hemoglobin and C-reactive protein levels as predictive factors for long-term successful glucocorticoid treatment for multicentric Castleman's disease","googleId":"Epx2kS_hzJ4J","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1834094","googleCitationCount":2,"googleAuthor":"","doi":"10.1080/10428194.2020.1834094","elsevierAuthor":"Ebisawa K.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"1"},{"title":"Primary refractory multiple myeloma: a real-world experience with 85 cases","googleId":"g_baKtWPLlcJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1788014","googleCitationCount":1,"googleAuthor":"A Jurczyszyn","doi":"10.1080/10428194.2020.1788014","elsevierAuthor":"Jurczyszyn A.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-10-14","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"1"},{"title":"Continuous high-dose ivermectin appears to be safe in patients with acute myelogenous leukemia and could inform clinical repurposing for COVID-19 infection","googleId":"3YQUfn26IQ8J","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1786559","googleCitationCount":3,"googleAuthor":"LJ Gregianin","doi":"10.1080/10428194.2020.1786559","elsevierAuthor":"de Castro C.G.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-08-23","elsevierCoverDisplayDate":"23 August 2020","elsevierCitationCount":"0"},{"title":"Angioimmunoblastic T-cell lymphoma in Taiwan reveals worse progression-free survival for RHOA G17V mutated subtype","googleId":"_HPJlIAWdAsJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2019.1702179","googleCitationCount":2,"googleAuthor":"LY Hung","doi":"10.1080/10428194.2019.1702179","elsevierAuthor":"Hsu Y.T.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-04-15","elsevierCoverDisplayDate":"15 April 2020","elsevierCitationCount":"1"},{"title":"Colonic mucosa-associated lymphoid tissue lymphoma: a case series","googleId":"eEbpGSN7eO4J","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2019.1686501","googleCitationCount":2,"googleAuthor":"F Lemonnier","doi":"10.1080/10428194.2019.1686501","elsevierAuthor":"Tannoury J.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-02-23","elsevierCoverDisplayDate":"23 February 2020","elsevierCitationCount":"1"},{"title":"Mutations of FLT3 receptor affect its surface glycosylation, intracellular localization, and downstream signaling","googleId":"OdudN-6RA2wJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S2213048919300500","googleCitationCount":2,"googleAuthor":"","doi":"10.1016/j.lrr.2019.100187","elsevierAuthor":"Takahashi S.","publicationName":"Leukemia Research Reports","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"1"},{"title":"Clonal evolution with acquisition of BCR-ABL1 in refractory acute myeloid leukemia post therapy with FLT3-inhibitor","googleId":"pfL2AQHBc-IJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1797008","googleCitationCount":2,"googleAuthor":"B Thakral","doi":"10.1080/10428194.2020.1797008","elsevierAuthor":"Thakral B.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"1"},{"title":"Nationwide epidemiological survey of familial myelodysplastic syndromes/acute myeloid leukemia in Japan: a multicenter retrospective study","googleId":"8OVc9axxUpUJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1734595","googleCitationCount":1,"googleAuthor":"J Koya","doi":"10.1080/10428194.2020.1734595","elsevierAuthor":"Takaoka K.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-06-06","elsevierCoverDisplayDate":"6 June 2020","elsevierCitationCount":"0"},{"title":"Poor graft function after T cell-depleted allogeneic hematopoietic stem cell transplant","googleId":"9RkGpFAECboJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1789622","googleCitationCount":1,"googleAuthor":"R Hafez","doi":"10.1080/10428194.2020.1789622","elsevierAuthor":"Reich-Slotky R.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"1"},{"title":"Consolidative or palliative whole brain radiation for secondary CNS diffuse large B-Cell lymphoma","googleId":"zCP151BOdfsJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1821014","googleCitationCount":1,"googleAuthor":"","doi":"10.1080/10428194.2020.1821014","elsevierAuthor":"Walburn T.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"2021","elsevierCitationCount":"1"},{"title":"The prognostic value of CD2, CD4, and HLA-DR expression and FLT3-ITD mutation in adult acute promyelocytic leukemia","googleId":"ZmdWudQnmbMJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1768386","googleCitationCount":1,"googleAuthor":"","doi":"10.1080/10428194.2020.1768386","elsevierAuthor":"Nie L.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-08-23","elsevierCoverDisplayDate":"23 August 2020","elsevierCitationCount":"1"},{"title":"Metabolic tumor volume, cancer cell fraction, and prognosis–the case of T-cell/histiocyte-rich large B-cell lymphoma","googleId":"b1bXx-Yt0xUJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1713319","googleCitationCount":1,"googleAuthor":"","doi":"10.1080/10428194.2020.1713319","elsevierAuthor":"Schmitz C.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-05-11","elsevierCoverDisplayDate":"11 May 2020","elsevierCitationCount":"1"},{"title":"Ponatinib-based therapy in adults with relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia: results of the real-life OPAL study","googleId":"UM1vdNOOaV4J","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1762876","googleCitationCount":1,"googleAuthor":"","doi":"10.1080/10428194.2020.1762876","elsevierAuthor":"Tavitian S.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-07-28","elsevierCoverDisplayDate":"28 July 2020","elsevierCitationCount":"1"},{"title":"The effect of ibrutinib on neutrophil and γδ T cell functions","googleId":"n8kvr__jj_IJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1753043","googleCitationCount":2,"googleAuthor":"","doi":"10.1080/10428194.2020.1753043","elsevierAuthor":"Risnik D.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-08-23","elsevierCoverDisplayDate":"23 August 2020","elsevierCitationCount":"1"},{"title":"Prognostic value of the metabolic bulk volume in patients with diffuse large B-cell lymphoma on baseline 18F-FDG PET-CT","googleId":"gdCNq2i1rZYJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1728750","googleCitationCount":1,"googleAuthor":"","doi":"10.1080/10428194.2020.1728750","elsevierAuthor":"Delaby G.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-06-06","elsevierCoverDisplayDate":"6 June 2020","elsevierCitationCount":"1"},{"title":"Identification of high-risk monomorphic post-transplant lymphoproliferative disorder following solid organ transplantation","googleId":"vnDI1Qte5KEJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1821006","googleCitationCount":1,"googleAuthor":"","doi":"10.1080/10428194.2020.1821006","elsevierAuthor":"Voorhees T.J.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"2021","elsevierCitationCount":"0"},{"title":"Association of genes ARID5B, CEBPE and folate pathway with acute lymphoblastic leukemia in a population from the Brazilian Amazon region","googleId":"rXfmoLSdwjAJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S2213048919300512","googleCitationCount":3,"googleAuthor":"","doi":"10.1016/j.lrr.2019.100188","elsevierAuthor":"Carvalho D.C.","publicationName":"Leukemia Research Reports","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"1"},{"title":"Real world data on histological transformation in patients with follicular lymphoma: incidence, clinico-pathological risk factors and outcome in a nationwide Danish …","googleId":"aMFKBrodm-kJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1779254","googleCitationCount":2,"googleAuthor":"","doi":"10.1080/10428194.2020.1779254","elsevierAuthor":"Madsen C.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-09-18","elsevierCoverDisplayDate":"November 2020","elsevierCitationCount":"2"},{"title":"Different outcomes for transplant-eligible newly diagnosed multiple myeloma patients in Latin America according to the public versus private management: a GELAMM …","googleId":"_ECXxkb4ky0J","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1804558","googleCitationCount":1,"googleAuthor":"N Schutz","doi":"10.1080/10428194.2020.1804558","elsevierAuthor":"Peña C.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"1"},{"title":"Fc gamma receptor expression serves as prognostic and diagnostic factor in AML","googleId":"uW-OfrhtV6UJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1775208","googleCitationCount":1,"googleAuthor":"","doi":"10.1080/10428194.2020.1775208","elsevierAuthor":"Heitmann J.S.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-08-23","elsevierCoverDisplayDate":"23 August 2020","elsevierCitationCount":"0"},{"title":"Healthcare utilization in patients with higher-risk MDS/low-blast count AML treated with azacitidine in the 'real-world'","googleId":"pvCG--6_TKwJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1723012","googleCitationCount":1,"googleAuthor":"","doi":"10.1080/10428194.2020.1723012","elsevierAuthor":"Mozessohn L.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-05-11","elsevierCoverDisplayDate":"11 May 2020","elsevierCitationCount":"0"},{"title":"Changing landscape of frontline therapy in chronic lymphocytic leukemia","googleId":"W2mtQv28BJEJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2019.1688321","googleCitationCount":2,"googleAuthor":"SA Bhat","doi":"10.1080/10428194.2019.1688321","elsevierAuthor":"Bhat S.A.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-02-23","elsevierCoverDisplayDate":"23 February 2020","elsevierCitationCount":"1"},{"title":"Timing of allogeneic hematopoietic cell transplantation (alloHCT) for chronic myeloid leukemia (CML) patients","googleId":"KVznLYZiWl4J","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1783444","googleCitationCount":1,"googleAuthor":"X Huang","doi":"10.1080/10428194.2020.1783444","elsevierAuthor":"Hu B.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"1"},{"title":"Recent developments and persisting challenges in the prevention and treatment of venous thromboembolism in patients with hematological malignancies","googleId":"aR2CILWKTy0J","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1713321","googleCitationCount":1,"googleAuthor":"","doi":"10.1080/10428194.2020.1713321","elsevierAuthor":"Sorigue M.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-05-11","elsevierCoverDisplayDate":"11 May 2020","elsevierCitationCount":"2"},{"title":"Measurable residual disease evaluated by flow cytometry using leukemia associated immune phenotypes following allogeneic stem cell transplantation is associated …","googleId":"42XkRwAqkFMJ","googleLink":"https://www.tandfonline.com/doi/full/10.1080/10428194.2019.1686500","googleCitationCount":2,"googleAuthor":"M Hara","doi":"10.1080/10428194.2019.1686500","elsevierAuthor":"Shimomura Y.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-02-23","elsevierCoverDisplayDate":"23 February 2020","elsevierCitationCount":"0"},{"title":"A prospective, crossover randomized trial of the optimal timing for leucovorin rescue after high-dose methotrexate management in adult non-Hodgkin's lymphoma …","googleId":"_oVztr7mrCYJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1747061","googleCitationCount":1,"googleAuthor":"","doi":"10.1080/10428194.2020.1747061","elsevierAuthor":"Peng C.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-07-02","elsevierCoverDisplayDate":"2 July 2020","elsevierCitationCount":"0"},{"title":"Final 5-year findings from the phase 3 HELIOS study of ibrutinib plus bendamustine and rituximab in patients with relapsed/refractory chronic lymphocytic leukemia …","googleId":"VjklbzA8vo8J","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1795159","googleCitationCount":3,"googleAuthor":"","doi":"10.1080/10428194.2020.1795159","elsevierAuthor":"Fraser G.A.M.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Trends in myeloma relative survival in Queensland by treatment era, age, place of residence, and socioeconomic status","googleId":"wgWGJ0ydjhQJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2019.1688322","googleCitationCount":2,"googleAuthor":"","doi":"10.1080/10428194.2019.1688322","elsevierAuthor":"Harwood M.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-02-23","elsevierCoverDisplayDate":"23 February 2020","elsevierCitationCount":"1"},{"title":"Phase I study of AR-42 and decitabine in acute myeloid leukemia","googleId":"si6grvOAsasJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1719095","googleCitationCount":3,"googleAuthor":"CC Coss","doi":"10.1080/10428194.2020.1719095","elsevierAuthor":"Liva S.G.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-05-11","elsevierCoverDisplayDate":"11 May 2020","elsevierCitationCount":"2"},{"title":"Lifitegrast ophthalmic solution for treatment of ocular chronic graft-versus-host disease","googleId":"tL3GtIstpF0J","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2019.1695049","googleCitationCount":3,"googleAuthor":"","doi":"10.1080/10428194.2019.1695049","elsevierAuthor":"Chhabra S.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-03-20","elsevierCoverDisplayDate":"20 March 2020","elsevierCitationCount":"3"},{"title":"Comparison of outpatient care following intensive induction versus post-remission chemotherapy for adults with acute myeloid leukemia and other high-grade myeloid …","googleId":"8fYDjtToaM0J","googleLink":"https://www.tandfonline.com/doi/full/10.1080/10428194.2020.1821008","googleCitationCount":1,"googleAuthor":"","doi":"10.1080/10428194.2020.1821008","elsevierAuthor":"Halpern A.B.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"2021","elsevierCitationCount":"0"},{"title":"Consolidation radiotherapy following positron emission tomography complete response in early-stage Hodgkin lymphoma: a meta-analysis","googleId":"dqmvFILQLssJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1725506","googleCitationCount":1,"googleAuthor":"","doi":"10.1080/10428194.2020.1725506","elsevierAuthor":"Shaikh P.M.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-06-06","elsevierCoverDisplayDate":"6 June 2020","elsevierCitationCount":"1"},{"title":"Genomic analysis of a familial myelodysplasia/acute myeloid leukemia and inherited RUNX1 mutations without a pre-existing platelet disorder","googleId":"4_4hxg-VLVAJ","googleLink":"https://www.tandfonline.com/doi/full/10.1080/10428194.2019.1648801","googleCitationCount":4,"googleAuthor":"","doi":"10.1080/10428194.2019.1648801","elsevierAuthor":"Prieto-Conde M.I.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-01-02","elsevierCoverDisplayDate":"2 January 2020","elsevierCitationCount":"2"},{"title":"Reduced-intensity fludarabine/melphalan confers similar survival to busulfan/fludarabine myeloablative regimens for patients with acute myeloid leukemia and …","googleId":"vS6e6547E3sJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1731498","googleCitationCount":1,"googleAuthor":"","doi":"10.1080/10428194.2020.1731498","elsevierAuthor":"DiMaggio E.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-06-06","elsevierCoverDisplayDate":"6 June 2020","elsevierCitationCount":"1"},{"title":"Safety of gemtuzumab ozogamicin as monotherapy or combination therapy in an expanded-access protocol for patients with relapsed or refractory acute myeloid …","googleId":"ZM4lMu9Ihn8J","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1742897","googleCitationCount":3,"googleAuthor":"R Aplenc","doi":"10.1080/10428194.2020.1742897","elsevierAuthor":"Wang E.S.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-07-02","elsevierCoverDisplayDate":"2 July 2020","elsevierCitationCount":"2"},{"title":"Chimeric antigen receptor T cells for treatment of transformed Waldenström macroglobulinemia","googleId":"SMhMkFUQtT4J","googleLink":"https://www.tandfonline.com/doi/full/10.1080/10428194.2019.1665668","googleCitationCount":5,"googleAuthor":"MY Mapara","doi":"10.1080/10428194.2019.1665668","elsevierAuthor":"Bansal R.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-01-28","elsevierCoverDisplayDate":"28 January 2020","elsevierCitationCount":"2"},{"title":"Machine learning derived genomics driven prognostication for acute myeloid leukemia with RUNX1-RUNX1T1","googleId":"XFkx8mkSJmsJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1798951","googleCitationCount":1,"googleAuthor":"","doi":"10.1080/10428194.2020.1798951","elsevierAuthor":"Shaikh A.F.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"1"},{"title":"Final safety and efficacy results from the CPX-351 early access program for older patients with high-risk or secondary acute myeloid leukemia","googleId":"s8vlAX3bGGIJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1725503","googleCitationCount":1,"googleAuthor":"","doi":"10.1080/10428194.2020.1725503","elsevierAuthor":"Roboz G.J.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-04-15","elsevierCoverDisplayDate":"15 April 2020","elsevierCitationCount":"1"},{"title":"Clinicopathologic characteristics and survival of patients with primary effusion lymphoma","googleId":"yvopAQP0hmMJ","googleLink":"https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1762881","googleCitationCount":1,"googleAuthor":"C Aguilar","doi":"10.1080/10428194.2020.1762881","elsevierAuthor":"Aguilar C.","publicationName":"Leukemia and Lymphoma","elsevierCoverDate":"2020-07-28","elsevierCoverDisplayDate":"28 July 2020","elsevierCitationCount":"1"}]